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Abstract 
Background 
Schizophrenia is treated as a single (continuous) disorder diagnosed according to reliable, 
internationally-accepted criteria, despite contention that its optimal structure may comprise 
multiple distinct entities labelled ‘schizophrenia’. 
 
Transcultural psychiatry studies that have examined the expression of schizophrenia 
across cultures have implicitly favoured the prevailing view that schizophrenia is universal, 
and consequently, that its structure is continuous. 
 
Transethnic schizophrenia samples can inform debate at every level of the diagnostic 
spectrum: (1) broad theoretical (universalist vs. relativist); (2) diagnostic (nosological vs. 
dimensional); (3) structure of psychosis generally; and (4) structure of schizophrenia 
specifically. While transethnic samples have been used (primarily from an anthropological 
perspective) to challenge DSM-IV at the two broader levels, little work has elucidated the 
more specific levels. Few transethnic psychiatric studies have incorporated current 
diagnostic knowledge to explore the expression of demographic, clinical, and symptom 
variables and inform debate regarding schizophrenia’s classification. 
 
Aims 
This thesis aims to: (1) compare and contrast the way ‘schizophrenia’ is experienced by 
three ethnically different populations, (2) identify significant demographic, clinical and 
symptom differences in these populations, (3) examine these differences in the context of 
their relevance to the structure of schizophrenia, and (4) identify dimensions and/or 
clusters based on these differences, both within and across these populations, which may 
contribute to the discourse on the diagnostic classification of schizophrenia.  
 
Methods 
Demographic, clinical and symptom variables were analysed, and frequencies of core 
DSM-IV schizophrenia diagnostic criteria were contrasted in ethnically-distinct 
schizophrenia/schizoaffective samples from Australia (n=821), Chennai, India (n=520) and 
the Iban of Sarawak (n=298). Statistical methods used included χ2, T-Tests, General 
Linear Models and Logistic Regression. Exploratory Factor Analysis, Latent Class 
Analysis, and Factor Mixture Modeling were used to attempt to identify deficit 
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schizophrenia (DS), which has been proposed as a stable, distinct schizophrenia subtype, 
in each sample, and the results were then tested using taxometric analyses.   
 
Results 
Significant differences in demographic and clinical characteristics were identified between 
sites: (1) more individuals were living alone in Australia than India or Sarawak; (2) drug 
use was lower in India than Australia or Sarawak; (3) duration of untreated psychosis 
(DUP) was longer in India than Australia or Sarawak; (4) the rate of schizoaffective 
disorder was lower in India than Australia or Sarawak; and (5) mean age at psychosis 
onset (AAO) was approximately six years older in Sarawak than Australia or India. 
 
More broadly, a distinct schizophrenia symptom profile was identified in the Sarawak 
sample. Compared with Australian and Indian populations, the Iban exhibit: low frequency 
of thought broadcast/insertion/withdrawal delusions, high frequency of auditory 
hallucinations and disorganized behaviour, with a comparatively short prodrome. 
 
Diagnostically, differences in both DSM-IV ‘criterion A’ symptom composition and content 
were apparent between sites. Indian individuals with schizophrenia reported negative 
symptoms more frequently than those in Australia or Sarawak, whereas individuals from 
Sarawak reported disorganized symptoms more frequently than other sites, in particular 
India. Delusions of control and thought broadcast, insertion or withdrawal were less 
frequent in Sarawak than Australia. Curiously, a subgroup of 20 Indian individuals with 
schizophrenia reported no lifetime delusions or hallucinations. Nine members of this 
subgroup no longer meet the criteria for schizophrenia when diagnosed using DSM-5 
criteria. 
 
When the DS subtype was modelled in the three samples, there was broad consistency in 
the structural appearance of the best-fitting models, with both single class (no evidence of 
a distinct DS class) and two class (demarcation of a potential DS class) models performing 
well. A category was identified within the Indian and Sarawak samples that resembled DS, 
while the distinction in Australia was less clear-cut. Taxometric analyses suggested a two 
class distribution within each population, with a larger ‘deficit’ class at each site. 
 
Conclusions 
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Overall, these results support schizophrenia not being a discrete, homogeneous condition. 
Some elements of individual experience and expression (individual socio-demographic 
and symptom variables, symptom profiles, diagnostic demarcations) differ between the 
three ethnically-distinct populations, whereas other elements (e.g. tentative evidence for a 
class resembling DS) appear stable across these samples. There is also evidence that 
some expressions are population-specific, for example the Indian subgroup (n=20) without 
positive symptoms. 
 
Whereas many differences in clinical phenotype can be explained by cultural factors, the 
older AAO finding in the Iban is a promising candidate for genetic studies in ethnically-
distinct populations, since the result is somewhat culturally counter-intuitive.     
 
Evidence generally supporting the universality of DS, albeit with a hybrid structure across 
these three ethnically-distinct populations contributes to the discourse on the latent 
structure and diagnostic classification of ‘schizophrenia’. 
 
Viewed in conjunction with evidence from recent genetic analyses, and mindful of the 
significant limitations on generalisability imposed by applying standardised assessment 
tools and diagnostic classifications across ethnic groups, these results expand our 
understanding of the nuances of schizophrenia and highlight the potential for comparing 
and contrasting transethnic schizophrenia samples to validate genetic clues, in order to 
better understand clinical heterogeneity. 
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Background and thesis outline 
The work undertaken in this thesis is necessarily grounded within the ‘no-mans-land’ 
between the disciplines of psychiatry and anthropology, although the thesis is undeniably 
and unapologetically conceptualised and operationalised from a psychiatry perspective. It 
is important however, to critically appraise and incorporate the contribution of anthropology 
to the topics of culture and classification, when analysing three ethnically distinct 
populations in seeking to modestly but meaningfully inform debate on the diagnostic 
classification of schizophrenia. 
 
Chapter One reviews the literature in several key areas relevant to this thesis, including: 
the classification of schizophrenia (historical and current); schizophrenia subtyping; the 
role of transethnic samples in research; and the operationalisation of culture (in 
schizophrenia classification and research more generally). 
 
Chapter Two details the establishment of cultural equivalence, data source equivalence, 
and data formatting equivalence across the three sites and samples examined in this 
thesis, as this is crucial to the validity of the results presented in subsequent chapters. Site 
characteristics and instruments used in subsequent chapters are discussed in detail. 
 
Chapter Three contrasts individual demographic and clinical characteristics in transethnic 
schizophrenia populations from Australia (n=821), India (n=520) and Sarawak, Malaysia 
(n=298) and proposes cultural explanations for identified site differences. From these the 
authors identify candidate variables free from significant cultural confounding that are 
hence suitable for inclusion in genetic analyses. 
 
Chapter Four broadens the search from individual characteristics to characteristic 
symptom profiles within populations, contrasting the Iban of Sarawak with both the Tamil 
Brahmin and proximal caste groups in Chennai, India, and a sample of European 
Caucasian ethnicity from Australia. 
 
Chapter Five broadens the search even further, contrasting, from a more anthropological 
perspective, both lifetime frequencies of DSM-IV criterion A (the core symptom criterion of 
the internationally recognized DSM classification system) symptoms and types/content of 
delusions and hallucinations in the three available transethnic schizophrenia populations to 
further elucidate clinical heterogeneity. 
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Chapter Six takes the knowledge accumulated in the previous three chapters and uses a 
targeted approach to attempt to statistically identify/validate a previously proposed subtype 
– deficit schizophrenia – within the three ethnically-distinct samples. 
 
Chapter Seven summarises the scope of the project, outlines the contributions to the 
literature made by the thesis, addresses important strengths and limitations of this work, 
considers application of this research (and its methods) to other settings, and maps out 
directions for future enquiry. 
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Chapter 1. General Introduction and Rationale 
History of diagnostic classification of schizophrenia 
“No aspect of any discipline is more fundamental than its classification capability” (Haier, 
1980: 417). 
 
Emil Kraepelin (1856-1926) used the term ‘dementia praecox’ to define a condition that 
was chronic in course and characterised by disorganisation and negative symptoms 
(Fischer and Carpenter, 2009). Eugen Bleuler (1857-1939) coined the term schizophrenia, 
which replaced dementia praecox in the literature (Sadock and Sadock, 2003). Although 
the existence of schizophrenia has been widely accepted in psychiatry for the past 
century, it has been a contested concept, as it has never been validated by biological 
markers, and consequently has never been ‘proven’ as a single disease entity (Dutta et al., 
2007). This uncertainty has been further complicated in recent decades because the key 
criteria for diagnosing schizophrenia in current diagnostic systems have diverged 
significantly from those relied on by Kraepelin and Bleuler. The incorporation of the 
Schneiderian and Langfeldt systems into modern diagnostic classification has tended to 
emphasise similarities between schizophrenia and bipolar disorder as key diagnostic 
markers, specifically psychotic symptoms, and sideline key differences such as 
disorganisation and avolition which were fundamental to Kraepelin and Bleuler (Fischer 
and Carpenter, 2009). 
 
Mood symptoms and schizophrenia 
Kasanin coined the term schizoaffective in 1933, and there has been a controversy ever 
since regarding the relationship between affective disorders and schizophrenia (Spitzer et 
al., 1978a). Both schizophrenia and schizoaffective disorder have generally been included 
in most schizophrenia linkage studies on the basis of tight definitions and evidence from 
multiple family studies showing that both disorders cluster in families ascertained through 
a proband with schizophrenia (Gershon et al., 1988; Kendler et al., 1993; Maier et al., 
1993; Taylor, 1992). 
 
Although researchers have tended to group schizoaffective disorder with schizophrenia the 
categorical distinction between schizophrenia and bipolar disorder remains problematic, as 
current epidemiological (Lichtenstein et al., 2009) and molecular genetic (Cross-Disorder 
Group of the Psychiatric Genomics Consortium et al., 2013; ISC, 2009) evidence suggest 
that the two conditions share genetic predisposition, challenging the dichotomous view of 
2 
 
functional psychoses (Craddock et al., 2009). This dichotomy has been widely accepted in 
Western psychiatry since the 1920s (Möller, 2008) and forms the foundation for the 
diagnosis of schizophrenia in both major current diagnostic systems, DSM-5 (APA, 2013a) 
and ICD-10 (WHO, 1992). 
 
The relationship between mood symptoms and schizophrenia is an important 
consideration in exploring cross-cultural variation in schizophrenia because in many non-
Western cultures there is no exclusive differentiation between thought and emotion (Lutz, 
1982), which are key differential concepts in the ‘Western’ classification of schizophrenia. 
Additionally, converting thoughts and feelings across languages can be difficult (Barrett, 
2004), which has implications for both the validity of diagnostic instruments used cross-
culturally and for the interpretation of comparative mood data obtained between cultures. 
 
Existing schizophrenia classification systems 
Although Kraepelin acknowledged the importance of culture in psychiatric diagnosis, and 
his 1903 voyage to the psychiatric institutions of Singapore and Java has been regarded 
as the foundation of transcultural psychiatry, schizophrenia as a clinical concept has both 
arisen and developed in a European and North American intellectual milieu (Jenkins and 
Barrett, 2004). Over the course of the 20th Century, diagnostic classification systems for 
schizophrenia developed in parallel in Europe and the United States. 
 
International Classification of Diseases 
The International Classification of Diseases (ICD) had its origins in Europe in the 1850s, 
although the first edition, then known as the International List of Causes of Death was 
adopted by the International Statistical Institute in 1893. The World Health Organisation 
(WHO) took responsibility for the ICD in 1948, when the manual’s sixth revision was 
published (WHO, 2010). 
The ICD is the international standard diagnostic classification for all general 
epidemiological, many health management purposes and clinical use. These include 
the analysis of the general health situation of population groups and monitoring of the 
incidence and prevalence of diseases and other health problems in relation to other 
variables such as the characteristics and circumstances of the individuals affected, 
reimbursement, resource allocation, quality and guidelines. 
It is used to classify diseases and other health problems recorded on many types of 
health and vital records including death certificates and health records. In addition to 
enabling the storage and retrieval of diagnostic information for clinical, 
epidemiological and quality purposes, these records also provide the basis for the 
compilation of national mortality and morbidity statistics by WHO Member States 
(WHO, 2010). 
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The current edition of the ICD is the tenth revision (ICD-10), released in 1992 and updated 
in 1999, with ICD-11 scheduled for release in approximately 2017 (WHO, 2015). Mental 
and behavioural disorders form one section of the system (Chapter V). Subsequent to the 
release of the ICD-10, several countries and regions have released their own adaptations, 
including the Chinese Classification of Mental Disorders, the Japanese Clinical 
Modification of ICD-10, the Cuban Glossary of Psychiatry, and the Latin American Guide 
for Psychiatric Diagnosis (Mezzich et al., 2001). Australia also has a version, The 
International Statistical Classification of Diseases and Related Health Problems: 10th 
Revision, Australian Modification (ICD-10-AM) (National Centre for Classification in Health, 
2000). An important addition to ICD-10 from a cultural viewpoint was the Diagnostic 
Criteria for Research (DCR-10), released in 1993 (WHO, 1993). 
 
Diagnostic and Statistical Manual of Mental Disorders 
The Diagnostic and Statistical Manual of Mental Disorders (DSM) is the series of 
diagnostic manuals produced by the American Psychiatric Association (APA). Some 
commentators regard DSM is the American adaptation of the ICD (Mezzich et al., 2001), 
particularly as the APA advises on the formulation of the ICD, and revisions of both 
manuals are undertaken concurrently (DSM-II and ICD-8 in 1968; DSM-III and ICD-9 in 
1979/80; DSM-IV and ICD-10 in 1993/94; and DSM-V and ICD-11 both being released 
between 2013 and 2017). 
 
The edition of the DSM used in the analyses presented in this thesis is the fourth revision 
(DSM-IV), released in 1994 (APA, 1994) and updated in 2000 (APA, 2000), which was 
current at the time of the sample recruitment and interviews for these studies. The fifth 
revision of the DSM was released in 2013 (APA, 2013a). This thesis primarily focuses on 
DSM-IV and DSM-IV TR, with reference to changes implemented in DSM-5 where 
appropriate. 
 
The validity of the empirical foundation supporting the DSM process has been robustly 
criticised. An overarching methodological criticism is that DSM does not use external 
validators such as quantitative biological measurements or psychological testing to 
evaluate diagnostic criteria or assess whether changes improve clinical validity (Dutta et 
al., 2007). With respect to schizophrenia there is little evidence for DSM’s operational 
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definition as the ‘true construct’ of schizophrenia (Gaebel and Zielasek, 2008). A detailed 
critique of DSM-IV, focussing on how it addresses cultural issues is presented below. 
 
Research Diagnostic Criteria 
The Research Diagnostic Criteria (RDC) were developed in the 1970s to enable 
researchers to apply a consistent set of criteria for the description or selection of subjects 
in research involving functional psychiatric illnesses including schizophrenia. Previously, 
both clinical work and research had suffered from inconsistencies in the inclusion and 
exclusion criteria for psychiatric diagnoses (criterion variance). The RDC stemmed from 
the diagnostic work carried out at the Washington University School of Medicine in St. 
Louis, which came to be known as the ‘Feighner criteria’ (Spitzer et al., 1978b). The RDC 
were developed after DSM-II, but directly preceded the publication of DSM-III, and formed 
the basis for the diagnostic classification of schizophrenia in that revision. Although the 
RDC were extensively used in schizophrenia research, they were superseded by ICD-10 
and DSM-IV. 
 
History of subtyping schizophrenia 
Substantial variability among individuals diagnosed with schizophrenia, even using ‘strict’ 
criteria, has always implied that schizophrenia may be a collection of disorders, with 
differing courses and etiologies (Haier, 1980). Kraepelin distinguished ‘catatonic’, 
‘hebephrenic’ and ‘paranoid’ subtypes, which came to be known as the ‘classic’ subtypes’. 
An effort was made in the formulation of the RDC, and subsequently the DSM-III to 
subtype schizophrenia in a reliable way, based on the phenomenology of the current 
episode. This effort produced the following subtypes: paranoid, disorganised, catatonic, 
mixed and residual (Spitzer et al., 1978b), which survived into DSM-IV, but were dropped 
from DSM-5 due to their limited diagnostic stability, low reliability, and poor validity (APA, 
2013b). 
 
Although these subtypes have proved to be of limited use, both clinically and in 
schizophrenia research (Helmes and Landmark, 2003) there have been promising 
developments in the subtyping of schizophrenia more recently, specifically in subtyping 
schizophrenia as: (1) paranoid versus non-paranoid (Fiedorowicz et al., 2008), and as (2) 
deficit versus non-deficit (Carpenter et al., 1988; Kirkpatrick et al., 2001), a distinction that 
built on the dichotomy proposed by Crow (1980a, 1980b) between Type I syndrome, 
characterised by positive symptoms – delusions, hallucinations and thought disorder, and 
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Type II syndrome, characterised by negative symptoms – affective flattening and poverty 
of speech. Furthermore, deriving symptom dimensions or clusters statistically, utilising 
methods such as cluster analysis and latent class analysis has yielded mixed, but 
generally promising results for future research (Jablensky, 2006). 
 
Certainly, subtyping schizophrenia in some way appears useful for detecting genetic 
signals, it may lead to identification of specific disease entities, and it may help to elucidate 
the overlap between schizophrenia and bipolar disorder. “Given the uncertainties 
surrounding traditional disease classifications, the use of clinical dimensions as markers 
should become increasingly important” (Allan et al., 2008: 340); therefore a focus on 
reducing phenotypic variability through splitting diagnoses into subsets based on clinical 
and symptom commonalities is a valid direction for further enquiry despite limited 
diagnostic utility in the past (Jablensky, 2006). 
 
Although research has traditionally relied on clinical classifications of disease, future 
research appears likely to incorporate validated endophenotypes (Allan et al., 2008) 
because they appear to be more stable and persistent than symptoms. Endophenotypes 
are measurable components with demonstrated heritability that provide a ‘window’ 
between expressed clinical traits and underlying genes (Gottesman and Gould, 2003). 
Although endophenotypes have been successfully used in gene identification in several 
disorders (Jablensky, 2006), their impact on schizophrenia genetics has been less 
profound. Proposed schizophrenia endophenotypes have broadly fallen within three 
categories: neurophysiological, neuroanatomic/neuroimaging, and 
neuropsychological/cognitive (Fiedorowicz et al., 2008; Jablensky, 2006). Regrettably, 
although endophenotypes have proven useful in schizophrenia research, they remain 
impractical for diagnostic tests (as the deficits identified are variable and present in other 
disorders), and were not ready for incorporation into DSM-5 (Fiedorowicz et al., 2008). 
Moreover, it is not clear that any one endophenotype for schizophrenia has a less complex 
genetic architecture than the actual disease itself. 
 
Statistical methods for subtyping 
Various statistical methods have been commonly used in attempts to subtype 
schizophrenia. Several of the most widely used approaches are summarised below. 
 
Factor analysis 
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“Factor analysis and related methods reduce the covariation of the primary data matrix to 
covariances of small numbers of latent factors which account for the interrelationships 
among the primary variables and explain a proportion of their variance” (Jablensky, 2006: 
821). Factor analysis was instrumental in the three-factor model proposed by Liddle 
(1987): psychomotor poverty (poverty of speech, lack of spontaneous movement and 
various aspects of blunting of affect), reality distortion (particular types of delusions and 
hallucinations) and disorganisation (inappropriate affect, poverty of content of speech, and 
disturbances of the form of thought), which was incorporated in DSM-IV. Factor analysis is 
highly dependent on the content of the clinical rating scales that are used for input 
(Jablensky, 2006). Factor analysis assumes that underlying factors and measured 
variables are interval level variables, and also that the relationships among factors and 
between factors and variables are linear, assumptions which are often incompatible with 
input data (Hagenaars and Halman, 1989). 
 
Cluster analysis 
Unlike factor analysis which creates groups of variables, cluster analysis groups 
individuals (cases) based on their shared characteristics, which is intuitively more useful 
clinically (Everitt et al., 1971). Cluster analysis generally makes less restrictive 
assumptions than factor analysis (Hagenaars and Halman, 1989). However, statistically, 
clusters tend to be ill-defined, with no agreed formal ruling for cluster finding (Farmer et al., 
1983). As with factor analysis, cluster analysis is dependent on the selection of input 
variables (Jablensky, 2006). Furthermore, studies employing cluster analysis have 
frequently been poor in reporting the details of the methodology used (Clatworthy et al., 
2005). 
 
Latent class analysis 
Latent class analysis (LCA) groups individuals into a finite number of mutually exclusive, 
jointly exhaustive sets based on discrete, categorical, underlying (not directly observable) 
variables. Advantages of latent class analysis include: (i) types are defined on the latent 
rather than manifest level, which tends to better represent underlying phenomena; (ii) all 
variables are considered nominal scales, which accommodates input from diagnostic 
rating scales more appropriately than typical factor analysis methods; and (iii) no 
restrictions are imposed on the form of relations between variables, which gives the model 
more versatility than cluster analysis (Hagenaars and Halman, 1989). 
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Factor mixture modeling 
Conceptually, factor mixture modeling (FMM) may be conceived as the simultaneous 
combination of factor analysis and latent class analysis. Whereas factor analysis can (and 
will) only find dimensions in data, and latent class analysis can (and will) only find classes 
(Linscott et al., 2009), FMM are latent variable models with categorical and continuous 
latent variables (Lubke and Neale, 2008); thus they are unbiased, and can provide 
evidence for either continuous or class hypotheses (Muthen and Asparouhov, 2006). By 
utilising all three modeling methods, and applying parameters for model fit aided by 
confirmation from observable data based on clinical experience (since these methods are 
not intelligent systems (Linscott et al., 2009)), it is possible to contrast the explanatory 
effectiveness of all likely combinations of factors and classes. This strategy avoids many of 
the subjective assumptions of methods such as cluster analysis, and avoids 
predetermining the structure of the data in statistical method selection. 
 
Taxometric methods 
In contrast to latent variable modeling procedures, taxometric procedures are designed to 
distinguish continuous latent distributions from two-class categorical distributions. 
Taxometric procedures vary in their specifics but most share a simple underlying principle, 
namely that if a class structure is present and there is conditional independence, 
manipulating the presence and prevalence of class members within subsets of a 
population sample will lead to systematic changes in statistical parameters (e.g., difference 
score, covariance, eigenvalue) derived from those subsets. Taxometric techniques have 
been shown to effectively detect existing latent class structures, and do not detect taxons 
(classes) where none exist (Meehl, 1995; Meehl and Yonce, 1996). As with factor mixture 
modeling, taxometric methods are not intelligent systems, rather they simply detect 
anomalies in observed variance (Linscott et al., 2009). This is both a strength and a 
limitation; they do not make prior assumptions about the input data used, but are highly 
reliant on their validity. 
 
Role of transethnic samples in genetic research 
Genetic research has a crucial role to play in clarifying the etiological pathway for 
schizophrenia, determining whether it is, as suspected, a collection of etiologically 
unrelated but dynamically interacting processes, thereby substantially recasting the 
present nosology (Jablensky, 2006). Eventually, it is hoped genetic research will reveal 
biologically valid disease markers of schizophrenia (Allan et al., 2008). “Biologic markers 
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are revolutionizing diagnosis and treatment. The majority of studies of 
psychopharmacology and biologic markers are conducted on Western populations, and 
have neglected [other] ethnic populations” (Flaskerud, 2000: 6). 
 
At a population level, differences in the expression of schizophrenia have been noted, for 
example the hebephrenic subtype has been identified as common in Japan and catatonia 
has been identified as common in India (Flaskerud, 2000). At a genetic level, differences in 
expression have been identified in different ethnicities. Recent schizophrenia genome-
wide association studies and subsequent replication studies have found significant genetic 
differences between Caucasians and African-Americans (ISC, 2009), with polygenic risk 
scores explaining more variance in European than African-American ancestral groups. 
Significant genetic differences have also been identified between Caucasians and Han 
Chinese (Li et al., 2010; Yue et al., 2011), with some significant loci shared and others 
identified in the Han Chinese only, results differing from those reported by the Psychiatric 
Genomics Consortium. 
 
Thus, the importance of studying non-European populations in genetics arises because (a) 
no single population is sufficient for uncovering variants underlying disease in all 
populations (Rosenberg et al., 2010); (b) the same genetic variant will likely have different 
prevalence across populations which may facilitate prospects for its discovery (McCarthy, 
2008); and (c) there will be a percentage of new variants identified that are population-
specific (e.g. Li et al., 2010), even though a majority of genetic variation is shared across 
ethnicities. 
 
Importance of transethnic research in understanding psychoses 
Whereas genetic studies of psychoses tend to contrast ethnicities at a broad population 
(trans-national) level, transethnic research has the ability to interrogate datasets in greater 
detail at the demographic, clinical and symptom levels, using ethnicity to explore 
differential impacts of environment and culture, and assess the limitations of diagnostic 
assessment. From an anthropological perspective, “what light can be thrown on psychotic 
illness without interview data, ethnographic description, videotape recording, or clinical 
interaction” (Jenkins and Barrett, 2004: 16)? Contrasting well-ascertained transethnic 
schizophrenia samples at the level of individual experience and expression allows 
researchers to meaningfully incorporate the data generated from these anthropologically-
driven methods, particularly in populations where extensive cross-cultural work has been 
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undertaken, such as in the Iban of Sarawak, Malaysia (Barrett, 2004) and in Southern 
India (Corin et al., 2004). 
 
The phenomenological differences identified are crucial to understanding and 
accommodating the different ways in which culture is involved in psychiatric assessment 
and diagnosis: (1) culture shapes the phenomenology of symptoms themselves; (2) culture 
is manifested through ethnopsychiatric diagnostic practices and rationales; (3) culture 
provides the matrix for the interpersonal situation of the diagnostic interview; (4) the 
dynamics of cross-cultural work are crucial for understanding and refining diagnostic 
categories and practices; and (5) culture informs the overall conceptualisation of 
diagnostic systems (Mezzich et al., 1999).  
 
In summary, given the uncertain diagnostic validity of schizophrenia, the search for genetic 
variants across populations must take place in parallel with the recognition of potential 
differences in etiology, environment and diagnostic assessment across populations. 
Transethnic samples are useful for subjecting any diagnostic system to a cross-cultural 
validity test. An overview of the theoretical divide between anthropology and psychiatry, 
and a synopsis of the debate on the cross-cultural validity of DSM-IV are provided below. 
 
Schizophrenia, Culture and Ethnicity 
Academic interest in the intersection between schizophrenia and culture has been traced 
to Harry Stack Sullivan, a psychiatrist, and Edward Sapir, an anthropologist, in New York 
in the 1930s. Yet the relationship between schizophrenia and culture has, until recently, 
remained somewhat neglected in academic debate. This lack of sustained, coherent effort 
to elucidate what is a nebulous concept has been attributed to two fundamental areas of 
contention. 
 
The first of these has been the inability of psychiatrists and anthropologists to successfully 
‘straddle’ the theoretical divide between the disciplines, in fact, it has been argued that “the 
interaction between nosologists and cultural experts has been traditionally antagonistic” 
(Mezzich et al., 2001: 407). Recent developments in the diagnostic classification of 
schizophrenia, summarised below, have brought renewed focus to this theoretical 
impasse. Historically, psychiatry takes a universalist perspective in relation to psychiatric 
diagnoses, which contends that disorders such as schizophrenia are essentially the same 
across societies, with culture mediating the content or expression, but not the form of 
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symptoms. This was traditionally known as the pathoplastic model of mental illness. The 
tacit assumption is that biology determines the cause and structure of the disorder 
(Kulhara and Chakrabarti, 2001). Anthropology, in contrast, takes a relativist perspective, 
contending that culture mediates all aspects of schizophrenia. 
Culture is critical in nearly every aspect of schizophrenic illness experience: the 
identification, definition and meaning of the illness during the prodromal, acute, and 
residual phases; the timing and type of onset; symptom formation in terms of content, 
form, and constellation; clinical diagnosis; gender and ethnic differences; the 
personal experience of schizophrenic illness; social response, support, and stigma; 
and, perhaps most important, the course and outcome of disorders with respect to 
symptomatology, work, and social functioning (Jenkins and Barrett, 2004: 6-7). 
 
In summary, psychiatry strives to find similarities in psychiatric presentations across 
cultures, whereas anthropology strives to elucidate differences. 
 
The second source of difficulty in integrating schizophrenia and culture in a meaningful 
way has been the imprecision with which schizophrenia is defined in psychiatry and culture 
is defined in anthropology. The discipline of psychiatry has attempted to define both these 
concepts more precisely and meaningfully for clinicians and researchers, with mixed 
success; the diagnostic classification of schizophrenia was robustly debated prior to the 
release of DSM-V, and culture in psychiatry was meaningfully incorporated for the first 
time into DSM-IV (summarised below). 
 
Summary of Relevant Research on Culture and Schizophrenia 
Despite the major methodological issues outlined above there have been many meaningful 
attempts to study the relationship between schizophrenia and culture. These efforts have 
generally focused on two areas: (1) studies of migrant groups within a (generally 
‘Western’) country in comparison to non-migrants; and (2) international studies based on 
cross-cultural comparisons of groups from developing countries with groups from 
developed, ‘Western’ countries. The focus of this summary is the latter body of literature, 
as this is directly relevant to the data included in this thesis. 
 
Early cross-cultural research studies (prior to the 1970s) generally hypothesised the 
universality of schizophrenia, but they were plagued by methodological inadequacies 
(Thakker and Ward, 1998), inextricably linked to the ethnocentric, essentialist, racist 
discourse within which they were undertaken, and which had underpinned medical science 
since the 18th Century (Pfeffer, 1998). 
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The World Health Organization Cross-Cultural Research Program significantly improved 
the quality of cross-cultural schizophrenia research (Thakker and Ward, 1998). This 
involved three major undertakings: the first across nine countries in the early 1970s (The 
International Pilot Study of Schizophrenia – IPSS); the second including more than 1300 
cases across 10 countries in the 1980s (The Study of Determinants of Outcome of Severe 
Mental Disorders – DOSMed); and the third beginning in 1990 (with results published in 
2007) and following up subjects from the first two studies across 12 countries (The 
International Study of Schizophrenia – ISOS). Although these studies have also been 
criticised on methodological grounds (Edgerton and Cohen, 1994), they were ground-
breaking in the field, were conducted with reasonable sophistication and rigor (Kleinman, 
1987), and are still widely referenced today. 
 
The major finding of the IPSS, supported by the DOSMed and ISOS, was that the outcome 
for individuals with schizophrenia is better in developing countries than developed 
countries (Alem et al., 2009; Sartorius et al., 1986). It was argued at the time of the second 
WHO study that this represented the single most important finding in cross-cultural 
psychiatry (Lin and Kleinman, 1988). A subsequent reanalysis of the DOSMeD data still 
identified type of centre (i.e. developing versus developed) as an important predictor of 
good outcome (along with acute mode of onset as found in the original study), but it 
suggested that there were complexities that make the original findings less convincing 
(Craig et al., 1997). Several studies from developing countries undertaken since the IPSS 
and DOSMed have supported the favourable outcome hypothesis (Kulhara and 
Chakrabarti, 2001), while recent challenges to the hypothesis have also been forthcoming 
(Alem et al., 2009). The distinction between Western/developed and non-
Western/developing cultures has pervaded the research ever since the first two WHO 
studies, and although this is not an ideal comparison, its ubiquity in the transcultural 
psychiatry literature has made it a sensible reference point for beginning to understand 
cross-cultural complexities in schizophrenia (Kulhara and Chakrabarti, 2001). 
 
With the notable exception of the WHO Cross-Cultural Research Program most modern 
schizophrenia ethnic comparison studies use ethnic minorities within a single Western 
country and health care system to provide contrasting samples. Genetic collaborative 
studies and pooling available datasets are certainly providing opportunities for ethnic 
comparative studies utilising multiple ethnicities, for example Lo et al. (2007) contrasted 
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Japanese (n=304) and German Caucasian (n=301) samples examining gamma-
aminobutyric acid receptor subunit beta-2 isoform 2 precursor (GABRB2) against 
Leonhard’s clinical subgroups (Leonhard, 1999), to validate previous findings from a 
Chinese sample (Lo et al., 2004). There have also been comparative studies across 
international sites examining different treatment centres, for example Iyer et al. (2010) 
contrasted first episode psychosis treatment in Montreal, Canada (n=88) and Chennai, 
India (n=61). However, recent studies across multiple sites with large sample sizes 
assessing individuals with schizophrenia using the same ascertainment method are 
scarce. 
 
Culture in DSM-IV 
Prior to the publication of DSM-IV the only mention of culture was one or two paragraphs 
in the introduction of DSM-III, supplied from a letter by Professor Kleinman, criticising the 
original draft (Good, 1996). The imperative to explicitly integrate culture into DSM-IV was 
brought about by the political reality of the increasing awareness of multiculturalism in the 
United States, the increased pace of intercultural exchange in the latter half of the 20th 
Century, and advances in the academic fields of cross-cultural psychiatry, psychology, 
medical anthropology, and sociology (Mezzich et al., 1999). The process of cultural 
incorporation was undertaken by an NIMH-sponsored multidisciplinary Group on Culture 
and Psychiatric Diagnosis, which had semi-official status compared to other DSM-IV 
workgroups; this limited direct access to decision-making processes, but allowed scholarly 
independence (Mezzich et al., 1999). An overarching concern for this group was the 
realisation that inadequate cultural understanding leads to misdiagnosis and perpetuation 
of inequality and differential class-based service access given that culture is inextricably 
linked with class/socioeconomic status, particularly in migrant groups in a country (Good, 
1996). The complex relationship between culture and socioeconomic status is highly 
contested and problematic for researchers (Dein, 2006). 
 
Below is a summary of the inclusion of culture in DSM-IV: 
Cultural concerns are represented in a significant manner in the text of DSM-IV – in 
the Introduction, in the introduction to the multi-axial structure, in the text associated 
with particular categories (as ‘cultural considerations’), in a glossary of cultural terms 
(‘culture-bound syndromes’), and in an ‘outline for cultural formulation’ appearing in 
Appendix I (Good, 1996: 128). 
 
The cultural formulation proposed five category headings to consider for a diagnostic 
assessment: cultural identity of the individual; cultural explanations of the individual’s 
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illness; cultural factors related to psychosocial environment and levels of functioning; 
cultural elements of the relationship between the individual and the clinician; and the 
overall cultural assessment for diagnosis and care (APA, 1994).  
 
Criticism of the way culture was incorporated into the DSM-IV has come from both the 
Group on Culture and Psychiatric Diagnosis, and from those outside the DSM-IV process. 
The criticism focuses on three areas: (1) The ‘sidelining’ placement of cultural material 
within the manual and the selective omission of recommendations in the final version; (2) 
The ethnocentric bias of the DSM-IV exemplified by the inclusion of ‘Western’ culture-
bound syndromes as core conditions; and (3) The lack of acknowledgement of the 
theoretical assumptions underpinning the manual and the resulting ambiguity in relation to 
the universalist/relativist debate for psychiatric diagnosis. Each of these criticisms is 
summarised below. 
 
In some ways culture was sidelined in DSM-IV from its inception; the Group on Culture 
and Psychiatric Diagnosis only had semi-official status (Mezzich et al., 1999). When 
recommendations from the cultural workgroup were included, they were selectively 
chosen, such that key components were omitted e.g. proposed definitions for ethnicity and 
culture were deleted from the introduction (Mezzich et al., 1999). Furthermore, placement 
of cultural content further sidelined it as ‘optional’ rather than universally important 
(Kleinman, 1997); e.g. cultural formulation guidelines were included as the 9th appendix 
(Mezzich et al., 1999). 
 
The DSM-IV inevitably represents the values and perspectives of certain segments of U.S. 
society (Fabrega, 1994; Fabrega, 1995). Although DSM-IV did not overtly claim to be 
atheoretical as DSM-III and DSM-III-R had, its guiding theory was not outlined (Thakker 
and Ward, 1998). Although DSM-IV is frequently portrayed as atheoretical, universal or 
culture-free, and this is implied in the introduction (Mezzich et al., 1999), a stark example 
of its cultural bias can be seen in the fact that ‘Western’ culture-bound syndromes such as 
anorexia nervosa and chronic fatigue syndrome are included as universal conditions and 
not as culture-bound syndromes (Rogler, 1996; Thakker and Ward, 1998), even though 
anorexia nervosa has been rarely reported outside the ‘West’ (Thakker and Ward, 1998), 
although the prevalence of eating disorders in developing countries is rising (e.g. Sharan 
and Sundar, 2015).   
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Ambiguity regarding the theoretical underpinnings of DSM-IV results in multiple unresolved 
conundrums and apparent contradictions. First, how can we rely on a biological theoretical 
model when our signs of pathology are overwhelmingly behavioural (Thakker and Ward, 
1998)? And, given this anomaly, how can we rely on ‘evidence’ presented for underlying 
pathological mechanisms, and how can we claim the manual is atheoretical (Mezzich et 
al., 1999)? Second, DSM-IV is a universalist venture (criteria based on similarities), 
attempting (in a non-comprehensive way) to incorporate relativism through sporadic 
recognition of cultural mediation (Thakker and Ward, 1998). This recognition of the 
significance of culture necessarily generates hypothetical questions that may undermine 
the universalist theoretical framework of the DSM system: what is the cultural effect on 
symptom application; what is the cultural effect on disorder attribution and assignment; 
and what is the cultural effect on the diagnostic process? 
 
These ambiguities highlight a fundamental conceptualisation of diagnostic classification 
that aligns well with the current direction of schizophrenia research, but which DSM-IV has 
not successfully evolved to accommodate: “Recognition of phenomenological diversity is 
essential to complement our understanding of core commonalities and both are required 
for a nosology that is comprehensive and has broad national and international relevance” 
(Alarcon et al., 2009: 560). 
 
Culture in DSM-5 
The ‘Emerging Measures and Models’ section of the DSM-5 attempts to address variation 
in a clinically meaningful way, specifically through the ‘Clinician-Rated Dimensions of 
Psychosis Symptom Severity’ scales, and the ‘Cultural Formulation Interview’ (APA, 
2013a), although a categorical classification system will inevitably inadequately 
incorporate real world complexity, as it is not designed for that purpose (Fiedorowicz et al., 
2008; Möller, 2008). Therefore, cultural impact is still peripheral to the DSM-5 (relegated to 
Section III, separated from the diagnostic criteria). It could be argued that embracing a 
dimensional approach to characterizing the expression of schizophrenia, without strict 
qualifications regarding applicability, would be incompatible with the very diagnostic 
foundation of the DSM. 
 
 
Culture in ICD-10 
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Although culture has been incorporated into the core ICD-10 manual to a lesser extent 
than DSM-IV, several countries and regions have released their own, culturally relevant 
versions of the ICD-10, including China, Japan, Cuba and Latin America. The most 
prominent cultural element in ICD-10 is a list of culture-specific disorders that forms Annex 
2 of the DCR-10 (WHO, 1993). It includes a brief definition and discussion of the concept 
of culture-specific disorders, and then lists twelve of these disorders. Of these eight are 
also listed in DSM-IV (Mezzich et al., 2001). The limited inclusion of culture in the ICD-10 
has been attributed to the diagnostic system being more suited to finding cross-cultural 
similarities and convergences than recognising variations in clinical presentations and 
needs (Mezzich et al., 2001). This criticism has also been levelled at the DSM-IV (Thakker 
and Ward, 1998). 
 
Operationalising Culture in other disciplines 
One key question pervades the debate regarding culture and schizophrenia: How can we 
meaningfully operationalise the concept of ‘culture’ without losing the value of the 
subjective experience of schizophrenia by individuals, which is fundamental to an 
anthropological understanding of the condition? Is it even possible?  
 
Other disciplines have attempted to measure culture in a manner that makes it meaningful 
for research, notably economics and epidemiology. Fernandez, an economist, proposed a 
working definition in order to express culture as a useful analytical concept: “think of 
differences in culture as systematic variation in beliefs and preferences across time, 
space, or social groups” (Fernandez, 2007: 305). The inappropriateness of using uniform, 
society-wide definitions of culture, especially to operationalise these concepts to generate 
‘cultural factors’ has been vigorously argued within the anthropology literature (Hopper, 
2004), although economists utilise proxy variables routinely. 
 
Epidemiology falls between economics and anthropology on the continuum of whether 
culture can be measured, and if so, how? Psychiatric epidemiology recognises the 
importance of being able to measure concepts such as race, ethnicity and culture, but 
acknowledges the complex meanings of these terms, their subtle differences, and the 
impossibility of breaking them down into three or four easily defined categories (Singh, 
1997). 
 
Ethnicity versus Culture 
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It is important, being mindful of the contested nature of the concept, to develop a working 
definition of culture in order to meaningfully interpret the rich multi-site data available. As 
early as 1871, E.B. Tylor formulated a definition of culture that is still widely quoted today, 
“that complex whole which includes knowledge, belief, art, morals, law, custom, and any 
other capabilities and habits acquired by man as a member of society” (Chestnut, 2000: 
110). Pasick et al. gave the following definition of culture specific to health behaviours, 
“unique shared values, beliefs, and practices that are directly associated with a health-
related behavior, indirectly associated with a behavior, or influence acceptance and 
adoption of a health education message” (Egede, 2006: 668). Importantly, as is captured 
by most definitions, the nature of culture and its effects are both implicit and explicit. In 
order to operationalise the concept in a way useful to research, it is necessary to 
understand the different levels on which culture can be understood: (1) Pragmatic: What 
we must know and do to function in a society; (2) Learning: Norms, values, beliefs and 
behaviours that are socially transmitted; and (3) Statistical: Norms, values, beliefs and 
behaviours that are common in a population (Hruschka and Hadley, 2008). The statistical 
dimension offers the most promise for finding a meaningful definition of culture that can 
assist data interpretation within this thesis.  
 
Culture is extremely challenging to measure, which explains why proxy measures such as 
race and ethnicity are commonly used (Hruschka and Hadley, 2008). The Centers for 
Disease Control recommended using ethnicity as the preferred measure, due to the 
decline of distinct racial groups, although measuring ‘ethnicity’ is also problematic 
(Flaskerud, 2000). Furthermore, even if ‘ethnicity’ can be accurately ascertained, its use in 
research is a fine balance between grouping individuals to make useful observations 
without committing essentialism: using ethnicity to incorrectly overgeneralise (Dein, 2006). 
 
Ethnicity as a categorising term has been used in many different ways and in many 
spheres, professional and non-professional, academic and non-academic. Most 
academics and policy makers stress some degree of cultural distinctiveness as the mark 
of an ethnic group (Dein, 2006), and most definitions suggest that common criteria for 
membership of an ethnic group include: shared national or territorial identity, shared racial 
identity, and shared language (Chestnut, 2000). 
 
Self-reported ethnicity is considered the research ‘gold-standard’ (Ma et al., 2007). Not 
only is a subjective sense of belonging important to ethnic identity (Chestnut, 2000), there 
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are also important ethical reasons underpinning self-selection stemming from the use of 
the categories ‘race’, ‘ethnicity’ and ‘culture’ to support racist essentialism in past health 
research (Dein, 2006; Pfeffer, 1998). Defining group boundaries is also simpler when 
ethnicity is self-selected (Dein, 2006). Major criticisms of relying on ethnicity as a category 
include: (a) that it only superficially dissociates research from the racist ideology of the 
past (Pfeffer, 1998; Singh, 1997), and (b) that a person’s ethnic identity or national origin 
does not reliably predict their beliefs and attitudes (Egede, 2006), which necessarily limits 
the generalisability of findings. 
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Chapter 2. Establishing Cultural and Data Equivalence 
A great strength of the datasets presented in this thesis is their equivalence, not only their 
cultural equivalence, but also their data source equivalence and their data format 
equivalence. As establishment of sample similarity across these three domains is crucial to 
the validity of the analyses presented in Chapters 3-6, and cultural equivalence is a 
predictable source of critique, these issues will now be explored. Since much of the work 
on equivalence was undertaken prior to the candidate’s PhD, and is therefore not directly 
assessable, this chapter will focus on the theoretical underpinning of cultural equivalence, 
and the candidate’s experience and assessment of the data sources. 
 
Overview of Site and Sample Characteristics 
The three ethnically-distinct schizophrenia populations were drawn from Caucasian 
Australians; Tamil Brahmin and proximal caste groups from Tamil Nadu, India; and the 
Iban of Sarawak, Malaysia. 
 
Australia: Sample characteristics and attitudes to mental illness and psychoses  
The Australian sample was recruited from two collaborative US/Australian studies 
examining genes and schizophrenia, known as the Molecular Genetics of Schizophrenia 
Studies (MGS). The first study (MGS1) examined affected sibling pairs (ASPs) for a 
linkage analysis, including families with a proband with schizophrenia, at least one other 
sibling with schizophrenia or schizoaffective disorder, and their parents if available. The 
second study (MGS2) examined unrelated probands (singletons) with schizophrenia or 
schizoaffective disorder for a genome-wide association study. Eligible participants were 
recruited from a range of sources, as outlined in Figure 2-1. 
 
Figure 2-1: Recruitment Flowchart - Australia 
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Most participants were recruited in South East Queensland (78%), although included 
individuals and families were also recruited from Melbourne (11%), Adelaide (6%), Sydney 
and surrounds (4%), Tasmania (<1%) and North Queensland (<1%). The total sample 
comprised 821 affected individuals, 654 of whom were unrelated singletons and 167 of 
whom were first-degree related individuals (ASPs) from 79 independent families (McLean 
et al., 2012). 
 
A SANE Australia survey (SANE Australia, 2007) reported that most individuals affected 
by mental illness believe that societal attitudes to mental illness in Australia are slowly 
improving, despite 74% experiencing stigma. A recent national survey carried out with 
5220 Australians, 1381 of whom reported a mental health problem or scored high on a 
symptom screening questionnaire, concluded that “the social environments of friends, 
families, workplaces and educational institutions in particular are sources of both 
discrimination and support, depending on the circumstances of the individual” (Reavley 
and Jorm, 2015: 910). It is noteworthy that 41.4% of the Australian individuals included in 
this thesis were living alone at the time of assessment, with only 34.7% living with family, 
in stark contrast to India and Sarawak, where almost all participants were living with family 
(India, 93.1%; Sarawak, 96.0%). This is potentially indicative of less social support being 
available for individuals with psychosis in Australia in comparison with other sites.    
 
India: Sample characteristics and attitudes to mental illness and psychoses 
For the Indian sample, affected sibling pairs (ASPs) and trio pedigrees (affected proband 
with both parents) were identified by caste/ethnicity for a genetic linkage analysis. The 
sample comprised those belonging to the Brahmin caste from Tamil, Kerala, Karnataka, or 
Andhra Pradesh, and those from geographically proximal caste groups from Tamil Nadu 
(Mudaliars, Chettiars, and Dalits) (Thara et al., 2009). Individuals and families were 
recruited both directly through the Schizophrenia Research Foundation, India (SCARF), a 
major psychiatric research facility in Chennai, and also through a network of clinicians in 
and around Chennai. A recruitment flowchart for the Indian sample is provided as Figure 
2-2. Several characteristics of the Indian sample are unusual (see Thara et al., 2009). The 
extremely low rates of alcohol, cannabis and other drug abuse and dependence are 
striking, as is the diagnostic homogeneity – there were only two cases of schizoaffective 
disorder diagnosed in a sample of 520 individuals (0.4%), contrasted with schizoaffective 
proportions of 6.8% in Australia and 19.1% in Sarawak (see Chapter Three). Also (as 
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noted above), 93.1% of included individuals were living with family at the time of 
assessment.  
 
Figure 2-2: Recruitment Flowchart - India 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In India, psychiatric hospital facilities are meagre and generally confined to urban areas, 
and community services are generally non-existent. Most individuals with psychoses live at 
home, and families tend to seek hospital admission only when their relative becomes 
violent or aggressive (Thara et al., 2009). 
 
A qualitative study in which eleven patients attending SCARF in the early stages of 
schizophrenia were interviewed about their experiences (Corin et al., 2004), offers insight 
into the individual experience of schizophrenia in the population included in this thesis. 
There were shared themes identified across the interviews: the most common was a 
feeling of fear or terror that threatened the core of the person. This experience 
subsequently resulted in three associated themes: “a sense of hostility of the outside 
world; a feeling that personal limits and boundaries had become porous; and a confusion 
that attacked the core of the person and undermined the possibility of that person forming 
an image of him or herself” (Corin et al., 2004: 118).     
 
Sarawak: Sample characteristics and attitudes to mental illness and psychoses 
The Iban are a people of proto-Malay stock who migrated from the central highlands of 
Borneo to Sarawak over ten generations, beginning 400 years ago. The Iban almost 
completely annihilated the pre-existing inhabitants there (the Bukitan and Seru). It was 
estimated there were 450,000 Iban in Sarawak in 1991. The Iban live in longhouses, 
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comprising a series of up to 50 apartments joined under one roof, housing up to 300 
individuals of a common kinship group (Barrett et al., 2005). Almost all individuals (96.0%) 
included in this thesis were living with family at the time of assessment. 
 
A review of Malaysian census data identified Iban individuals in Sri Aman and Betong 
(where a majority of Iban live), and all available medical records were screened for the 
presence of psychoses. Narrative summaries were compiled for all individuals who 
screened positive, and then a detailed pedigree subset was identified and interviewed 
using the full diagnostic battery outlined in this thesis. There were 298 included individuals 
(from a total of 486 individuals with psychoses) identified through the medical records 
screen with schizophrenia or schizoaffective disorder; of these, 145 were included in 
pedigree subset. A flowchart of recruitment in Sarawak is provided as Figure 2-3. 
 
Figure 2-3: Recruitment Flowchart - Sarawak 
 
 
 
 
 
 
The Iban have a preoccupation with bodily symptoms and illness, which leads them to 
present early and often for medical attention. With regard to their attitudes to psychoses, 
patients and their families uniformly seek assistance from both traditional healers and 
government health services, in spite of the stigma attached to mental illness (Barrett et al., 
2005). 
 
Establishing Cultural Equivalence: A framework for transcultural research 
Unlike absolutism, which contends that schizophrenia does not vary significantly across 
cultures, and relativism, which contends that all aspects of schizophrenia vary across 
cultures, universalism acknowledges that there are commonalities in the form of 
symptoms, but differences in the expression or content. The great challenge, from a 
universalist approach, is therefore to develop a research method that is culturally 
equivalent across populations in order to appropriately accommodate differing 
conceptualisations of similar concepts across societies.  
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Herdman et al. (1998) propose a useful framework to establish cultural equivalence in 
universalist research. They propose six types of equivalence that should be established 
when converting (diagnostic) instruments across cultural groups. In summary they include: 
conceptual equivalence – are concepts of health and illness understood the same way 
across groups; item equivalence – are questions that assess domains equally relevant and 
acceptable across groups; semantic equivalence – do key concepts translate appropriately 
across languages; operational equivalence – is the format of instruments equally valid 
across groups; measurement equivalence – do different versions of instruments have 
equal reliability, responsiveness and construct validity; and functional equivalence – 
overall, does the instrument achieve its purpose equally well across groups? 
 
Establishing cultural equivalence across these six domains thereby gives a stable 
‘reference point’ from which to explore identified differences, with a degree of confidence 
that all findings are not confounded by culture and associated measurement bias. 
 
Anthropological Contributions Relevant to These Datasets 
A major strength of the datasets analysed in this thesis is the ability of the research site 
coordinators in both India and Sarawak to successfully traverse the theoretical gulf 
between psychiatry and anthropology. Both Professor Barrett, in Sarawak, and Dr. Thara, 
in India, have conducted qualitative research and written extensively on how culture 
mediates the experience of psychosis, and the implications for using standardised 
diagnostic instruments and applying universal diagnostic criteria within these cultures 
(Barrett, 2004; Corin et al., 2004). An appreciation of the relational or interactional notion 
of ‘self’ in both Sarawak (Barrett, 2004) and India (Corin et al., 2004; Kakar, 1991), in 
contrast to individual uniqueness defining ‘self’ in post-Enlightenment Western cultures 
(Kakar, 1991) such as Australia, is central to establishing diagnostic equivalence across 
sites. The establishment of cultural equivalence across the three datasets analysed in this 
thesis is dealt with in greater detail in Chapter Five.  
 
Establishing and Confirming Data Source Equivalence 
Five main data sources were available for each of the three ethnically-distinct 
schizophrenia populations. 
 
Diagnostic Interview for Genetic Studies (DIGS) 
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Trained clinicians used the semi-structured DIGS (Nurnberger et al., 1994) to obtain 
information relevant to the diagnosis of psychotic, mood, and substance-use disorders in 
accordance with DSM-IV criteria (APA, 1994), the comorbidity of these disorders, proband 
medical history, and ratings of the positive and negative symptoms of schizophrenia. DIGS 
interviews were obtained in all populations except individuals from the initial Sarawak 
medical records-based screen. 
 
The DIGS was developed and piloted as a collaborative effort of investigators form sites in 
the National Institute of Mental Health (NIMH) Genetics Initiative in the United States. It 
has the following features: (1) polydiagnostic capacity; (2) a detailed assessment of the 
course of illness, chronology of mood and psychotic symptoms, and comorbidity; (3) 
additional phenomenological assessment of symptoms; and (4) algorithmic scoring 
capacity. The interview is semi-structured, often requiring clinical judgement to code 
responses properly (Nurnberger et al., 1994). The sections of the DIGS included in the 
work presented in the thesis include: demographics, medical history, overview of 
psychiatric disturbance, major depression, mania, dysthymia, alcohol and drug abuse and 
dependence, psychosis, comorbidity, suicidal behaviour, global assessment scale, SANS, 
SAPS, and interviewer’s reliability assessment. 
 
An initial two phase reliability study showed that: (1) reliabilities for assessing major 
depression, bipolar disorder, schizophrenia and schizoaffective disorder were excellent 
(0.73 to 0.95), except for schizoaffective disorder, for which disagreement on estimates of 
duration of mood syndromes relative to psychosis reduced reliability; and (2) cross-site 
training procedures were successful in producing clinical interviewers who would apply a 
skilled and uniform approach to this ascertainment (Nurnberger et al., 1994). With regard 
to validity, the agreement between two DIGS interviewers’ generated diagnoses, and the 
baseline referral diagnosis (three independent assessments) was high for depression 
(45/53; 85%) and bipolar disorder (42/55; 76%), adequate for schizophrenia (29/51; 57%), 
and poor for schizoaffective disorder (2/48; 4%) for the reason noted above (Nurnberger et 
al., 1994).  
 
Family Interview for Genetic Studies (FIGS) 
A family informant, when possible, or the proband was interviewed about the family 
psychiatric history using the FIGS (Gershon et al., 1988; Maxwell, 1992). FIGS ratings 
were obtained in all populations except individuals from the initial Sarawak medical 
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records-based screen. Approximately 60% of FIGS were from both proband and family 
informants, the remainder being from probands only. The candidate found that the 
additional corroborating information provided by the FIGS was particularly rich in both 
India and Sarawak, where a greater proportion of study participants were living with family 
than in Australia. 
 
“The FIGS is a guide for gathering diagnostic information about relatives in the pedigrees 
being studied. This diagnostic information becomes part of a pool of data on each 
individual relative, to be added to data from the completed Diagnostic Interview for 
Genetic Studies (DIGS) and from medical records” (Maxwell, 1992: 1). Whereas the DIGS 
is designed to be used verbatim, the FIGS is designed to be a guide for interviewers. It has 
three main parts: a pedigree drawing, a set of general screening questions, and symptom 
checklists for each first-degree relative of interest (Maxwell, 1992). Symptom checklists 
include depression, mania, psychosis, drug and alcohol misuse, and personality disorders. 
 
The cumulative importance of FIGS verification of information from the DIGS is shown in 
results of a study by Gershon and Guroff (1984). For major affective disorders, 
informant/relative information (n=1093) agreed on the presence of a disorder for 96% of 
probands (n=159). Additionally, of those diagnosed with a major affective disorder by 
diagnostic interview, there was only diagnostic agreement in only 15% of cases when 
there was a single informant, this rose to 64% agreement with four or more informants. 
Thus, additional sources of diagnostic information increase the accuracy of diagnosis.  
 
The cultural equivalence of the DIGS and FIGS was extensively addressed by the chief 
investigators at the three sites, with specific focus on conceptual equivalence, item 
equivalence, and functional equivalence. Professor Barrett completed his PhD in 
Anthropology/Psychiatry, living for several years immersed in Iban culture; Dr. Thara has a 
long track record of schizophrenia research in India; and Professor Mowry oversaw 
diagnostic equivalence across all sites by reviewing every case.  
 
The DIGS and FIGS were translated into both Iban (Sarawak) and Tamil (India) with 
appropriate back-translation procedures. Interview schedules were translated into Tamil 
and Iban, affected individuals were interviewed by experienced research clinicians, and 
responses to questions were recorded and back-translated into English. This process was 
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repeated several times until the research teams were sure that the final version accurately 
reflected clinical phenomenology. 
 
Inter-rater reliability was assessed within the Australian/American sample (Suarez et al., 
2006); within the Indian sample; within the Sarawak sample; between the Australian and 
Indian samples (disagreement in one of 20 cases; κ=0.886); and between the Australian 
and Sarawak samples (disagreement in one of 20 cases; κ=0.828). 
 
Crucially, the candidate had access to the original paper copies of the DIGS interviews for 
all three sites (containing all handwritten notes from the interviewer), and these could be 
(and were) consulted during data cleaning (see Appendix C). 
 
There are several good examples of the site-specific DIGS interview for Sarawak reflecting 
subtle, culturally-influenced differences in clinical phenomenology (broadly discussed in 
Chapter Five). These include, but are not limited to, the questions relating to auditory 
hallucinations, erotomanic delusions, religious delusions and delusions of magic. 
 
In the US/Australian DIGS (2.0 modified), there were eight questions relating to auditory 
hallucinations and related phenomena: 
1. Auditory – Voices, Noises, Music: Have you ever heard sounds or voices other 
people could not hear? 
2. (If yes:) Did they say bad things about you or threaten you? 
3. Auditory – Running Commentary: Have you ever heard voices that described or 
commented on what you were doing or thinking? 
4. Auditory – Two or More Voices: Have you ever heard two or more voices talking 
with each other? 
5. Thought Echo: Have you ever experienced hearing your thoughts repeated or 
echoed? 
6. Audible Thoughts: Have you ever heard your own thoughts as a voice spoken out 
loud? 
7. Did you ever talk to any voices you heard? 
8. When you heard the voices, did you also see the person talking, even though 
others did not see that person? 
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The English translation of the Iban DIGS also contained these eight core questions, given 
in a different order, with five additional questions. Prior to the first question (Auditory – 
Voices, Noises, Music), the Iban DIGS contained a question formulated by Professor 
Barrett: 
1. Talking to self? 
There were three additional questions asked after the Auditory – Running Commentary 
question: 
 2. Voices wanting you to follow them? 
 3. Voices commanding? 
 4. Nice voices? 
Following the question on talking visions (question 8 above), the Iban DIGS had an 
additional question: 
 5. Talking Noises? 
 
The question relating to erotomanic delusions in the US/Australian DIGS had an additional 
interviewer instruction inserted in the Iban DIGS in order to differentiate the experience 
from other reported experiences: Only mark it as an erotomanic delusion if the patient is 
convinced a living person has fallen in love with them. 
 
A question relating to delusions of magic was inserted into the Iban DIGS that had no 
equivalent question in the US/Australian version. Both this question, and the question 
rating religious delusions had additional interviewer instructions inserted in the Iban DIGS 
to assess the cultural appropriateness of these experiences: 
Check whether the family agree or disagree with the patient. Record what they 
think. 
If they agree, then mark it as a cultural belief “1”. 
If they disagree, then mark it as a delusion “2”. 
 
It is evident from these subtle modifications to the Iban version of the DIGS (and FIGS) 
that having fluent Iban-speaking interviewers familiar with Iban cultural beliefs and 
experienced in Iban clinical presentations was crucial to the validity of these diagnostic 
instruments. This ascertainment rigor was replicated in both India and Australia, which is a 
great strength of these studies. 
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Thus, although the majority of work adapting the DIGS and FIGS to achieve cultural 
equivalence was undertaken prior to the candidate’s PhD, it is undeniably crucial to the 
validity of Chapters Two to Six. A detailed decision framework was employed by Professor 
Mowry and the late Professor Barrett in regard to Iban/Australian equivalence. As has 
been previously noted Professor Barrett completed his PhD in Anthropology/Psychiatry, 
living for several years immersed in Iban culture, and he published extensively on Iban 
culture as it relates to schizophrenia (see Barrett, 2004; Barrett et al., 2005), and the 
cross-cultural interpretation of schizophrenia more generally (see Barrett, 1988a, 1988b). 
With regard to the equivalence of the Australian and Indian DIGS, the candidate 
painstakingly compiled a worksheet containing each variable (685 in total) in the Australian 
interview booklet, and then mapped each variable in the Indian interview to its equivalent 
item in Australia. 
 
Medical records assessment 
All available medical records were retrieved for each participant and then assessed by 
trained clinicians. Medical records formed the primary source of diagnostic information for 
the general screening population in Sarawak, for whom DIGS interviews were unavailable. 
Although the quality and quantity of medical records obtained varied between and within 
sites, both the records themselves and the clinician summaries for the Iban were of a 
general high standard, which was important given the candidate’s reliance on them for a 
significant number of Iban participants (n=153).  
 
Narrative summary 
A trained clinician, usually the interviewer who conducted the DIGS, prepared a case 
summary based on all information obtained from the DIGS, FIGS and medical records 
assessment. The narrative summary was typically between two and ten pages in length, 
and was invaluable in recording the first-hand impressions of the interviewer. This 
facilitated diagnostic assessment by augmenting the DIGS interview information, 
especially when the participant’s responses lacked clarity. Narrative summaries were 
available for over 90% of participants in Australia and Sarawak, and over 75% in India. 
These reports were crucial in data cleaning (see Appendix C), and the candidate read and 
took notes on every narrative summary across the three sites.  
 
Best Estimate Final Diagnosis (BEFD) 
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DIGS interview, interviewer narrative, available medical records, and FIGS reports formed 
the basis for diagnostic review. Diagnoses were assigned using the BEFD procedure 
(Leckman et al., 1982), with two experienced psychiatrists independently reviewing all 
available information then conferring to assign a consensus diagnosis. Outstanding 
questions were resolved through discussion and sometimes involved collection of further 
clinical information. Best estimate diagnoses were formulated for all populations, except 
the detailed family subset in Sarawak, where diagnosis was routinely formulated by one 
experienced psychiatrist, with a BEFD generated in a random subset (20 cases). The 
BEFD diagnostic sheets recorded not only primary diagnostic information, but also 
comorbid diagnoses, which the candidate relied on heavily when extracting variables such 
as intellectual disability, mania, depression, and substance abuse and/or dependence. 
 
Establishing and Confirming Data Formatting Equivalence 
Overall, the data identification, extraction, cleaning and formatting steps for this thesis took 
eighteen months. The candidate was the recruitment coordinator for the Australian site for 
the second Molecular Genetics of Schizophrenia (MGS2) study (which provided all data for 
the majority of the Australian individuals included in this thesis), and he personally 
conducted ~100 diagnostic interviews. While this data collection preceded the candidate’s 
PhD, this experience gave him an intimate knowledge of all data sources, instruments 
used in the study, and the nuances of the dataset, such as the theoretical underpinnings of 
coding conventions. This knowledge was vital in guiding the exhaustive data identification, 
extraction, cleaning and formatting strategy used in this thesis (see Appendix C). 
 
Addressing Equivalence Issues Throughout the Thesis 
Certain ‘global’ measures were taken to establishing cultural and data equivalence, as 
outlined above and in Appendix C. A key component of creating a valid starting point for 
comparing and contrasting the samples was ascertaining and confirming the ethnicity of all 
included individuals across the three sites (see Chapters Five and Seven for more detail). 
There were also Chapter-specific equivalence issues that were addressed during the 
thesis. Table 2-4 shows the aims of the following four chapters, the samples included for 
each study, and how study-specific potential equivalence issues and biases were 
addressed.
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Table 2-4 Addressing Equivalence Issues in Each Chapter 
Chapter Title Aims Samples Addressing Potential Biases 
Chapter 3 
Refining Clinical Phenotypes in 
Schizophrenia 
Identify candidate variables free 
from significant cultural 
confounding that are hence 
suitable for inclusion in genetic 
analyses. 
Australia n=821 
India n=520 
Sarawak n=298 
Total n=1639 
Report ‘raw’ differences and then discuss and 
acknowledge potential sources of bias: direct 
cultural, indirect cultural, measurement bias. 
Chapter 4 
Identifying Characteristic 
Symptom Profiles 
Explore symptom variables 
reported to be characteristic of 
schizophrenia in the Iban. Test 
site differences to confirm 
previous research, and to explore 
implications of differences across 
populations for future 
investigations. 
Australia n=609 
India n=310 
Sarawak n=205 
Total n=1124 
Sample contains only unrelated individuals to 
remove familial relatedness as a confounder 
(i.e. individuals within families may be more 
similar with regard to demographic and 
symptom characteristics than unrelated 
individuals owing to shared socioeconomic and 
environmental circumstances). This accounts 
for the smaller sample sizes.  
Chapter 5 
DSM-IV “criterion A” 
schizophrenia symptoms across 
ethnically different populations:  
evidence for differing psychotic 
symptom content or structural 
organization? 
Contrast lifetime frequencies of 
DSM-IV criterion A symptoms and 
types/content of delusions and 
hallucinations (with a particular 
focus on Schneiderian First Rank 
Symptoms) to elucidate clinical 
heterogeneity. 
Australia n=776 
India n=504 
Sarawak n=259 
Total n=1539 
Acknowledge and discuss the transcultural 
importance of Schneiderian First Rank 
Symptoms in highlighting culturally-contingent 
versus culturally-robust characteristics. 
 
Acknowledge and discuss the role of culturally 
formed notions of self in illness expression.   
Chapter 6 
Is ‘Deficit schizophrenia’ a distinct 
class within the syndrome of 
schizophrenia? Evidence from 
factor mixture modeling in three 
ethnically distinct population 
Test the underlying statistical 
demarcation of deficit 
schizophrenia (DS). Analyse 
twelve characteristic DS variables 
by exploratory factor analysis, 
latent class analysis, and factor 
mixture modelling (FMM). Test 
results using taxometric analyses: 
MAXCOV, MAXEIG, LMODE. 
Australia n=812 
India n=474 
Sarawak n=145 
Total n=1431 
FMM and taxometric methods not intelligent 
systems (i.e. they are not influenced by data 
content). Thus, equivalence issues are 
discussed in the discussion (and specifically 
the limitations) section in terms of their effect 
on data distribution. 
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Chapter 3. Refining Clinical Phenotypes in Schizophrenia 
McLean D, John S, Barrett R, McGrath J, Loa P, Thara R and Mowry B (2012) Refining 
clinical phenotypes by contrasting ethnically different populations with schizophrenia from 
Australia, India and Sarawak. Psychiatry Research 196(2-3): 194-200. 
 
Abstract 
We contrasted demographic and clinical characteristics in transethnic schizophrenia 
populations from Australia (n=821), India (n=520) and Sarawak, Malaysia (n=298) and 
proposed cultural explanations for identified site differences. From these we aimed to 
identify candidate variables free from significant cultural confounding that are hence 
suitable for inclusion in genetic analyses. We observed five phenomena: (1) more 
individuals were living alone in Australia than India or Sarawak; (2) drug use was lower in 
India than Australia or Sarawak; (3) duration of untreated psychosis (DUP) was longer in 
India than Australia or Sarawak; (4) the rate of schizoaffective disorder was lower in India 
than Australia or Sarawak; and (5) age at psychosis onset (AAO) was older in Sarawak 
than Australia or India. We suggest that site differences for living arrangements, drug use 
and DUP are culturally confounded. The schizoaffective site difference likely results from 
measurement bias. The AAO site difference, however, has no obvious cultural or 
measurement bias explanation. Therefore, this may be an ideal candidate for use in 
genetic studies, given that genetic variants affecting AAO have already been proposed. 
 
Key words: psychotic disorders, age of onset, culture 
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Introduction 
Similarities and differences in the expression of psychotic illness across cultural groups 
have attracted significant interest, primarily from social scientists and anthropologists 
(Larsen, 2004). Transethnic samples are also important in identifying genetic variants 
underlying complex disorders, such as type 2 diabetes (Unoki et al., 2008; Yasuda et al., 
2008) and schizophrenia (ISC, 2009; Li et al., 2010). The importance of studying non-
European populations in genetics arises because (i) no single population is sufficient for 
uncovering variants underlying disease in all populations (Rosenberg et al., 2010); (ii) the 
same genetic variant will likely have different prevalence across populations which may 
facilitate prospects for its discovery (McCarthy, 2008); and (iii) there will be a percentage 
of new variants identified that are population-specific (e.g. Li et al., 2010). 
 
In the clinic schizophrenia is treated as a single entity diagnosed according to reliable, 
internationally accepted criteria consisting of symptoms, duration, illness course, and 
exclusion of allied disorders (APA, 1994; WHO, 1992). However, current epidemiological 
(Lichtenstein et al., 2009) and molecular genetic (ISC, 2009) evidence suggest that it 
shares genetic predisposition with bipolar disorder, challenging the dichotomous view of 
functional psychoses (Craddock et al., 2009); indeed the concept of schizophrenia may 
well represent a group of heterogeneous disorders (Fiedorowicz et al., 2008). 
  
Given uncertain diagnostic validity, one approach to facilitate progress in correlating 
genotypes with phenotypes is to identify homogeneous sub-groups or dimensional 
phenotypes (Allan et al., 2008; Holliday et al., 2009; Jablensky, 2006). This approach has 
proven effective in other complex disorders (Nyholt et al., 2005; Todd et al., 2005). 
Moreover, given clinical (Thakker and Ward, 1998) and genetic (Li et al., 2010; Suarez et 
al., 2006) variation in schizophrenia across populations, the search for refined clinical 
phenotypes is incomplete if we neglect the study of transethnic samples. 
 
Traditionally in psychiatric research non-European populations have either been neglected 
(Flaskerud, 2000) or simply used to validate Western diagnostic classification (Thakker 
and Ward, 1998). Phenomenological diversity and commonality are both important if we 
are to develop a comprehensive nosological understanding (Alarcon et al., 2009). Thus, 
evaluating demographic and clinical differences across populations complements genetic 
research, since these differences may have relevance in identifying homogeneous 
phenotypes. 
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However, cultural factors may confound our ability to identify relevant differences. First, 
cultural factors can influence behavior and create true group differences that are unrelated 
to genetic variation; for example a societal preference to support mentally ill individuals in 
the workplace may result in less measurable disability in individuals with schizophrenia in 
that society contrasted with a society where those supports are absent. Second, cultural 
factors can influence both behavior and resource allocation, indirectly resulting in group 
differences through measurement differences; for example help-seeking behavior and/or 
greater availability of mental health services in a society may result in higher reported 
rates of schizophrenia and higher hospitalization rates in contrast to a society where 
services are unavailable or services are not actively sought. Third, cultural factors can 
influence interpretation of clinical diagnostic concepts, thereby resulting in group 
differences due to measurement bias resulting from the different conceptualization and/or 
application of diagnostic instruments. Arguably, culture is critical in almost every aspect of 
the experience of schizophrenia, including identification, diagnosis, symptomatology, 
ethnic differences and social responses (Jenkins, 1998). 
 
Some clinical and demographic differences across schizophrenia populations may not be 
confounded, however, and hence truly correlate with genetic variation. To isolate these, 
we can use clinical judgment and cultural insight in conjunction with previously published 
evidence (where available). Whenever no cultural confounding explanation is apparent, a 
demographic or clinical group difference across sites may be a promising candidate 
phenotype for investigating phenotype-genotype correlations. 
 
The Genetics Research group at the Queensland Centre for Mental Health Research 
(QCMHR) recruited three cohorts of individuals with psychosis for genetic analyses. We 
studied demographic and clinical characteristics of schizophrenia in three ethnic groups: 
Caucasian Australians (n=821); Tamil Brahmin and proximal caste groups from Tamil 
Nadu, India (n=520); and the Iban of Sarawak, Malaysia (n=298). We examined a broad 
cross-section of variables that characterize each population, and based on previous 
research and clinical experience across the three sites we expected to observe five 
phenomena. 
 
First, a greater proportion of individuals in Australia would be living alone (Jablensky et al., 
1999) than in Tamil Nadu, India (Thara et al., 2009) or Sarawak (Barrett et al., 2005). 
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Second, drug use in India would be significantly lower than in Australia or Sarawak. 
International drug statistics suggest a higher prevalence of drug abuse in Australia than 
India (United Nations Office on Drugs and Crime, UNODC, 2008), and a previous Chennai 
schizophrenia study revealed extremely low drug use (Thara, 2004). 
 
Third, the duration of untreated psychosis (DUP) would be significantly longer in India than 
in Australia or Sarawak. The average mean DUP from low-and-middle-income (LAMI) 
countries, including India and Malaysia, is significantly higher than for high-income 
countries, including Australia (Large et al., 2008), and DUP is lower for indigenous groups, 
including the Iban, than other Malaysian sub-groups (Chee et al., 2010). 
 
Fourth, the rate of schizoaffective disorder would be significantly lower in India (Thara et 
al., 2009) than in Australia or Sarawak. 
  
Fifth, the age of onset of psychosis (AAO) would be significantly older in Sarawak (Chee et 
al., 2010) than in Australia (Kessler et al., 2007) or India (Thara et al., 2009). 
Schizophrenia AAO is an attractive variable to examine because heritability has been 
reported in a Mexican/Central American sample (Hare et al., 2010), and AAO-associated 
genetic variants have been observed in an American-Caucasian sample (Renou et al., 
2007). 
 
Utilizing three large, uniformly ascertained, ethnically distinct schizophrenia samples we 
aimed to identify clinical variables of potential genetic relevance. A focus on clinical 
variation complementary to the search for genetic variants may eventually assist in refining 
the complex schizophrenia phenotype. 
 
Methods 
Sample recruitment 
At each site we included all probands and relatives who had a Diagnostic and Statistical 
Manual of Mental Disorders, fourth edition (DSM-IV) (APA, 1994) diagnosis of 
schizophrenia or schizoaffective disorder. To standardise schizoaffective diagnoses, we 
operationalized the mood syndrome duration criterion at ≥30% of total illness duration, 
consistent with other major genetic studies (Suarez et al., 2006). Individuals were included 
if they met the ethnicity criterion for each study: Australia – self-reported European 
 
 
48 
 
Caucasian ancestry; India – membership of Brahmin caste from Tamil, Kerala, Karnataka, 
or Andhra Pradesh, or membership of geographically proximal caste groups from Tamil 
Nadu (Mudaliars, Chettiars, and Dalits) (for details see Thara et al., 2009); and Sarawak – 
self reported Iban ethnicity. Ethnicity was subsequently confirmed through genetic analysis 
across all three samples. In Sarawak, individuals diagnosed with psychotic disorders other 
than schizophrenia or schizoaffective disorder were excluded from this study. 
 
Exclusion criteria for individuals were: (i) inability to give informed consent to all aspects of 
the study; (ii) psychosis judged to be secondary to substance use or a known neurological 
disorder such as epilepsy; and (iii) severe intellectual disability (any impairment that 
precluded informed consent, and any individual with an IQ assessed below 55 according 
to formal testing/medical record evidence). 
 
The Australian sample was recruited during two related collaborative US/Australian studies 
examining genes and schizophrenia, collectively termed the Molecular Genetics of 
Schizophrenia Study. The first examined affected sibling pairs for a linkage analysis (for 
details see Suarez et al., 2006), where included families had a proband with 
schizophrenia, and one or more siblings of the proband with schizophrenia or 
schizoaffective disorder. The second examined unrelated individuals with schizophrenia or 
schizoaffective disorder for a genome-wide association study (for details see Shi et al., 
2009). Eligible families and individuals were recruited from a range of sources, including 
local treatment facilities, physician referrals, community organizations, supported 
accommodation facilities and advertisements. 
 
The Indian sample was recruited as an ethnically homogeneous sample for genetic studies 
of schizophrenia. Both affected sibling pairs and trios (a single affected offspring and both 
parents) were recruited. Eligible families were identified and invited to participate through 
The Schizophrenia Research Foundation India’s (SCARF’s) well-established recruitment 
network of clinicians (for details see Thara et al., 2009). 
 
The Sarawak sample was recruited through Malaysian census data from the two major 
regional divisions (Sri Aman and Betong) where the Iban live (for details see Barrett et al., 
2005). Institutional Review Board approval was obtained, and then medical records (1960-
2000) for individuals in the Sri Aman and Betong divisions were screened for psychosis 
and narrative summaries and research diagnoses generated. Families where individuals 
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were identified as having any psychotic illness were then approached using the same 
clinical ascertainment battery that was used for the studies in Australia and India. Although 
the Sarawak sample was based on treated rates (approximating population prevalence) of 
schizophrenia, whereas the Australian and Indian samples were opportunistically 
recruited, the similarities in the ascertainment methods across sites still make comparison 
of these groups valuable.    
 
All participants in Australia and India gave written informed consent, and individuals in 
Sarawak who participated in the detailed screening follow-up gave verbal, videotaped 
informed consent (given that the Iban is traditionally a preliterate society). Individuals 
consented to an interview, a blood sample for DNA, and review of their psychiatric records. 
Local Institutional Review Board approval was obtained for each study. 
 
Clinical ascertainment 
The following routine sources of information were obtained across the studies in each 
country. 
 
Diagnostic Interview for Genetic Studies (DIGS) 
Trained clinicians used the semi-structured DIGS (Nurnberger et al., 1994) to obtain 
information relevant to the diagnosis of psychotic, mood, and substance-use disorders in 
accordance with DSM-IV criteria (APA, 1994), the comorbidity of these disorders, proband 
medical history, and ratings of the positive and negative symptoms of schizophrenia. DIGS 
interviews were obtained in all populations except individuals from the initial Sarawak 
medical records-based screen. 
 
Family Interview for Genetic Studies (FIGS) 
A family informant, when possible, or the proband was interviewed about the family 
psychiatric history using the FIGS (Gershon et al., 1988; Maxwell, 1992). FIGS ratings 
were obtained in all populations except individuals from the initial Sarawak medical 
records-based screen. Approximately 60% of FIGS were from both proband and family 
informants, the remainder being from probands only. 
 
The cultural equivalence of the DIGS and FIGS was extensively addressed by the chief 
investigators at the three sites, with specific focus on conceptual equivalence, item 
equivalence, and functional equivalence (for details of a cultural equivalence framework 
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see Herdman et al., 1998). Professor Barrett completed his PhD in 
Anthropology/Psychiatry, living for several years immersed in Iban culture; Dr. Thara has a 
long track record of schizophrenia research in India; and Professor Mowry oversaw 
diagnostic equivalence across all sites by reviewing every case.  
 
The DIGS and FIGS were translated into both Iban (Sarawak) and Tamil (India) with 
appropriate back-translation procedures. Interview schedules were translated into Tamil 
and Iban, affected individuals were interviewed by experienced research clinicians, and 
responses to questions were recorded and back-translated into English. This process was 
repeated several times until the research teams were sure that the final version accurately 
reflected clinical phenomenology. 
 
Medical records assessment 
All available medical records were retrieved for each participant and then assessed by 
trained clinicians. Medical records were obtained for all populations. 
 
Narrative summary 
A trained clinician, usually the interviewer who conducted the DIGS, prepared a case 
summary based on all information obtained from the DIGS, FIGS and medical records 
assessment. The narrative summary was invaluable in recording the first-hand 
impressions of the interviewer. This facilitated diagnostic assessment by augmenting the 
DIGS interview information, especially when the participant’s responses lacked clarity. 
Narrative summaries were obtained in all populations. 
 
Best Estimate Final Diagnosis (BEFD) 
DIGS interview, interviewer narrative, available medical records, and FIGS reports formed 
the basis for diagnostic review. Diagnoses were assigned using the BEFD procedure 
(Leckman et al., 1982), with two experienced psychiatrists independently reviewing all 
available information then conferring to assign a consensus diagnosis. Outstanding 
questions were resolved through discussion and sometimes involved collection of further 
clinical information. Best estimate diagnoses were formulated for all populations, except 
the detailed family subset in Sarawak, where diagnosis was routinely formulated by one 
experienced psychiatrist, with a BEFD generated in a random subset (20 cases). 
 
Diagnostic inter-rater reliability 
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Inter-rater reliability was assessed within the Australian/American sample (Suarez et al., 
2006); within the Indian sample; within the Sarawak sample; between the Australian and 
Indian samples (disagreement in one of 20 cases; κ=0.886); and between the Australian 
and Sarawak samples (disagreement in one of 20 cases; κ=0.828). One psychiatrist (BM) 
was a Principal Investigator on all five studies, and has reviewed all included cases. 
 
Data analysis 
We analyzed a broad range of variables potentially relevant to the five phenomena 
outlined in the introduction, including: demographic variables, (i) age, (ii) marital status, (iii) 
living arrangements, (iv) years of formal schooling, (v) current employment status, (vi) five-
year employment history; illness variables, (vii) DSM-IV diagnosis, (viii) age at onset of 
psychosis, (ix) age at first psychiatric treatment, (x) duration of illness in years, (xi) 
duration of untreated psychosis, (xii) whether ever hospitalized for psychiatric treatment, 
(xiii) number of lifetime hospitalizations; and drug use variables, (xiv) lifetime DSM-IV 
alcohol abuse or dependence, (xv) lifetime DSM-IV cannabis abuse or dependence, (xvi) 
lifetime DSM-IV other drug abuse or dependence. 
 
Age at onset of psychosis was assessed as the age at which active psychotic symptoms 
were first recognized, and duration of untreated psychosis was assessed as the period 
between the onset of psychosis, and the age at which formal psychiatric treatment was 
first accessed.  
 
Sources of data were audited (both electronic and hard copy), and all potential cases were 
identified for whom diagnostic information was available. Data were extracted from 
diagnostic interview databases, where possible, then responses were checked, corrected, 
and missing values retrieved from all available sources. These variables were tested for 
significant differences by site (Australia, India, Sarawak), by sex, and by site controlling for 
sex. Statistical analyses used SAS software, version 9.2 for Windows (SAS Institute Inc.), 
and the tests used included: Chi-Square for nominal and ordinal variables, Proc T-Test 
when comparing two means for interval variables, and Proc GLM when comparing more 
than two means for interval variables. Adequate statistical power for assessing the sixteen 
variables utilizing three-way tests was confirmed using a Bonferroni correction. 
 
Results 
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The present study was drawn from 1831 individuals from Australia (n=821), India (n=524) 
and Sarawak (n=486). We excluded 192 individuals because their DSM-IV diagnosis was 
a psychotic disorder other than schizophrenia or schizoaffective disorder (Australia, n=0; 
India, n=4; Sarawak, n=188). Therefore, the final sample comprised 1639 individuals from 
Australia (n=821), India (n=520) and Sarawak (n=298). DIGS and FIGS data were 
available for over 90% of participants in Australia and India, and approximately 50% of 
participants in Sarawak. Narrative summaries were available for over 90% of participants 
in Australia and Sarawak, and for over 75% of participants in India. Best-estimate final 
diagnoses were available for all participants across the three sites (except as previously 
noted). 
 
A summary of demographic and clinical variables by site is provided in table 3-1. 
 
Table 3-1: Demographic and Clinical Characteristics of Affected Individuals by Site 
Variable Australia India Sarawak Total Test statistic df/dferr P 
N a 821 
(50.1%) 
520 
(31.7%) 
298 
(18.2%) 
1639 (100%)    
Demographic variables        
Age, Mean ± SD 39.10 ± 
11.86 
38.00 ± 
11.98 
46.73 ± 
14.70 
 F = 51.38 2, 1627 < 0.001 
Marital status b 
 
    χ2 = 180.55 4 < 0.001 
Married 56 (6.9%) 163 
(32.3%) 
 
96 
(34.5%) 
 
315 (19.8%) 
 
   
Never married 637 
(78.5%) 
283 
(56.2%) 
 
137 
(49.3%) 
 
1057 (66.3%) 
 
   
Separated/divorced 119 
(14.7%) 
58 
(11.5%) 
45 
(16.2%) 
222 (13.9%)    
Living arrangements    
 
 χ2 = 604.47 6 < 0.001 
Alone 334 
(41.4%) 
6 (1.3%) 8 (2.9%) 348 (22.3%)    
Facility 118 
(14.6%) 
23 
(4.8%) 
1 (0.4%) 142 (9.1%)    
Family 280 
(34.7%) 
444 
(93.1%) 
265 
(96.0%) 
989 (63.4%)    
Others 75 (9.3%) 4 (0.8%) 2 (0.7%) 81 (5.2%)    
Years of formal schooling, Mean 
± SD 
10.95 ± 
2.24 
12.60 ± 
3.39 
5.62 ± 
3.95 
 F = 345.56 2, 1422 < 0.001 
Current employment status     χ2 = 720.75 10 < 0.001 
Disabled: formerly 
worked, no longer 
able 
474 
(58.0%) 
123 
(25.8%) 
7 (2.9%) 604 (39.3%)    
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Homemaker 5 (0.6%) 72 
(15.1%) 
17 (7.0%) 94 (6.1%)    
Never worked 231 
(28.2%) 
102 
(21.4%) 
13 (5.4%) 346 (22.5%)    
Student 10 (1.2%) 22 
(4.6%) 
0 (0%) 32 (2.1%)    
Unemployed 21 (2.6%) 57 
(12.0%) 
30 
(12.4%) 
108 (7.0%)    
Working 77 (9.4%) 101 
(21.2%) 
176 
(72.4%) 
354 (23.0%)    
Occupational dysfunction (past 
five years) 
    χ2 = 189.36 8 < 0.001 
Always worked 18 (2.2%) 68 
(14.4%) 
24 
(16.6%) 
110 (7.7%)    
Periods of 
unemployment not 
related to illness 
6 (0.7%) 17 
(3.6%) 
0 (0%) 23 (1.6%)    
Minor occupational 
dysfunction 
79 (9.7%) 103 
(21.7%) 
20 
(13.8%) 
202 (14.1%)    
Moderate 
occupational 
dysfunction 
115 
(14.1%) 
98 
(20.7%) 
24 
(16.6%) 
237 (16.5%)    
Severe occupational 
dysfunction 
600 
(73.4%) 
188 
(39.7%) 
77 
(53.1%) 
865 (60.2%)    
Illness variables        
Diagnosis     χ2 = 114.09 4 < 0.001 
Schizoaffective, 
depressed 
24 (2.9%) 1 (0.2%) 38 
(12.8%) 
63 (3.8%)    
Schizoaffective, 
bipolar 
32 (3.9%) 1 (0.2%) 19 (6.4%) 52 (3.2%)    
Schizophrenia 765 
(93.2%) 
518 
(99.6%) 
241 
(80.9%) 
1524 (93.0%)    
Age at onset, Mean ± SD 22.09 ± 
6.39 
23.25 ± 
7.60 
29.14 ± 
11.37 
 F = 79.38 2, 1623 < 0.001 
Age at first treatment, Mean ± 
SD 
22.99 ± 
6.69 
25.85 ± 
10.10 
29.45 ± 
11.32 
 F = 53.87 2, 1604 < 0.001 
Illness duration (years) 17.01 ± 
10.68 
14.71 ± 
10.47 
17.50 ± 
10.15 
 F = 11.72 2, 1628 < 0.001 
Duration of untreated psychosis 
(DUP) (years) 
0.89 ± 
2.76 
2.63 ± 
6.99 
0.31 ± 
1.88 
 F = 30.65 2, 1604 < 0.001 
Hospitalized (ever) 787 
(96.0%) 
215 
(46.6%) 
255 
(95.2%) 
1257 (81.2%) χ2 = 511.10 2 < 0.001 
Hospitalizations (lifetime) 8.10 ± 
11.09 
1.01 ± 
1.69 
6.07 ± 
8.65 
 F = 89.36 2, 1543 < 0.001 
Substance use variables        
Alcohol abuse/dependence 
(lifetime) 
333 
(40.7%) 
3 (0.8%) 28 
(10.5%) 
364 (24.5%) χ2 = 265.53 2 < 0.001 
Cannabis abuse/dependence 
(lifetime) 
372 
(45.5%) 
0 (0%) 2 (0.8%) 374 (25.3%) χ2 = 397.06 2 < 0.001 
Other drug abuse/dependence 
(lifetime) 
216 
(26.5%) 
0 (0%) 7 (2.6%) 223 (15.1%) χ2 = 185.94 2 < 0.001 
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a Sample size varies across variables due to exclusion of missing data 
b Widowed individuals not included in marital status analysis (n=26) 
Note: A breakdown of the demographic and clinical characteristics of affected females by site (table 3-2S) 
and affected males by site (table 3-3S) are provided as supplementary material. 
 
Sex breakdown by site 
There were 1055 males (64%) and 584 females included in the sample, comprising: 
Australia, 580 males (71%) and 241 females; India, 302 males (58%) and 218 females; 
and Sarawak, 173 males (58%) and 125 females. 
 
Age by site 
There was a significant age effect (see table 3-4S) across all tested demographic and 
clinical variables, except diagnosis. We tested site differences for each of the 15 non-age 
variables controlling for age (see supplemental tables 3-5S and 3-6S), and our site 
differences remained significant in all instances. 
 
Demographic variables 
The site effects for marital status, living arrangements, current employment status, and 
occupational dysfunction all remained significant once sex was controlled for. Current age 
was significant by site and by sex, however, the relationship between current age and both 
site and sex was not significant, indicating that sex does not confound the site effect. 
Although years of formal schooling was significant by site and by sex, the relationship 
between years of school and both site and sex was also significant, F(2, 1422) = 14.86, p 
< 0.001, which indicates that sex may confound the site effect. All site combinations 
(Sarawak-Australia, Sarawak-India, Australia-India) were significant at 0.05 level using 
Scheffe’s Test for years of formal schooling, whereas two site combinations (Sarawak-
Australia, Sarawak-India) were significant at 0.05 level for current age. 
 
Illness variables 
The site effects for diagnosis and whether hospitalized (ever) remained significant after 
controlling for sex. The site effects for age at onset, age at first treatment, illness duration, 
DUP, and mean hospitalizations do not appear confounded by sex, as the relationship 
between each of these variables by both site and sex was not significant. All site 
combinations (Sarawak-Australia, Sarawak-India, Australia-India) were significant at 0.05 
level using Scheffe’s Test for age at onset, age at first treatment, and mean 
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hospitalizations. Two site combinations (India-Australia, India-Sarawak) were significant at 
0.05 level for both illness duration and DUP. 
 
Substance abuse variables 
The site difference for alcohol, cannabis, and other drug abuse/dependence remained 
significant after controlling for sex. 
 
Power analyses 
All sixteen variables remained significant using a corrected p-value=0.001. 
 
Discussion 
Each of the five studied phenomena was strongly supported by the data, although there 
were interesting variations from what may have been expected from the literature. The 
virtual absence of lifetime drug abuse/dependence in India was lower than expected from 
international figures (UNODC, 2008), although comparable with other studies from 
Chennai (Thara, 2004; Thara et al., 2009). The rate of cannabis abuse/dependence in the 
Iban was very low (<1%); conversely the rate in Australia was very high, with more 
individuals rating for lifetime cannabis abuse/dependence (n=372) than for lifetime alcohol 
abuse/dependence (n=333). 
 
Although the mean DUP reported for indigenous groups in Malaysia was 117 weeks (Chee 
et al., 2010), the mean DUP in our Iban sample was significantly shorter at 16 weeks. Our 
reported DUP for Australian individuals was also somewhat shorter, 46 weeks, than 
expected from the reported average for high-income countries, 63 weeks (Large et al., 
2008). 
 
While our reported mean age at onset of psychosis in Australia (22.1 years) was 
comparable with international literature (Kessler et al., 2007), our Indian AAO was younger 
(23.3 years) than the reported mean for LAMI countries (27.3 years), although closer to the 
reported mean for low-income countries (25.7 years), which included India (Large et al., 
2008). Our Sarawak AAO (29.1 years) was older than both the LAMI figure, and that 
reported for indigenous groups in Malaysia (28.3 years) (Chee et al., 2010). 
 
Potential cofounders for each candidate variable are discussed subsequently, mindful of 
their suitability as phenotypes for genetic studies. 
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Living arrangements 
Culture likely plays an important role in differences in living arrangements by site, with the 
family unit being far more important socially and support-wise in both Sarawak and India. 
This trend was consistently reflected in the narrative summaries, and has been identified in 
the literature (Barrett et al., 2005; Thara et al., 2009). Indian individuals who lack family 
support frequently find other community supports non-existent and consequently reside in 
state-run institutions. 
 
Drug use 
We suggest that the almost non-existent rate of alcohol and drug use in our Indian sample 
is likely due in part to a higher proportion of individuals with schizophrenia and related 
conditions recruited for this study living with family, which limits their access to drugs. 
There have now been two schizophrenia studies based in Chennai reporting extremely low 
drug use (Thara, 2004; Thara et al., 2009). Caste may also play a role in this 
phenomenon; there is a disinclination in the Tamil Brahmin community to use substances 
such as alcohol, although cannabis use has been noted historically (Sharma, 1996). 
 
Duration of untreated psychosis 
The significantly longer mean DUP in India is likely cultural; India was the only site where 
some individuals had never accessed any psychiatric treatment at the time of study 
assessment. Previous Indian schizophrenia studies have identified many individuals who 
have never accessed treatment (McCreadie et al., 2005; Srinivasan et al., 2004). Indian 
individuals were frequently looked after at home with family, a premise supported by the 
analysis of the hospitalization variables, with a lower proportion of Indian individuals 
having ever been hospitalized, and Indian individuals also having the fewest mean number 
of hospitalizations. 
 
Schizoaffective rate 
The comparatively low rate of schizoaffective disorder in India and the conversely high rate 
in Sarawak in contrast to Australia may be indirectly cultural in genesis, resulting from 
different weighting given to mood symptoms either by the local diagnosticians or study 
participants. Alternatively, there may be measurement bias involved which is not cultural in 
origin; the site differences may stem from the different sampling methods and inclusion 
criteria used in Sarawak. A proportion of individuals interviewed in a psychosis-wide 
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assessment protocol (Sarawak) may have an illness course that would not bring them into 
contact with the research team in an opportunistic, schizophrenia-focused recruitment 
setting (India) (Thara et al., 2009). Further analysis of symptom and illness course data will 
be necessary to test this explanation.  
 
Age at onset 
The AAO site difference is puzzling. The mean AAO in Sarawak is almost six years older 
than in either Australia or India, with our reported AAOs similar to those reported in other 
studies in Australia (Kessler et al., 2007) and Malaysia (Chee et al., 2010). Sarawak was a 
representative sample, whereas Australia and India were convenience samples 
comprising both singletons and sib-pairs, although how this would account for such a large 
difference is not apparent. Furthermore, our Australian and Indian AAOs are broadly 
consistent with those reported in systematic review (Large et al., 2008) and representative 
sample data (Kessler et al., 2007). Culturally influenced measurement bias appears 
unlikely; conversely, the societal tendency toward help-seeking behaviour in Sarawak 
would be expected to result in a younger AAO, with cases of psychosis identified and 
documented reliably at an early stage. This phenomenon has been noted with regard to 
shorter DUP for indigenous Malaysians, including the Iban, compared to other groups in 
Malaysia (Chee et al., 2010). 
 
Older AAO has been noted in LAMI countries than high-income countries (Large et al., 
2008), although the difference was not as great as the difference we report, and our AAO 
difference was also seen between India and Sarawak (Malaysia), which are both LAMI 
countries. Thus, while a trend similar to what we report has been identified in the literature, 
there has been no definitive explanation proffered.  
 
Cultural considerations 
Categorization of research participants by ethnicity and/or culture is problematic and highly 
contested (Egede, 2006; Ma et al., 2007). The fact that our cohorts are both ethnically 
homogeneous and geographically constrained enables assessment of cultural 
confounders because these two factors represent the best available proxy for culture 
(Azuonye, 1994). Our sample is large for a transethnic comparative schizophrenia study 
(n=1639) and individuals were assessed with uniform instruments and diagnostic methods 
including the benchmark BEFD. We assessed ethnicity by self-report, which is considered 
the research ‘gold standard’ in transcultural research (Ma et al., 2007). Furthermore, we 
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ascertained birthplace for individuals’ parents and grandparents, confirmed ethnic 
homogeneity genetically, and interviewed individuals in their home countries using local 
interviewers. These measures avoid many confounding factors frequently experienced in 
cross-cultural research, which can limit generalizability of findings (McKenzie and 
Crowcroft, 1996a, 1996b). 
 
We acknowledge that elucidating the complex confounding role of culture in cross-cultural 
research is problematic; therefore, we have not attempted this. Rather, with many 
demographic and clinical site differences available for further investigation, we simply 
eliminated those with readily apparent plausible cultural explanations in order to focus on 
those with no plausible cultural or measurement bias explanations. The stark difference in 
age at onset in Sarawak is such a finding. 
 
Methodological limitations 
First, a lack of measurement equivalence was unavoidable. The samples were collected 
for specific genetic studies, thus there were differences in selection methods of included 
individuals. Both the Indian and Sarawak samples were chosen from ethnically 
homogeneous populations, whereas the Australian sample was not specifically recruited 
as such. Furthermore, the Australian and Indian cohorts included sib-pairs as well as 
unrelated individuals recruited opportunistically, while only the Sarawak sample can be 
considered relatively epidemiologically sound. A high rate of recruitment from hostels in 
Australia, for example, may result in overrepresentation of drug abuse and dependence in 
that sample, although increased drug abuse in boarding house accommodation was not 
identified in a study of substance abuse and schizophrenia in Australia (Fowler et al., 
1998). The opportunistic recruitment methods may have accessed a population with a 
higher level of disability in Australia, which will be investigated in future analyses. The 
different recruitment methods also resulted in DIGS and FIGS data being unavailable for 
approximately half the Sarawak sample (i.e. those from the initial medical records screen). 
 
Second, the limited precision or validity of diagnostic criteria may be problematic. Caution 
must always be exercised when using instruments across cultures, as converting thoughts 
and feelings across languages can be difficult (Barrett, 2004). To address this issue we 
employed state-of-the-art methods, translating and back-translating the DIGS, and using 
local interviewers who interviewed in the native language across the three sites, and 
recorded responses in Iban (Sarawak) and English (India and Australia). The reliability of 
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the instrument (inter-rater reliability within and across the samples) was also tested to 
establish reliability and validity across sites, although diagnostic inter-rater reliability was 
not assessed between India and Sarawak, nor was inter-rater reliability assessed on 
individual diagnostic components other than the DIGS. 
 
Third, the generalizability of our findings is limited, particularly given that both the Iban in 
Malaysia and the Brahmin in India are homogeneous groups within diverse societies. 
Furthermore, we did not specifically collect socioeconomic data across our samples, which 
further limits the generalizability of any findings attributed to ethnicity/culture, as 
socioeconomic position has been proposed as a stronger determinant of health outcomes 
than ethnicity (Egede, 2006). 
 
However, given that we were seeking specific site differences and using cultural 
explanations to prioritize candidates for further investigation, we argue that these 
limitations do not detract from the exploratory value of our methodology or findings. 
Moreover, we hope that our study will energize discourse on tackling the confounding role 
of culture in transethnic psychiatric research - an inherently worthwhile though challenging 
task. Given the clinical heterogeneity of schizophrenia there is ample scope to test a range 
of potential refinements to this complex phenotype in order to facilitate genetic analyses. 
 
Concluding remark 
Our finding that the age of onset in Sarawak is significantly older than in Australia or India 
is worthy of further investigation. As there is no obvious cultural or measurement bias 
explanation to explain this, age at onset emerges as a promising phenotypic candidate for 
genetic studies across ethnically distinct schizophrenia populations. 
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Chapter 3 Supplemental Tables 
This material supplements but does not replace the content of the peer-reviewed paper 
published in Psychiatry Research. 
 
Table 3-2S: Demographic and Clinical Characteristics of Affected Individuals 
(Females) by Site 
Variable Australia India Sarawak Total Test 
statistic 
df/dferr P 
N a 241 (41.3%) 218 (37.3%) 125 (21.4%) 584 (100%)    
Demographic variables        
Age, Mean ± SD 40.63 ± 12.38 37.77 ± 
12.86 
48.49 ± 14.71  F = 26.75 2, 577 < 0.001 
Marital status b 
 
    χ2 = 62.51 4 < 0.001 
Married 25 (10.7%) 80 (38.1%) 
 
49 (43.0%) 
 
154 (27.6%) 
 
   
Never married 159 (68.0%) 90 (42.9%) 
 
42 (36.8%) 
 
291 (52.2%) 
 
   
Separated/divorced 50 (21.4%) 40 (19.1%) 23 (20.2%) 113 (20.3%)    
Living arrangements    
 
 χ2 = 211.88 6 < 0.001 
Alone 97 (40.9%) 2 (1.0%) 1 (0.9%) 100 (18.1%)    
Facility 28 (11.8%) 9 (4.4%) 0 (0%) 37 (6.7%)    
Family 97 (40.9%) 193 (94.6%) 110 (98.2%) 400 (72.3%)    
Others 15 (6.3%) 0 (0%) 1 (0.9%) 16 (2.9%)    
Years of formal schooling, 
Mean ± SD 
10.99 ± 2.06 11.93 ± 3.59 4.04 ± 4.42  F = 148.04 2, 488 < 0.001 
Current employment status     χ2 = 280.18 10 < 0.001 
Disabled: formerly worked, 
no longer able 
117 (48.8%) 41 (20.3%) 2 (2.0%) 160 (29.5%)    
Homemaker 5 (2.1%) 71 (35.2%) 15 (15.0%) 91 (16.8%)    
Never worked 77 (32.1%) 40 (19.8%) 10 (10.0%) 127 (23.4%)    
Student 4 (1.7%) 15 (7.4%) 0 (0%) 19 (3.5%)    
Unemployed 9 (3.8%) 16 (7.9%) 10 (10.0%) 35 (6.5%)    
Working 28 (11.7%) 19 (9.4%) 63 (63.0%) 110 (20.3%)    
Occupational dysfunction 
(past five years) 
    χ2 = 64.26 8 < 0.001 
Always worked 8 (3.3%) 31 (15.4%) 14 (25.0%) 53 (10.7%)    
Periods of unemployment 
not related to illness 
4 (1.7%) 8 (4.0%) 0 (0%) 12 (2.4%)    
Minor occupational 
dysfunction 
36 (15.0%) 50 (24.9%) 7 (12.5%) 93 (18.7%)    
Moderate occupational 
dysfunction 
38 (15.8%) 47 (23.4%) 9 (16.1%) 94 (18.9%)    
Severe occupational 
dysfunction 
154 (64.2%) 65 (32.3%) 26 (46.4%) 245 (49.3%)    
Illness variables        
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Diagnosis     χ2 = 45.61 4 < 0.001 
Schizoaffective, depressed 12 (5.0%) 1 (0.5%) 19 (15.2%) 32 (5.5%)    
Schizoaffective, bipolar 15 (6.2%) 1 (0.5%) 6 (4.8%) 22 (3.8%)    
Schizophrenia 214 (88.8%) 216 (99.1%) 100 (80.0%) 530 (90.8%)    
Age at onset, Mean ± SD 22.69 ± 6.14 23.49 ± 7.70 29.24 ± 11.51  F = 28.46 2, 575 < 0.001 
Age at first treatment, Mean 
± SD 
23.45 ± 6.43 25.99 ± 
10.59 
29.73 ± 11.40  F = 18.66 2, 566 < 0.001 
Illness duration (years) 17.94 ± 11.18 14.19 ± 
10.72 
19.00 ± 10.60  F = 10.03 2, 578 < 0.001 
Duration of untreated 
psychosis (DUP) (years) 
0.75 ± 2.45 2.35 ± 6.97 0.49 ± 2.38  F = 8.88 2, 566 < 0.001 
Hospitalized (ever) 233 (97.1%) 91 (46.7%) 104 (93.7%) 428 (78.4%) χ2 = 180.69 2 < 0.001 
Hospitalizations (lifetime) 8.44 ± 11.27 0.94 ± 1.68 5.25 ± 9.15  F = 40.95 2, 543 < 0.001 
Substance use variables        
Alcohol abuse/dependence 
(lifetime) 
60 (25.1%) 0 (0%) 0 (0%) 60 (11.7%) χ2 = 78.43 2 < 0.001 
Cannabis 
abuse/dependence 
(lifetime) 
74 (31.1%) 0 (0%) 1 (0.9%) 75 (14.6%) χ2 = 96.88 2 < 0.001 
Other drug 
abuse/dependence 
(lifetime) 
43 (18.1%) 0 (0%) 1 (0.9%) 44 (8.6%) χ2 = 51.25 2 < 0.001 
a Sample size varies across variables due to exclusion of missing data 
b Widowed individuals not included in marital status analysis (n=19) 
 
 
Table 3-3S: Demographic and Clinical Characteristics of Affected Individuals (Males) 
by Site 
Variable Australia India Sarawak Total Test 
statistic 
df/dferr P 
N a 580 (55.0%) 302 (28.6%) 173 (16.4%) 1055 (100%)    
Demographic variables        
Age, Mean ± SD 38.47 ± 
11.59 
38.16 ± 11.33 45.47 ± 
14.60 
 F = 25.02 2, 1050 < 0.001 
Marital status b 
 
    χ2 = 109.39 4 < 0.001 
Married 31 (5.4%) 83 (28.2%) 
 
47 (28.7%) 
 
161 (15.5%) 
 
   
Never married 478 (82.7%) 193 (65.7%) 
 
95 (57.9%) 
 
766 (73.9%) 
 
   
Separated/divorced 69 (11.9%) 18 (6.1%) 22 (13.4%) 109 (10.5%)    
Living arrangements    
 
 χ2 = 382.11 6 < 0.001 
Alone 237 (41.6%) 4 (1.5%) 7 (4.3%) 248 (24.6%)    
Facility 90 (15.8%) 14 (5.1%) 1 (0.6%) 105 (10.4%)    
Family 183 (32.1%) 251 (91.9%) 155 (94.5%) 589 (58.5%)    
Others 60 (10.5%) 4 (1.5%) 1 (0.6%) 65 (6.5%)    
Years of formal schooling, 10.93 ± 2.31 13.08 ± 3.16 6.59 ± 3.31  F = 204.27 2, 934 < 0.001 
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Mean ± SD 
Current employment status     χ2 = 439.48 10 < 0.001 
Disabled: formerly worked, 
no longer able 
357 (61.8%) 82 (29.8%) 5 (3.5%) 444 (44.6%)    
Homemaker 0 (0%) 1 (0.4%) 2 (1.4%) 3 (0.3%)    
Never worked 154 (26.6%) 62 (22.6%) 3 (2.1%) 219 (22.0%)    
Student 6 (1.0%) 7 (2.6%) 0 (0%) 13 (1.3%)    
Unemployed 12 (2.1%) 41 (14.9%) 20 (14.0%) 73 (7.3%)    
Working 49 (8.5%) 82 (29.8%) 113 (79.0%) 244 (24.5%)    
Occupational dysfunction 
(past five years) 
    χ2 = 119.50 8 < 0.001 
Always worked 10 (1.7%) 37 (13.6%) 10 (11.2%) 57 (6.1%)    
Periods of unemployment 
not related to illness 
2 (0.4%) 9 (3.3%) 0 (0%) 11 (1.2%)    
Minor occupational 
dysfunction 
43 (7.4%) 53 (19.4%) 13 (14.6%) 109 (11.6%)    
Moderate occupational 
dysfunction 
77 (13.3%) 51 (18.7%) 15 (16.9%) 143 (15.2%)    
Severe occupational 
dysfunction 
446 (77.2%) 123 (45.1%) 51 (57.3%) 620 (66.0%)    
Illness variables        
Diagnosis     χ2 = 74.42 4 < 0.001 
Schizoaffective, depressed 12 (2.1%) 0 (0%) 19 (11.0%) 31 (2.9%)    
Schizoaffective, bipolar 17 (2.9%) 0 (0%) 13 (7.5%) 30 (2.8%)    
Schizophrenia 551 (95.0%) 302 (100.0%) 141 (81.5%) 994 (94.2%)    
Age at onset, Mean ± SD 21.85 ± 6.48 23.07 ± 7.53 29.06 ± 
11.30 
 F = 57.54 2, 1048 < 0.001 
Age at first treatment, Mean 
± SD 
22.79 ± 6.79 25.75 ± 9.75 29.25 ± 
11.30 
 F = 40.73 2, 1038 < 0.001 
Illness duration (years) 16.63 ± 
10.46 
15.07 ± 10.29 16.42 ± 9.70  F = 2.33 2, 1050 0.098 
Duration of untreated 
psychosis (DUP) (years) 
0.95 ± 2.88 2.82 ± 7.00 0.18 ± 1.42  F = 25.72 2, 1038 < 0.001 
Hospitalized (ever) 554 (95.5%) 124 (46.6%) 151 (96.2%) 829 (82.7%) χ2 = 327.89 2 < 0.001 
Hospitalizations (lifetime) 7.97 ± 11.03 1.06 ± 1.69 6.65 ± 8.25  F = 53.76 2, 1000 < 0.001 
Substance use variables        
Alcohol abuse/dependence 
(lifetime) 
273 (47.2%) 3 (1.3%) 28 (18.0%) 304 (31.4%) χ2 = 177.85 2 < 0.001 
Cannabis 
abuse/dependence (lifetime) 
298 (51.5%) 0 (0%) 1 (0.7%) 299 (30.9%) χ2 = 285.25 2 < 0.001 
Other drug 
abuse/dependence (lifetime) 
173 (29.9%) 0 (0%) 6 (3.9%) 179 (18.5%) χ2 = 125.14 2 < 0.001 
a Sample size varies across variables due to exclusion of missing data 
b Widowed individuals not included in marital status analysis (n=7) 
 
 
Table 3-4S: Demographic and Clinical Characteristics of Affected Individuals by 
Agea 
Variable Old (>37 years) Young (<38 years) Total Test statistic df P 
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N b 860 (52.7%) 773 (47.3%) 1633 (100%)    
Demographic variables       
Marital status c 
 
   χ2 = 166.39 2 < 0.001 
Married 234 (28.3%) 
 
77 (10.1%) 
 
311 (19.6%) 
 
   
Never married 429 (51.8%) 
 
627 (82.4%) 
 
1056 
(66.5%) 
 
   
Separated/divorced 165 (19.9%) 57 (7.5%) 222 (14.0%)    
Living arrangements   
 
 χ2 = 34.80 3 < 0.001 
Alone 233 (28.1%) 115 (15.8%) 348 (22.3%)    
Facility 67 (8.1%) 75 (10.3%) 142 (9.1%)    
Family 492 (59.4%) 495 (67.9%) 987 (63.4%)    
Others 37 (4.5%) 44 (6.0%) 81 (5.2%)    
Years of formal schooling    χ2 = 57.93 2 < 0.001 
Primary (<9 years) 158 (21.8%) 57 (8.1%) 215 (15.1%)    
Secondary (9-12 years) 413 (56.9%) 427 (60.8%) 840 (58.8%)    
Tertiary (>12 years) 155 (21.4%) 218 (31.1%) 373 (26.1%)    
Current employment status    χ2 = 44.02 5 < 0.001 
Disabled: formerly worked, no longer 
able 
313 (38.6%) 291 (40.1%) 604 (39.3%)    
Homemaker 59 (7.3%) 34 (4.7%) 93 (6.1%)    
Never worked 170 (21.0%) 176 (24.2%) 346 (22.5%)    
Student 2 (0.3%) 30 (4.1%) 32 (2.1%)    
Unemployed 52 (6.4%) 56 (7.7%) 108 (7.0%)    
Working 215 (26.5%) 139 (19.2%) 354 (23.0%)    
Occupational dysfunction (past five 
years) 
   χ2 = 17.97 4 0.001 
Always worked 67 (9.2%) 43 (6.1%) 110 (7.7%)    
Periods of unemployment not related 
to illness 
12 (1.6%) 11 (1.6%) 23 (1.6%)    
Minor occupational dysfunction 90 (12.3%) 112 (15.9%) 202 (14.1%)    
Moderate occupational dysfunction 99 (13.5%) 138 (19.6%) 237 (16.5%)    
Severe occupational dysfunction 463 (63.3%) 402 (56.9%) 865 (60.2%)    
Illness variables       
Diagnosis    χ2 = 2.87 2 0.238 
Schizoaffective, depressed 39 (4.5%) 24 (3.1%) 63 (3.9%)    
Schizoaffective, bipolar 30 (3.5%) 22 (2.9%) 52 (3.2%)    
Schizophrenia 791 (92.0%) 727 (94.1%) 1518 
(93.0%) 
   
Age at onset    χ2 = 235.72 3 < 0.001 
< 19 years 146 (17.1%) 298 (38.6%) 444 (27.3%)    
19 to 28 years 416 (48.6%) 427 (55.2%) 843 (51.8%)    
29 to 38 years 200 (23.4%) 48 (6.2%) 248 (15.2%)    
39+ years 94 (11.0%) 0 (0%) 94 (5.8%)    
Age at first treatment    χ2 = 257.63 3 < 0.001 
< 19 years 106 (12.5%) 238 (31.2%) 344 (21.4%)    
19 to 28 years 393 (46.5%) 457 (59.8%) 850 (52.8%)    
29 to 38 years 221 (26.1%) 69 (9.0%) 290 (18.0%)    
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39+ years 126 (14.9%) 0 (0%) 126 (7.8%)    
Illness duration (years)    χ2 = 436.28 3 < 0.001 
< 6 years 31 (3.6%) 222 (28.7%) 253 (15.5%)    
6 to 25 years 532 (62.0%) 551 (71.3%) 1083 
(66.4%) 
   
26 to 45 years 282 (32.9%) 0 (0%) 282 (17.3%)    
46+ years 13 (1.5%) 0 (0%) 13 (0.8%)    
Duration of untreated psychosis 
(DUP) (years) 
   χ2 = 45.98 2 < 0.001 
< 1 year 668 (79.0%) 550 (72.0%) 1218 
(75.7%) 
   
1 to 4 years 99 (11.7%) 178 (23.3%) 277 (17.2%)    
5+ years 79 (9.3%) 36 (4.7%) 115 (7.1%)    
Hospitalized (ever) 682 (83.1%) 573 (78.9%) 1255 
(81.1%) 
χ2 = 4.32 1 0.038 
Hospitalizations (lifetime)    χ2 = 44.58 4 < 0.001 
None 139 (16.9%) 153 (21.1%) 292 (18.9%)    
One 105 (12.8%) 152 (20.9%) 257 (16.6%)    
2-3 167 (20.3%) 154 (21.2%) 321 (20.8%)    
4-9 223 (27.2%) 179 (24.7%) 402 (26.0%)    
10+ 187 (22.8%) 88 (12.1%) 275 (17.8%)    
Substance use variables       
Alcohol abuse/dependence (lifetime) 168 (21.0%) 196 (28.8%) 364 (24.6%) χ2 = 12.02 1 < 0.001 
Cannabis abuse/dependence 
(lifetime) 
118 (14.8%) 256 (37.7%) 374 (25.3%) χ2 = 101.78 1 < 0.001 
Other drug abuse/dependence 
(lifetime) 
70 (8.8%) 153 (22.5%) 223 (15.1%) χ2 = 53.82 1 < 0.001 
a Age stratified into binary variable based on median age of sample (38 years) 
b Sample size varies across variables due to exclusion of missing data 
c Widowed individuals not included in marital status analysis (n=26) 
 
 
Table 3-5S: Demographic and Clinical Characteristics of Affected Individuals by Site 
Controlling for Age (Old: Age > 37 Years) 
Variable Australia India Sarawak Total Test statistic df P 
N a 423 (49.2%) 232 (27.0%) 205 (23.8%) 860 (100%)    
Demographic variables        
Marital status b 
 
    χ2 = 133.55 4 < 0.001 
Married 43 (10.4%) 105 (47.1%) 
 
86 (45.3%) 
 
234 (28.3%) 
 
   
Never married 271 (65.3%) 89 (39.9%) 
 
69 (36.3%) 
 
429 (51.8%) 
 
   
Separated/divorced 101 (24.3%) 29 (13.0%) 35 (18.4%) 165 (19.9%)    
Living arrangements    
 
 χ2 = 393.19 6 < 0.001 
Alone 220 (52.8%) 6 (2.7%) 7 (3.7%) 233 (28.1%)    
Facility 57 (13.7%) 9 (4.1%) 1 (0.5%) 67 (8.1%)    
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Family 108 (25.9%) 203 (91.9%) 181 (94.8%) 492 (59.4%)    
Others 32 (7.7%) 3 (1.4%) 2 (1.1%) 37 (4.5%)    
Years of formal schooling     χ2 = 276.16 4 < 0.001 
Primary (<9 years) 56 (13.4%) 29 (13.4%) 73 (79.4%) 158 (21.8%)    
Secondary (9-12 years) 299 (71.7%) 96 (44.2%) 18 (19.6%) 413 (56.9%)    
Tertiary (>12 years) 62 (14.9%) 92 (42.4%) 1 (1.1%) 155 (21.4%)    
Current employment status     χ2 = 514.25 10 < 0.001 
Disabled: formerly worked, no 
longer able 
260 (61.8%) 49 (22.3%) 4 (2.4%) 313 (38.6%)    
Homemaker 2 (0.5%) 43 (19.6%) 14 (8.2%) 59 (7.3%)    
Never worked 122 (29.0%) 43 (19.6%) 5 (2.9%) 170 (21.0%)    
Student 0 (0%) 2 (0.9%) 0 (0%) 2 (0.3%)    
Unemployed 8 (1.9%) 30 (13.6%) 14 (8.2%) 52 (6.4%)    
Working 29 (6.9%) 53 (24.1%) 133 (78.2%) 215 (26.5%)    
Occupational dysfunction (past 
five years) 
    χ2 = 136.44 8 < 0.001 
Always worked 12 (2.9%) 35 (16.0%) 20 (22.0%) 67 (9.2%)    
Periods of unemployment not 
related to illness 
3 (0.7%) 9 (4.1%) 0 (0%) 12 (1.6%)    
Minor occupational dysfunction 28 (6.7%) 50 (22.8%) 12 (13.2%) 90 (12.3%)    
Moderate occupational 
dysfunction 
44 (10.5%) 40 (18.3%) 15 (16.5%) 99 (13.5%)    
Severe occupational dysfunction 334 (79.3%) 85 (38.8%) 44 (48.4%) 463 (63.3%)    
Illness variables        
Diagnosis     χ2 = 61.47 4 < 0.001 
Schizoaffective, depressed 15 (3.6%) 0 (0%) 24 (11.7%) 39 (4.5%)    
Schizoaffective, bipolar 13 (3.1%) 0 (0%) 17 (8.3%) 30 (3.5%)    
Schizophrenia 395 (93.4%) 232 
(100.0%) 
164 (80.0%) 791 (92.0%)    
Age at onset     χ2 = 98.07 6 < 0.001 
< 19 years 93 (22.0%) 39 (17.0%) 14 (6.9%) 146 (17.1%)    
19 to 28 years 237 (56.0%) 103 (44.8%) 76 (37.4%) 416 (48.6%)    
29 to 38 years 71 (16.8%) 68 (29.6%) 61 (30.1%) 200 (23.4%)    
39+ years 22 (5.2%) 20 (8.7%) 52 (25.6%) 94 (11.0%)    
Age at first treatment     χ2 = 76.15 6 < 0.001 
< 19 years 70 (16.6%) 24 (10.9%) 12 (5.9%) 106 (12.5%)    
19 to 28 years 234 (55.5%) 84 (38.0%) 75 (37.0%) 393 (46.5%)    
29 to 38 years 90 (21.3%) 68 (30.8%) 63 (31.0%) 221 (26.1%)    
39+ years 28 (6.6%) 45 (20.4%) 53 (26.1%) 126 (14.9%)    
Illness duration (years)     χ2 = 19.64 6 0.003 
< 6 years 10 (2.4%) 11 (4.7%) 10 (4.9%) 31 (3.6%)    
6 to 25 years 246 (58.2%) 147 (63.4%) 139 (68.5%) 532 (62.0%)    
26 to 45 years 161 (38.1%) 67 (28.9%) 54 (26.6%) 282 (32.9%)    
46+ years 6 (1.4%) 7 (3.0%) 0 (0%) 13 (1.5%)    
Duration of untreated psychosis 
(DUP) (years) 
    χ2 = 77.73 4 < 0.001 
< 1 year 337 (79.9%) 137 (62.0%) 194 (95.6%) 668 (79.0%)    
1 to 4 years 55 (13.0%) 42 (19.0%) 2 (1.0%) 99 (11.7%)    
5+ years 30 (7.1%) 42 (19.0%) 7 (3.5%) 79 (9.3%)    
Hospitalized (ever) 406 (96.2%) 96 (45.1%) 180 (96.8%) 682 (83.1%) χ2 = 295.32 2 < 0.001 
Hospitalizations (lifetime)     χ2 = 395.09 8 < 0.001 
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None 16 (3.8%) 117 (54.9%) 6 (3.2%) 139 (16.9%)    
One 28 (6.6%) 44 (20.7%) 33 (17.7%) 105 (12.8%)    
2-3 81 (19.2%) 38 (17.8%) 48 (25.8%) 167 (20.3%)    
4-9 152 (36.0%) 11 (5.2%) 60 (32.3%) 223 (27.2%)    
10+ 145 (34.4%) 3 (1.4%) 39 (21.0%) 187 (22.8%)    
Substance use variables        
Alcohol abuse/dependence 
(lifetime) 
150 (35.7%) 3 (1.5%) 15 (8.1%) 168 (21.0%) χ2 = 117.87 2 < 0.001 
Cannabis abuse/dependence 
(lifetime) 
117 (27.9%) 0 (0%) 1 (0.5%) 118 (14.8%) χ2 = 121.15 2 < 0.001 
Other drug abuse/dependence 
(lifetime) 
68 (16.3%) 0 (0%) 2 (1.1%) 70 (8.8%) χ2 = 61.77 2 < 0.001 
a Sample size varies across variables due to exclusion of missing data 
b Widowed individuals not included in marital status analysis (n=26) 
 
 
Table 3-6S: Demographic and Clinical Characteristics of Affected Individuals by Site 
Controlling for Age (Young: Age < 38 Years) 
Variable Australia India Sarawak Total Test statistic df P 
N a 398 (51.5%) 285 (36.9%) 90 (11.6%) 773 (100%)    
Demographic variables        
Marital status b 
 
    χ2 = 64.07 4 < 0.001 
Married 13 (3.3%) 55 (19.8%) 
 
9 (10.5%) 
 
77 (10.1%) 
 
   
Never married 366 (92.2%) 194 (69.8%) 
 
67 (77.9%) 
 
627 (82.4%) 
 
   
Separated/divorced 18 (4.5%) 29 (10.4%) 10 (11.6%) 57 (7.5%)    
Living arrangements    
 
 χ2 = 226.27 6 < 0.001 
Alone 114 (29.2%) 0 (0%) 1 (1.2%) 115 (15.8%)    
Facility 61 (15.6%) 14 (5.5%) 0 (0%) 75 (10.3%)    
Family 172 (44.1%) 241 (94.1%) 82 (98.8%) 495 (67.9%)    
Others 43 (11.0%) 1 (0.4%) 0 (0%) 44 (6.0%)    
Years of formal schooling     χ2 = 183.71 4 < 0.001 
Primary (<9 years) 13 (3.3%) 22 (8.6%) 22 (39.3%) 57 (8.1%)    
Secondary (9-12 years) 295 (75.6%) 98 (38.3%) 34 (60.7%) 427 (60.8%)    
Tertiary (>12 years) 82 (21.0%) 136 (53.1%) 0 (0%) 218 (31.1%)    
Current employment status     χ2 = 213.21 10 < 0.001 
Disabled: formerly worked, no 
longer able 
214 (53.9%) 74 (28.8%) 3 (4.2%) 291 (40.1%)    
Homemaker 3 (0.8%) 29 (11.3%) 2 (2.8%) 34 (4.7%)    
Never worked 109 (27.5%) 59 (23.0%) 8 (11.1%) 176 (24.2%)    
Student 10 (2.5%) 20 (7.8%) 0 (0%) 30 (4.1%)    
Unemployed 13 (3.3%) 27 (10.5%) 16 (22.2%) 56 (7.7%)    
Working 48 (12.1%) 48 (18.7%) 43 (59.7%) 139 (19.2%)    
Occupational dysfunction (past 
five years) 
    χ2 = 67.85 8 < 0.001 
Always worked 6 (1.5%) 33 (12.9%) 4 (7.4%) 43 (6.1%)    
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Periods of unemployment not 
related to illness 
3 (0.8%) 8 (3.1%) 0 (0%) 11 (1.6%)    
Minor occupational dysfunction 51 (12.9%) 53 (20.8%) 8 (14.8%) 112 (15.9%)    
Moderate occupational 
dysfunction 
71 (17.9%) 58 (22.8%) 9 (16.7%) 138 (19.6%)    
Severe occupational dysfunction 266 (67.0%) 103 (40.4%) 33 (61.1%) 402 (56.9%)    
Illness variables        
Diagnosis     χ2 = 66.59 4 < 0.001 
Schizoaffective, depressed 9 (2.3%) 1 (0.4%) 14 (15.6%) 24 (3.1%)    
Schizoaffective, bipolar 19 (4.8%) 1 (0.4%) 2 (2.2%) 22 (2.9%)    
Schizophrenia 370 (93.0%) 283 (99.3%) 74 (82.2%) 727 (94.1%)    
Age at onset c     ********* ** ****** 
< 19 years 165 (41.5%) 107 (37.5%) 26 (28.9%) 298 (38.6%)    
19 to 28 years 215 (54.0%) 161 (56.5%) 51 (56.7%) 427 (55.2%)    
29 to 38 years 18 (4.5%) 17 (6.0%) 13 (14.4%) 48 (6.2%)    
39+ years 0 (0%) 0 (0%) 0 (0%) 0 (0%)    
Age at first treatment c     ********* ** ****** 
< 19 years 133 (33.4%) 79 (28.6%) 26 (28.9%) 238 (31.2%)    
19 to 28 years 242 (60.8%) 164 (59.4%) 51 (56.7%) 457 (59.8%)    
29 to 38 years 23 (5.8%) 33 (12.0%) 13 (14.4%) 69 (9.0%)    
39+ years 0 (0%) 0 (0%) 0 (0%) 0 (0%)    
Illness duration (years) c     ********* ** ****** 
< 6 years 94 (23.6%) 99 (34.7%) 29 (32.2%) 222 (28.7%)    
6 to 25 years 304 (76.4%) 186 (65.3%) 61 (67.8%) 551 (71.3%)    
26 to 45 years 0 (0%) 0 (0%) 0 (0%) 0 (0%)    
46+ years 0 (0%) 0 (0%) 0 (0%) 0 (0%)    
Duration of untreated psychosis 
(DUP) (years) 
    χ2 = 43.45 4 < 0.001 
< 1 year 291 (73.1%) 173 (62.7%) 86 (95.6%) 550 (72.0%)    
1 to 4 years 95 (23.9%) 79 (28.6%) 4 (4.4%) 178 (23.3%)    
5+ years 12 (3.0%) 24 (8.7%) 0 (0%) 36 (4.7%)    
Hospitalized (ever) 381 (95.7%) 119 (48.0%) 73 (91.3%) 573 (78.9%) χ2 = 217.61 2 < 0.001 
Hospitalizations (lifetime)     χ2 = 296.42 8 < 0.001 
None 17 (4.3%) 129 (52.0%) 7 (8.8%) 153 (21.1%)    
One 61 (15.3%) 67 (27.0%) 24 (30.0%) 152 (20.9%)    
2-3 98 (24.6%) 34 (13.7%) 22 (27.5%) 154 (21.2%)    
4-9 145 (36.4%) 18 (7.3%) 16 (20.0%) 179 (24.7%)    
10+ 77 (19.4%) 0 (0%) 11 (13.8%) 88 (12.1%)    
Substance use variables        
Alcohol abuse/dependence 
(lifetime) 
183 (46.0%) 0 (0%) 13 (16.3%) 196 (28.8%) χ2 = 145.60 2 < 0.001 
Cannabis abuse/dependence 
(lifetime) 
255 (64.1%) 0 (0%) 1 (1.3%) 256 (37.7%) χ2 = 285.49 2 < 0.001 
Other drug abuse/dependence 
(lifetime) 
148 (37.2%) 0 (0%) 5 (6.3%) 153 (22.5%) χ2 = 120.40 2 < 0.001 
a Sample size varies across variables due to exclusion of missing data 
b Widowed individuals not included in marital status analysis (n=26) 
c No statistics computed for these tables due to a row sum being zero. 
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Chapter 4. Identifying Characteristic Symptom Profiles 
McLean D, Barrett R, Loa P, Thara R, John S, McGrath J, Gratten J and Mowry B (2015) 
Comparing schizophrenia symptoms in the Iban of Sarawak with other populations to 
elucidate clinical heterogeneity. Asia-Pacific Psychiatry 7(1): 36-44. 
 
Abstract 
Introduction 
The symptom profile of schizophrenia can vary between ethnic groups. We explored 
selected symptom variables previously reported to be characteristic of schizophrenia in the 
Iban of Sarawak in transethnic populations from Australia, India and Sarawak, Malaysia. 
We tested site differences to confirm previous research, and to explore implications of 
differences across populations for future investigations. 
 
Methods 
We recruited schizophrenia samples in Australia (n=609), India (n=310) and Sarawak 
(n=205) primarily for the purposes of genetic studies. We analyzed seven identified 
variables and their relationship to site using logistic regression, including: global delusions, 
bizarre delusions, thought broadcast/insertion/withdrawal delusions, global hallucinations, 
auditory hallucinations, disorganized behavior, and prodromal duration. 
 
Results 
We identified a distinct symptom profile in our Sarawak sample. Specifically, the Iban 
exhibit: low frequency of thought broadcast/insertion/withdrawal delusions, high frequency 
of auditory hallucinations and disorganized behavior, with a comparatively short prodrome 
when compared with Australian and Indian populations. 
 
Discussion 
Understanding between-site variation in symptom profile may complement future 
transethnic genetic studies, and provide important clues as to the nature of differing 
schizophrenia expression across ethnically distinct groups. A comprehensive approach to 
subtyping schizophrenia is warranted, utilizing comprehensively ascertained transethnic 
samples to inform both schizophrenia genetics and nosology. 
 
Key words: psychotic disorders, schizophrenia, culture, diagnosis, population 
characteristics 
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Introduction 
In the past, the syndrome of schizophrenia has been treated as a single entity diagnosed 
according to reliable, internationally accepted criteria consisting of symptoms, disability, 
duration, illness course, and exclusion of allied disorders (APA, 1994; WHO, 1992). 
However, there is now clear evidence that schizophrenia shares a genetic predisposition 
with bipolar disorder (ISC, 2009; Lichtenstein et al., 2009), which challenges the 
dichotomous view of functional psychosis (Craddock et al., 2009). There is currently little 
consensus on whether the latent structure of schizophrenia is best represented as a single 
(continuous) entity, with clinical variation represented as dimensions within a single class, 
or as two or more distinct, separate entities, with variation indicative of a number of distinct 
classes grouped under the label ‘schizophrenia’ (Fiedorowicz et al., 2008; Kendler et al., 
1998; Linscott et al., 2009). 
 
While the field has been mindful of within-group heterogeneity of schizophrenia, the 
between-group, transethnic differences in the phenotypes have received less scrutiny. 
Examination of transethnic schizophrenia samples provides an opportunity to elucidate 
differences in schizophrenia expression, which are important to a comprehensive 
understanding of this disorder (Kleinman, 1988). 
 
Previous anthropological (Barrett, 2004) and psychiatric (Barrett et al., 2005) research on 
the Iban of Sarawak has proposed the following symptoms as characteristic of 
schizophrenia in that population: low rates of bizarre delusions, specifically thought 
broadcast, insertion and withdrawal delusions; and high rates of auditory hallucinations, 
disorganized behavior, restlessness and insomnia. Additionally, a comparatively short 
prodrome has been consistently noted in case review, particularly in comparison with other 
studied populations. 
 
The Genetics Research group at the Queensland Centre for Mental Health Research 
(QCMHR) and our collaborators recruited three cohorts of individuals with psychosis for 
genetic analyses: European Australians (n=821); Tamil Brahmin and proximal caste 
groups from Tamil Nadu, India (n=520); and the Iban of Sarawak, Malaysia (n=298). In this 
paper, we examined nine variables previously associated with schizophrenia in the Iban, 
and compared the frequencies of these variables in the Iban sample with our Australian 
and Indian cohorts. 
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Our available Iban sample is an extension of the sample described in a previous 
publication (Barrett et al., 2005). Their sample included individuals with schizophrenia 
identified through an initial medical records screen (n=275). We recontacted and 
comprehensively assessed 122 of these individuals plus an additional 23 individuals who 
were primarily new cases diagnosed after the initial screen. Thus we increased both 
sample size (of included individuals with schizophrenia) and quality of clinical information 
available. We aimed to confirm the previous research proposing these characteristic 
symptoms, and explore the implications of differences across populations. 
 
We hypothesized that (i) hallucinations (specifically auditory), disorganized behavior, sleep 
disturbance, and psychomotor changes would occur more frequently in the Iban than in 
samples derived from Australian or Indian populations; (ii) bizarre delusions (specifically 
broadcast, insertion and withdrawal delusions) would occur less frequently in the Iban than 
in Australia or India; and (iii) the prodrome would be shorter in the Iban than in Australia or 
India. 
 
Methods 
Sample details 
Sample recruitment across sites and clinical ascertainment are detailed elsewhere (see 
McLean et al., 2012). Briefly, recruitment at each site involved: Australia – sibling pairs and 
unrelated individuals were recruited as part of a major US/Australian collaboration 
(Molecular Genetics of Schizophrenia [MGS] Consortium) from multiple sources, including 
local treatment facilities, physician referrals, community organizations, supported 
accommodation facilities and advertisements; India – sibling pairs, trios and unrelated 
individuals were identified and invited to participate through The Schizophrenia Research 
Foundation India (SCARF); and Sarawak – Iban individuals were identified through 
Malaysian census data, an initial medical records assessment was undertaken, then a 
subset of individuals and families were contacted for in-depth follow-up. We included all 
individuals with a Diagnostic and Statistical Manual of Mental Disorders, fourth edition 
(DSM-IV) (APA, 1994) diagnosis of schizophrenia or schizoaffective disorder who met the 
(self-reported) ethnicity inclusion criterion. Ethnicity was subsequently confirmed through 
genetic analysis (Australia: Shi et al., 2009; India and Sarawak: manuscripts in 
preparation). Exclusion criteria for individuals were: (i) inability to give informed consent; 
(ii) psychosis assessed as secondary to substance use or a neurological disorder; and (iii) 
severe intellectual disability. Informed consent was obtained across all sites, and local 
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Institutional Ethics Committee approval was obtained for each study. This research 
conforms to the provisions of the Declaration of Helsinki (as revised in Edinburgh 2000). 
 
Clinical ascertainment 
Clinical ascertainment included five elements. 
(i) Trained clinicians used the semi-structured Diagnostic Interview for Genetic 
Studies (DIGS) (Nurnberger et al., 1994) to obtain DSM-IV relevant diagnostic information. 
(ii) A family informant, when possible, or the proband was interviewed about the 
family psychiatric history using the Family Interview for Genetic Studies (FIGS) (Gershon 
et al., 1988; Maxwell, 1992). The cultural equivalence of the DIGS and FIGS was 
extensively addressed by the chief investigators at the three sites, and each instrument 
was translated into Iban (Sarawak) and Tamil (India) with appropriate back-translation 
procedures.  
(iii) All available medical records were retrieved for each participant and assessed by 
trained clinicians. 
(iv) A trained clinician prepared a case summary based on all available information, 
which facilitated diagnostic review. 
(v) DIGS interview, case summary, available medical records, and FIGS reports 
formed the basis for diagnostic review. Diagnoses were assigned using the Best Estimate 
Final Diagnosis (BEFD) procedure (Leckman et al., 1982), with two experienced 
psychiatrists independently reviewing all available information then conferring to assign a 
consensus diagnosis. Approximately half the Sarawak sample had diagnoses formulated 
by one experienced psychiatrist, with a BEFD generated in a random subset (20 cases). 
 
Inter-rater reliability was assessed within the Australian/US sample (Shi et al., 2009; 
Suarez et al., 2006); within the Indian sample (Thara et al., 2009); within the Sarawak 
sample; between the Australian and Indian samples (disagreement in one of 20 cases; 
κ=0.886); and between the Australian and Sarawak samples (disagreement in one of 20 
cases; κ=0.828). One psychiatrist (BM) was a Principal Investigator on all studies, and has 
reviewed all included cases. 
 
Data analysis 
We analyzed nine clinical variables identified in previous research: (i) lifetime delusions; (ii) 
bizarre delusions; (iii) delusions of thought broadcast, insertion or withdrawal; (iv) lifetime 
hallucinations; (v) auditory hallucinations; (vi) lifetime disorganized or catatonic motor 
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behavior; (vii) sleep disturbance; (viii) psychomotor changes; and (ix) length of prodromal 
period. We also included the following potentially confounding variables: (x) sex; (xi) age; 
and (xii) presence of lifetime major depressive episodes. 
 
Prodromal duration was obtained from all available information (DIGS interview, case 
summary, medical records, FIGS reports), and was assessed as the period between when 
social and/or occupational decline was first observed and when definite psychotic 
symptoms were first recorded. It was coded as dichotomous: rapid=onset within 4 weeks; 
gradual=onset longer than 4 weeks. Two outcome variables (sleep disturbance and 
psychomotor changes) were dropped from the model due to a lack of statistical 
equivalence across sites, after the preliminary models exhibited unacceptable levels of 
overdispersion and failure to converge. 
 
Sources of data were audited (both electronic and hard copy), and all potential cases were 
identified for whom comprehensive diagnostic information was available. Data were 
extracted from diagnostic interview databases, where possible, then responses were 
checked, corrected, and missing values retrieved from all available sources, including a 
detailed review of all narrative summaries. 
 
Due to the potential confounding effect of including both related and unrelated individuals 
in our sample, we selected a conservative model. Individuals within families may be more 
similar with regard to demographic and symptom characteristics than unrelated individuals 
owing to shared socioeconomic and environmental circumstances. Given that between-
site similarities and differences across these variables were a focus of this study, and the 
degree of inter-relatedness differed across sites, we included only unrelated individuals, 
with a single individual randomly selected from each of the 1124 families across the three 
sites. 
 
Outcome variables were then assessed individually by logistic regression, fitting site, 
presence of lifetime depressive episode(s), age, and sex as explanatory variables, plus all 
second level effects (e.g. site-by-sex) for these variables. We performed model 
simplification based on AIC, with the least significant effect being removed from the model 
at each iteration, until all remaining effects were significant. The minimal adequate model 
is presented for each outcome variable. Statistical analyses used Proc Logistic in SAS 
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software, version 9.3 for Windows (SAS Institute Inc.). We used Bonferroni correction to 
account for multiple testing. 
 
The present study was drawn from 1831 individuals from Australia (n=821), India (n=524) 
and Sarawak (n=486). We excluded 192 individuals because their DSM-IV diagnosis was 
a psychotic disorder other than schizophrenia or schizoaffective disorder (Australia, n=0; 
India, n=4; Sarawak, n=188). Of the resulting 1639 individuals we then excluded all 
individuals with missing data for any of the eleven variables (seven outcome, four 
explanatory) of interest (Australia, n=136; India, n=24; Sarawak, n=62), leaving 1417 
individuals from 1124 independent families. One individual from each family was randomly 
selected to constitute the final sample of 1124 individuals (Australia, n=609; India, n=310; 
Sarawak, n=205). DIGS and FIGS data were available for over 90% of participants in 
Australia and India, and approximately 50% of participants in Sarawak. Case summaries 
were available for over 90% of participants in Australia and Sarawak, and for over 75% of 
participants in India. Best-estimate final diagnoses were available for all participants 
across the three sites (except as previously noted). 
 
Results 
A summary of symptom variable frequencies by site, including all outcome and 
explanatory variables, is provided in table 4-1. 
 
Table 4-1: Demographic and symptom characteristics of affected individuals by site † 
Variable Australia India Sarawak Total 
N 609 (54.2%) 310 (27.6%) 205 (18.2%) 1124 (100%) 
Demographic variables     
Age, Mean ± SD 38.95 ± 11.55 36.57 ± 11.37 47.19 ± 14.67 39.80 ± 12.66 
Sex     
Female 173 (28.4%) 128 (41.3%) 85 (41.5%) 386 (34.3%) 
Male 436 (71.6%) 182 (58.7%) 120 (58.5%) 738 (65.7%) 
Symptom variables     
Diagnosis     
Schizoaffective, depressed 22 (3.6%) 1 (0.3%) 30 (14.6%) 53 (4.7%) 
Schizoaffective, bipolar 26 (4.3%) 0 (0%) 16 (7.8%) 42 (3.7%) 
Schizophrenia 561 (92.1%) 309 (99.7%) 159 (77.6%) 1029 (91.6%) 
Onset type     
Rapid (4 weeks or less) 109 (17.9%) 70 (22.6%) 90 (43.9%) 269 (23.9%) 
Gradual (longer than 4 weeks) 500 (82.1%) 240 (77.4%) 115 (56.1%) 855 (76.1%) 
Presence of any delusions (lifetime) 599 (98.3%) 283 (91.3%) 164 (80.0%) 1046 (93.1%) 
Presence of bizarre delusions (lifetime) 410 (67.3%) 113 (36.5%) 40 (19.5%) 563 (50.1%) 
Presence of thought broadcast/insertion/withdrawal 
delusions (lifetime) 
322 (52.9%) 44 (14.2%) 22 (10.7%) 388 (34.5%) 
Presence of any hallucinations (lifetime) 566 (92.9%) 253 (81.6%) 194 (94.6%) 1013 (90.1%) 
Presence of auditory hallucinations (lifetime) 551 (90.5%) 244 (78.7%) 192 (93.7%) 987 (87.8%) 
Presence of disorganized behavior (lifetime) 464 (76.2%) 244 (78.7%) 177 (86.3%) 885 (78.7%) 
Presence of major depressive episode(s) (lifetime) 261 (42.9%) 9 (2.9%) 44 (21.5%) 314 (27.9%) 
† One affected family member randomly generated from each family included in the sample. 
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A summary of the logistic regression performed is provided in table 4-2, with associated 
odds ratios and 95% confidence intervals provided in table 4-3. 
 
Table 4-2: Logistic regression showing predictors of the presence of identified 
characteristic Iban symptoms † 
Outcome Variable Explanatory Variables ‡ DF Wald Χ2 P-value § 
Global Delusions     
 Intercept 1 19.85 <0.0001*** 
 Site 2 23.78 <0.0001*** 
 Age 1 0.84 0.36 
 Major depressive episodes 1 7.59 0.006** 
 Age by Site 2 4.62 0.10 
Bizarre Delusions     
 Intercept 1 7.77 0.005** 
 Site 2 38.67 <0.0001*** 
 Age 1 16.56 <0.0001*** 
 Sex 1 3.56 0.06 
 Age by Site 2 9.63 0.008** 
 Sex by Site 2 5.17 0.08 
Broadcast/Insertion/Withdrawal Delusions     
 Intercept 1 19.09 <0.0001*** 
 Site 2 65.97 <0.0001*** 
 Age 1 10.57 0.001** 
 Major depressive episodes 1 2.57 0.11 
 Age by Site 2 6.38 0.041* 
Global Hallucinations     
 Intercept 1 51.18 <0.0001*** 
 Site 2 24. 24 <0.0001*** 
 Age 1 4.82 0.028* 
 Sex 1 5.68 0.017* 
 Major depressive episodes 1 0.96 0.33 
 Sex by Major depressive episodes 1 4.31 0.038* 
Auditory Hallucinations     
 Intercept 1 90.76 <0.0001*** 
 Site 2 65.40 <0.0001*** 
 Age 1 4.89 0.027* 
 Sex 1 0.16 0.69 
 Sex by Site 2 9.39 0.009** 
Disorganized Behavior     
 Intercept 1 60.33 <0.0001*** 
 Site 2 6.38 0.041* 
 Age 1 3.10 0.08 
 Major depressive episodes 1 3.46 0.06 
Rapid Onset Type     
 Intercept 1 2.52 0.11 
 Site 2 43.03 <0.0001*** 
 Age 1 10.56 0.001** 
 Sex 1 6.90 0.009** 
 Major depressive episodes 1 1.42 0.23 
 Age by Site 2 5.18 0.08 
 Sex by Site 2 5.96 0.05 
 Age by Sex 1 8.06 0.005** 
 Sex by Major depressive episodes 1 2.81 0.09 
* p<0.05 ** p<0.01 *** p<0.001 
† Iteration with best AIC (model fit) that passes overdispersion test shown for each outcome 
variable  
‡ Odds ratios and 95% confidence intervals for relevant effect combinations presented as Table 3 
§ Effects surpassing Bonferroni correction shown in bold 
 
Table 4-3: Odds ratios and 95% confidence intervals for all variable combinations presented 
in Table 4-2 
Outcome 
Variable 
Explanatory Variable Combinations Estimate (95% CI) 
Global 
Delusions 
  
 Site (Australia vs. India) at mean age 5.06 (1.94 – 13.18) 
 Site (Australia vs. Sarawak) at mean age 15.57 (6.17 – 39.32) 
 Site (India vs. Sarawak) at mean age 3.08 (1.71 – 5.57) 
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 Age in Australia 0.21 (0.04 – 1.05) 
 Age in India 0.22 (0.09 – 0.52) 
 Age in Sarawak 0.70 (0.33 – 1.49) 
 No major depressive episodes vs. one or more major depressive episodes 0.26 (0.10 – 0.68) 
Bizarre 
Delusions 
  
 Site (Australia vs. India) at mean age, males 3.64 (2.40 – 5.54) 
 Site (Australia vs. Sarawak) at mean age, males 11.91 (6.32 – 22.43) 
 Site (India vs. Sarawak) at mean age, males 3.27 (1.64 – 6.51) 
 Site (Australia vs. India) at mean age, females 4.40 (2.53 – 7.65) 
 Site (Australia vs. Sarawak) at mean age, females 4.61 (2.31 – 9.18) 
 Site (India vs. Sarawak) at mean age, females 1.05 (0.50 – 2.18) 
 Age in Australia 0.73 (0.50 – 1.07) 
 Age in India 0.49 (0.28 – 0.88) 
 Age in Sarawak 0.17 (0.07 – 0.39) 
 Sex (Male vs. Female) in Australia 1.15 (0.76 – 1.74) 
 Sex (Male vs. Female) in India 1.39 (0.81 – 2.38) 
 Sex (Male vs. Female) in Sarawak 0.44 (0.19 – 1.03) 
Broadcast/ 
Insertion/ 
Withdrawal 
Delusions 
  
 Site (Australia vs. India) at mean age 6.29 (4.08 – 9.70) 
 Site (Australia vs. Sarawak) at mean age 9.15 (5.09 – 16.44) 
 Site (India vs. Sarawak) at mean age 1.45 (0.74 – 2.85) 
 Age in Australia 0.65 (0.46 – 0.93) 
 Age in India 0.79 (0.37 – 1.71) 
 Age in Sarawak 0.15 (0.05 – 0.47) 
 No major depressive episodes vs. one or more major depressive episodes 0.76 (0.54 – 1.06) 
Global 
Hallucinations 
  
 Site (Australia vs. India) 3.58 (2.00 – 6.39) 
 Site (Australia vs. Sarawak) 0.73 (0.32 – 1.66) 
 Site (India vs. Sarawak) 0.20 (0.09 – 0.47) 
 Age 0.58 (0.35 – 0.94) 
 Sex (Male vs. Female), no major depressive episodes 0.46 (0.25 – 0.87) 
 Sex (Male vs. Female) , one or more major depressive episodes 1.68 (0.59 – 4.74) 
 Depressive episodes (none vs. one or more),  males 0.66 (0.29 – 1.52) 
 Depressive episodes (none vs. one or more), females 2.39 (0.89 – 6.40) 
Auditory 
Hallucinations 
  
 Site (Australia vs. India), males 3.73 (2.61 – 5.34) 
 Site (Australia vs. Sarawak), males 0.58 (0.31 – 1.10) 
 Site (India vs. Sarawak), males 0.16 (0.08 – 0.30) 
 Site (Australia vs. India), females 1.47 (0.86 – 2.50) 
 Site (Australia vs. Sarawak), females 0.62 (0.30 – 1.30) 
 Site (India vs. Sarawak), females 0.43 (0.20 – 0.90) 
 Age 0.72 (0.54 – 0.96) 
 Sex (Male vs. Female) in Australia 1.12 (0.72 – 1.76) 
 Sex (Male vs. Female) in India 0.44 (0.28 – 0.70) 
 Sex (Male vs. Female) in Sarawak 1.19 (0.50 – 2.83) 
Disorganized 
Behavior 
  
 Site (Australia vs. India) 0.96 (0.67 – 1.38) 
 Site (Australia vs. Sarawak) 0.57 (0.36 – 0.89) 
 Site (India vs. Sarawak) 0.59 (0.36 – 0.97) 
 Age 1.31 (0.97 – 1.76) 
 Depressive episodes (none vs. one or more) 1.38 (0.98 – 1.94) 
Rapid Onset 
Type 
  
 Site (Australia vs. India) at mean age, males 0.80 (0.50 – 1.29) 
 Site (Australia vs. Sarawak) at mean age, males 0.20 (0.13 – 0.32) 
 Site (India vs. Sarawak) at mean age, males 0.25 (0.15 – 0.43) 
 Site (Australia vs. India) at mean age, females 0.34 (0.17 – 0.68) 
 Site (Australia vs. Sarawak) at mean age, females 0.23 (0.12 – 0.43) 
 Site (India vs. Sarawak) at mean age, females 0.66 (0.35 – 1.23) 
 Age, males in Australia 0.66 (0.42 – 1.05) 
 Age, males in India 0.88 (0.46 – 1.67) 
 Age, males in Sarawak 0.36 (0.19 – 0.66) 
 Age, females in Australia 1.62 (0.88 – 2.99) 
 Age, females in India 2.15 (1.14 – 4.07) 
 Age, females in Sarawak 0.87 (0.43 – 1.73) 
 Sex (Male vs. Female) at mean age, no major depressive episodes in 
Australia 
1.59 (0.83 – 3.04) 
 Sex (Male vs. Female) at mean age, no major depressive episodes in India 0.68 (0.39 – 1.17) 
 Sex (Male vs. Female) at mean age, no major depressive episodes in 
Sarawak 
1.76 (0.95 – 3.25) 
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 Sex (Male vs. Female) at mean age, one or more major depressive episodes 
in Australia 
0.84 (0.48 – 1.47) 
 Sex (Male vs. Female) at mean age, one or more major depressive episodes 
in India 
0. 36 (0.15 – 0.88) 
 Sex (Male vs. Female) at mean age, one or more major depressive episodes 
in Sarawak 
0.93 (0.42 – 2.07) 
 Depressive episodes (none vs. one or more), males 0.77 (0.50 – 1.18) 
 Depressive episodes (none vs. one or more), females 0.41 (0.22 – 0.75) 
 
Each of the seven outcome variables had significant site effects, while all outcome 
variables except global delusions and disorganized behavior had significant age effects. 
Both lifetime hallucinations and length of prodrome had significant sex effects, whereas 
only lifetime delusions had a significant depressive episode(s) effect. 
 
Multiple testing correction 
The site effect for six of the seven outcome variables remained significant using a 
Bonferroni corrected p-value=0.0007, with only the disorganized behavior effect (p=0.041) 
failing to reach this threshold. Age remained significant for bizarre delusions, with younger 
individuals having greater odds of reporting bizarre delusions. No other effects remained 
significant for any of the outcome variables. 
 
Discussion 
Consistent with previous reports (Barrett, 2004; Barrett et al., 2005), we found that 
individuals with schizophrenia from the Iban sample differed on key symptom variables. In 
addition, we identified a range of differences for these variables between the Iban, 
Australia and India.  
 
Delusions 
While the proportion of individuals reporting bizarre delusions and delusions of thought 
broadcast, insertion and withdrawal was lowest in the Iban, it is noteworthy that the 
frequencies in India were also low in contrast to Australia, and that India and Sarawak 
were similar in their reported frequencies of broadcast/insertion/withdrawal delusions 
(India 14.2%; Sarawak 10.7%). The difficulty of assessing bizarreness of beliefs is widely 
recognized (Kendler et al., 1983), particularly across cultures (APA, 1994). Moreover, the 
greater frequency of Schneiderian first-rank symptoms reported in Western populations 
has been attributed to bizarre experiences in Western cultures being considered normative 
in non-Western cultures (Barrett, 2004). However, several alternative explanations for 
these cross-cultural differences have also been proposed (for a summary see Barrett, 
2004). 
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Younger individuals had significantly greater odds of experiencing lifetime bizarre 
delusions, after correction for multiple testing. This somewhat counter-intuitive result may 
reflect recall bias, with an under-reporting of bizarre delusions in older individuals, since 
age has been associated with decreased occurrence of delusions and hallucinations 
(Schultz et al., 1997).  
 
Hallucinations 
Auditory hallucinations were, as expected, reported most frequently in the Iban, although 
rates of both lifetime hallucinations and auditory hallucinations did not differ between 
Sarawak (lifetime 94.6%; auditory 93.7%) and Australia (lifetime 92.9%; auditory 90.5%), 
with Indian rates (lifetime 81.6%; auditory 78.7%) significantly lower. A ‘striking 
resemblance’ in the appearance of auditory hallucinations, between Australian and Iban 
samples with schizophrenia, has been noted (Barrett, 2004). This finding offers an 
interesting contrast to our delusion finding, in that any explanation relying on Western/non-
Western cultural norms explaining site differences is not sufficient to explain the significant 
difference in rates of auditory hallucinations between the non-Western cultures of India 
and Sarawak.  
 
Disorganized behavior 
The frequency of disorganized behavior was marginally higher in the Iban (86.3%) than in 
Australia (76.2%) or India (78.7%), although this site difference was non-significant after 
correction for multiple testing.  
 
Onset type 
The clear site difference regarding greater frequency of rapid onset in Sarawak (43.9%) in 
contrast to Australia (17.9%) and India (22.6%) is of particular interest. A later age of onset 
(~6 years) finding in the Iban compared with Australia and India has been previously 
reported (McLean et al., 2012), yet the greater proportion of Iban individuals with rapid 
onset type is equally stark. Because the majority of Iban live with close family contact, and 
there is a societal propensity to seek early medical treatment (Barrett et al., 2005), early 
changes in behavior would likely be readily noted; thus, a longer reported prodrome may 
be expected, with social/occupational decline prior to psychosis onset identified more 
readily than in other populations. Clearly, the data do not support this. Alternatively, help-
seeking behavior may prompt earlier diagnosis, truncating the period regarded as 
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prodromal, with definite psychosis detected earlier in the Iban, in contrast to other 
populations, where later detection may ‘artificially’ lengthen the period regarded as 
prodromal. Cultural considerations may also be fundamental to the identified site 
difference: e.g. the Iban may be more tolerant of aberrant behavior than other societies, 
and may not rate atypical behavior as ‘prodromal’ until immediately prior to recognition of 
definite psychosis. 
 
Cultural considerations 
Categorization of research participants by ethnicity and/or culture is problematic and highly 
contested (Egede, 2006; Ma et al., 2007). The fact that our cohorts are both ethnically 
homogeneous and geographically constrained enables assessment of cultural 
confounders because these two factors represent the best available proxy for culture 
(Azuonye, 1994). Our sample is large for a transethnic comparative schizophrenia study 
(n=1124), individuals were assessed using the same battery of instruments, and 
individuals were diagnosed using the best-estimate final diagnosis method, which offers 
consistently high diagnostic reliability and stability (Beckmann et al., 1996; Calkins et al., 
2007), and is the benchmark method available with current methods of classifying 
schizophrenia (McLean et al., 2012). We assessed ethnicity by self-report, which is 
considered the research ‘gold standard’ in transcultural research (Ma et al., 2007). 
Furthermore, we ascertained birthplace for individuals’ parents and grandparents, 
confirmed ethnic homogeneity genetically, and interviewed individuals in their home 
countries using local interviewers. These measures avoid many confounding factors 
frequently experienced in cross-cultural research, which can limit generalizability of 
findings (McKenzie and Crowcroft, 1996a, 1996b). 
 
Methodological limitations 
First, a lack of measurement equivalence was unavoidable. The samples were collected 
for specific genetic studies, thus there were differences in selection methods of included 
individuals. Both the Indian and Sarawak samples were chosen from ethnically 
homogeneous populations, whereas the Australian sample was not specifically recruited 
as such (although we did focus on Caucasian ethnicity). Furthermore, the Australian and 
Indian cohorts included sib-pairs as well as unrelated individuals recruited 
opportunistically, while only the Sarawak sample can be considered relatively 
epidemiologically sound (Barrett et al., 2005). As previously noted, we negated any effect 
of familial relatedness in our model by randomly selecting one individual per family for 
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analyses. The different recruitment methods also resulted in DIGS and FIGS data being 
unavailable for approximately half the Sarawak sample (see McLean et al., 2012). 
 
Second, caution must always be exercised when using diagnostic instruments across 
cultures, since converting thoughts, feelings, and concepts such as bizarreness across 
languages can be difficult (Barrett, 2004). Consequently, we addressed cultural 
equivalence extensively in the preliminary planning for the studies (for a cultural 
equivalence framework see Herdman et al., 1998). We also employed state-of-the-art 
methods, translating and back-translating the DIGS, and using local interviewers who 
interviewed in the native language across the three sites, and recorded responses in Iban 
(Sarawak) and English (India and Australia). The reliability of the instrument (inter-rater 
reliability within and across the samples) was also tested across sites, although diagnostic 
inter-rater reliability was not assessed between India and Sarawak. 
 
Third, the generalizability of our findings is limited, particularly given that both the Iban in 
Malaysia and the Tamil Brahmin and other geographically proximal castes in India are 
homogeneous groups within diverse societies. Furthermore, we did not specifically collect 
socioeconomic data across our samples, which further limits the generalizability of any 
findings attributed to ethnicity/culture, as socioeconomic position has been proposed as a 
stronger determinant of health outcomes than ethnicity (Egede, 2006). 
 
Fourth, utilizing a sample of individuals meeting the DSM-IV criteria for either 
schizophrenia or schizoaffective disorder to study the nature of psychosis and/or 
schizophrenia itself may be problematic, in that we are not able to make comparisons with 
other DSM-IV diagnoses such as bipolar disorder, which would give a ‘broader 
perspective’. Furthermore, restricting the sample to those meeting DSM-IV schizophrenia 
criteria excludes cases with psychosis demonstrating the most clinical variation; these may 
be important to cultural understanding of psychosis (Kleinman, 1988). 
 
Finally, because the samples were collected for specific genetic studies, there are 
limitations to the assumptions and generalizations we can make regarding difficult-to-
quantify culturally-sensitive concepts such as length of prodrome, notwithstanding our 
extensive cross-cultural equivalence work and use of carefully ascertained ethnicity as our 
distinguishing factor between sites. In order to validate and interpret our finding of 
significantly shorter prodrome in Sarawak, further qualitative in-depth interviews 
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specifically addressing cultural interpretations of illness progression and associated 
concepts across sites should be undertaken. This follow-up research, while worthwhile, 
was beyond the scope of this study. 
 
Conclusions 
We have observed significant differences in the frequency of symptoms of schizophrenia 
across three ethnically different populations. A comprehensive search for clinical subtypes 
using ethnically distinct populations is warranted, as this may contribute to our 
understanding of between-group clinical variation, which may not only benefit future 
genetic studies, but also inform the ongoing nosological debate regarding schizophrenia. 
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Chapter 5. DSM-IV “criterion A” schizophrenia symptoms across ethnically different 
populations:  evidence for differing psychotic symptom content or structural 
organization? 
McLean D, Thara R, John S, Barrett R, Loa P, McGrath J and Mowry B (2014) DSM-IV 
“criterion A” schizophrenia symptoms across ethnically different populations: evidence for 
differing psychotic symptom content or structural organization? Culture, Medicine and 
Psychiatry 38(3): 408-426. 
 
 
Abstract 
There is significant variation in the expression of schizophrenia across ethnically different 
populations, and the optimal structural and diagnostic representation of schizophrenia are 
contested. We contrasted both lifetime frequencies of DSM-IV criterion A (the core 
symptom criterion of the internationally recognized DSM classification system) symptoms 
and types/content of delusions and hallucinations in transethnic schizophrenia populations 
from Australia (n=776), India (n=504) and Sarawak, Malaysia (n=259), to elucidate clinical 
heterogeneity. Differences in both criterion A symptom composition and symptom content 
were apparent. Indian individuals with schizophrenia reported negative symptoms more 
frequently than other sites, whereas individuals from Sarawak reported disorganized 
symptoms more frequently. Delusions of control and thought broadcast, insertion or 
withdrawal were less frequent in Sarawak than Australia. Curiously, a subgroup of 20 
Indian individuals with schizophrenia reported no lifetime delusions or hallucinations. 
These findings potentially challenge the long-held view in psychiatry that schizophrenia is 
fundamentally similar across cultural groups, with differences in only the content of 
psychotic symptoms, but equivalence in structural form. 
 
Key words: psychotic disorders, culture, diagnosis, taxonomy 
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Introduction/Background 
Schizophrenia is often treated as a discrete diagnostic entity based on widely-used and 
reliable criteria consisting of symptoms, duration, illness course, and exclusion of allied 
disorders (APA, 1994; WHO, 1992). However, schizophrenia shares a genetic 
predisposition with bipolar disorder (ISC, 2009; Lichtenstein, et al., 2009; Mowry and 
Gratten, 2013), which challenges the dichotomous view of functional psychosis (Craddock, 
et al., 2009). There is contention regarding the optimal representation of schizophrenia’s 
structure: (1) a single (continuous) entity, with clinical variation represented as dimensions 
within a single class, or (2) two or more distinct, separate entities, with variation indicative 
of multiple classes grouped under the label “schizophrenia” (Fiedorowicz, et al., 2008; 
Kendler, et al., 1998; Linscott, et al., 2009). 
 
Examination of the variation in schizophrenia expression across cultures may help clarify 
the complex nature of this disorder (Kleinman, 1988; Thakker and Ward, 1998). Whereas 
transethnic samples have been traditionally used to validate mainstream diagnostic criteria 
(Thakker and Ward, 1998), they provide an opportunity to examine differences in 
schizophrenia expression, as well as commonalities, both of which are important to a 
comprehensive nosological understanding (Alarcon et al., 2009; Kleinman, 1988). 
 
While many transcultural psychiatry studies have sought to understand the expression of 
schizophrenia across cultures (e.g. the World Health Organization’s groundbreaking 
Cross-Cultural Research Program (Jablensky et al., 1992)), they have implicitly favoured 
the prevailing view (Linscott et al., 2009) that schizophrenia is universal: it has similar 
manifestations in all cultures (Thakker and Ward, 1998). This view, consistent with the 
pathoplastic model favoured in Western psychiatry (Kulhara and Chakrabarti, 2001), 
contends that schizophrenia is fundamentally similar across cultural groups, with 
differences expressed only in the content (e.g. demons, government conspiracy) of 
symptoms, not the underlying cause and structure (Kleinman, 1988; Kulhara and 
Chakrabarti, 2001). The WHO International Pilot Study of Schizophrenia (IPSS) and the 
follow-up Determinants of Outcome of Severe Mental Disorder Project (DOSMeD) 
reported similar symptom profiles in all centers, although the DOSMeD noted important 
differences in the frequencies of traditional schizophrenia subtypes (utilizing ICD-9 (WHO, 
1977)) across international sites. The acute subtype was reported almost twice as often 
(~40%) in developing countries as the paranoid subtype (~23%), in contrast with 
developed countries where the paranoid subtype (~34%) was diagnosed three times as 
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often as the acute subtype (~11%). Hebephrenic schizophrenia was more commonly 
diagnosed in developed counties (~13% developed vs. ~4% developing), whereas 
catatonic schizophrenia was more commonly diagnosed in developing countries (~1% 
developed vs. ~10% developing) (Sartorius et al., 1986). However, these studies widely 
reported similarities between sites, while differences received only a brief mention 
(Kleinman, 1988). Data indicating symptom differences deserve as much credence as data 
indicating broad similarities (Thakker and Ward, 1998).  
 
A necessary (but not sufficient) diagnostic component of schizophrenia (and 
schizoaffective disorder) in the Diagnostic and Statistical Manual of Mental Disorders, 
fourth edition (DSM-IV) (APA, 1994) is criterion A, which comprises five symptom types: 
delusions, hallucinations, disorganized speech, grossly disorganized or catatonic behavior, 
and negative symptoms. Two or more of these are required for a diagnosis of 
schizophrenia (unless bizarre delusions or auditory hallucinations containing commentary 
or third person conversations are present, when one is sufficient) (for full details see APA, 
1994). 
 
The five criterion A symptoms align well with three well established dimensions (see 
Fiedorowicz et al., 2008): positive – delusions and hallucinations; negative – negative 
symptoms; and disorganized – disorganized speech and grossly disorganized or catatonic 
behavior. These dimensions form the basis for three corresponding syndromes within the 
schizophrenia diagnosis, which have been isolated using factor analysis in multiple 
cultures (e.g. Arora et al., 1997; Gureje et al., 1995), providing strong evidence for their 
cross-cultural robustness (Kulhara and Chakrabarti, 2001). 
 
Similarities in the prevalence of different criterion A symptom types between groups would 
generally support schizophrenia having a continuous structure (similar organization of 
underlying symptoms). Significant differences in criterion A composition across sites, 
however, would potentially suggest multiple classes within the schizophrenia diagnosis 
(differences in underlying structural organization), given both genetic evidence for latent 
classes within the broad schizophrenia diagnosis evident in distinct ethnic groups (e.g. 
Holliday et al., 2009), and the current lack of biological confirmation of common etiology. 
Holliday et al. (2009) reported genomewide significant linkage of a deficit subtype 
(identified by latent class analysis), characterized by moderate to severe negative 
symptoms, prominent disorganization, and marked to severe functional impairment, in a 
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Han Chinese schizophrenia sample (n=606 affected sibling pair pedigrees; >1200 
schizophrenia cases). This linked chromosomal region, previously implicated in 
schizophrenia pathogenesis, was not detected when the traditional DSM-IV schizophrenia 
diagnosis was used in the analysis.  
 
The Genetics Research group at the Queensland Centre for Mental Health Research 
(QCMHR) and our collaborators recruited three cohorts of individuals with schizophrenia 
and related conditions for genetic analyses: European Australians (n=821); Tamil Brahmin 
and proximal caste groups from Tamil Nadu, India (n=520); and the Iban of Sarawak, 
Malaysia (n=298). We examined symptom organization and content in these three 
ethnically distinct populations in two ways: (1) we contrasted frequencies of the five DSM-
IV criterion A schizophrenia symptoms by site, and (2) we contrasted frequencies of 
delusion and hallucination content by site, with a particular focus on Schneiderian First 
Rank Symptoms (FRS) (see Mellor, 1970), since the cross-cultural applicability of FRS has 
been questioned (Barrett, 2004), specifically in the Iban. 
 
Much of the trans-ethnic schizophrenia research since the WHO’s Cross-Cultural 
Research Program (Sartorius, 2007) has involved migrant groups within countries (e.g. 
Cantor-Graae and Selten, 2005; Fearon et al., 2006), with few recent studies contrasting 
core components of diagnostic classification across multiple international sites. Nuevo et 
al. (2012) conducted an analysis of psychotic symptoms in the general population with a 
large sample (n=256,445) comprising samples from 52 countries worldwide. They 
assessed the number of psychotic symptoms individuals experienced in the 12 months 
prior to interview and their impact on health status. They did report prevalence of 
diagnosed schizophrenia between countries, although this was not a focus of the study, 
their study design did not include institutionalized individuals, and their interview schedule 
only assessed four core symptoms: delusional mood, delusions of reference and 
persecution, delusions of control, and auditory or visual hallucinations. They found a very 
wide range in the prevalence of psychotic symptoms between countries; however 
significant differences in study goals and design with our study make drawing comparisons 
problematic. 
 
Methods 
Sample details 
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Sample recruitment across sites and clinical ascertainment are detailed elsewhere (see 
McLean et al., 2012). Briefly, recruitment at each site involved: Australia – sibling pairs and 
individuals were recruited as part of a major US/Australian collaboration (Molecular 
Genetics of Schizophrenia [MGS] Consortium) from a range of sources, including local 
treatment facilities, physician referrals, community organizations, supported 
accommodation facilities and advertisements; India – sibling pairs and individuals were 
identified and invited to participate through The Schizophrenia Research Foundation 
India’s (SCARF’s) well-established recruitment network of clinicians; and Sarawak – Iban 
individuals were identified through Malaysian census data, an initial medical records 
screen was undertaken, then a subset of individuals and families were contacted for in-
depth follow-up. We included all individuals (probands and relatives) with a Diagnostic and 
Statistical Manual of Mental Disorders, fourth edition (DSM-IV) (APA, 1994) diagnosis of 
schizophrenia or schizoaffective disorder who met the (self-reported) ethnicity inclusion 
criterion: Australia – self-reported European Caucasian ancestry; India – membership of 
Brahmin caste from Tamil, Kerala, Karnataka, or Andhra Pradesh, or membership of 
geographically proximal caste groups from Tamil Nadu (Mudaliars, Chettiars, and Dalits) 
(for details see Thara et al., 2009); and Sarawak – self-reported Iban ethnicity. Ethnicity 
was subsequently confirmed through genetic analysis (Australia: Shi et al., 2009; India and 
Sarawak: manuscripts in preparation). Briefly, genomewide association analyses (GWAS) 
were undertaken for each sample; one quality control procedure involved conducting 
principal component analyses to confirm each individual’s GWAS data against 
international control population GWAS data in order to exclude ancestral/ethnic outliers 
from further analyses. Clinical exclusion criteria for individuals were: (1) inability to give 
informed consent; (2) psychosis assessed as secondary to substance use or a 
neurological disorder; and (3) severe intellectual disability. 
 
All participants in Australia and India gave written informed consent, and individuals in 
Sarawak who participated in the detailed screening follow-up gave verbal, videotaped 
informed consent (given that the Iban is traditionally a preliterate society). Individuals 
consented to an interview, a blood sample for DNA, and review of their psychiatric records. 
Local Institutional Review Board approval was obtained for each study. 
 
Clinical ascertainment 
Clinical ascertainment included five elements. 
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(1) Trained clinicians used the semi-structured Diagnostic Interview for Genetic Studies 
(DIGS) (Nurnberger et al., 1994) to obtain DSM-IV relevant diagnostic information. 
(2) A family informant, when possible, or the proband was interviewed about the family 
psychiatric history using the Family Interview for Genetic Studies (FIGS) (Gershon et al., 
1988; Maxwell, 1992). 
(3) All available medical records were retrieved for each participant and then assessed by 
trained clinicians. 
(4) A trained clinician prepared a case summary based on all available information which 
facilitated diagnostic review. 
(5) DIGS interview, case summary, available medical records, and FIGS reports formed 
the basis for diagnostic review. Diagnoses were assigned using the Best Estimate Final 
Diagnosis (BEFD) procedure (Leckman et al., 1982), with two experienced psychiatrists 
independently reviewing all available information then conferring to assign a consensus 
diagnosis. Approximately half the Sarawak sample had diagnoses formulated by one 
experienced psychiatrist, with a BEFD generated in a random subset (20 cases). 
 
Inter-rater reliability was assessed within the Australian/US sample (50 cases; κ=0.88 for 
schizophrenia, κ=0.89 for schizoaffective disorder) (Suarez et al., 2006); within the Indian 
sample; within the Sarawak sample; between the Australian and Indian samples 
(disagreement in one of 20 cases; κ=0.886); and between the Australian and Sarawak 
samples (disagreement in one of 20 cases; κ=0.828). The robustness of inter-rater 
reliability within the unpublished assessments (India, Sarawak) is consistent with the other 
assessments presented here. 
 
The cultural equivalence of the DIGS and FIGS was extensively addressed by the chief 
investigators at the three sites, with specific focus on conceptual equivalence, item 
equivalence, and functional equivalence (for details of a cultural equivalence framework 
see Herdman et al., 1998). Professor Barrett completed his PhD in 
Anthropology/Psychiatry, living for several years immersed in Iban culture, and pioneered 
modern schizophrenia research in the Iban; Dr. Thara has a long track record of 
schizophrenia research in India; and Professor Mowry oversaw diagnostic equivalence 
across all sites by reviewing every case. Both Professor Barrett, in Sarawak, and Dr. 
Thara, in India, have conducted qualitative research and written extensively on how culture 
mediates the experience of psychosis, and the implications for using standardized 
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diagnostic instruments and applying universal diagnostic criteria within these cultures 
(Barrett, 2004; Corin et al., 2004). An appreciation of the relational or interactional notion 
of ‘self’ in both Sarawak (Barrett, 2004) and India (Corin et al., 2004; Kakar, 1991), in 
contrast to individual uniqueness defining ‘self’ in post-Enlightenment Western cultures 
(Kakar, 1991) such as Australia, is central to establishing diagnostic equivalence across 
sites.  
 
The DIGS and FIGS were translated into both Iban (Sarawak) and Tamil (India) with 
appropriate back-translation procedures. Interview schedules were translated into Tamil 
and Iban, affected individuals were interviewed by experienced bilingual research 
clinicians, and responses to questions were recorded and back-translated into English. 
This process was repeated several times until the research teams were sure that the final 
version accurately reflected clinical phenomenology. 
 
Data analysis 
We classified included individuals according to the lifetime-ever presence of DSM-IV 
criterion A symptoms that comprised their schizophrenia or schizoaffective diagnosis. 
Twenty-eight possible symptom combinations meet criterion A: two combinations where an 
included individual rates positive for only one of the five symptom types (i.e. bizarre 
delusions or third person auditory hallucinations); ten combinations with two symptoms 
(e.g. delusions and disorganized speech); ten combinations with three symptoms; five 
combinations with four symptoms; and one combination with all five symptoms.  
 
These 28 categories were collapsed into six based on criterion A symptoms belonging to 
one of the three previously noted dimensions: positive – delusions and hallucinations; 
negative – negative symptoms; and disorganized – disorganized speech and grossly 
disorganized or catatonic behavior. Thus, the six discrete categories were: (1) positive 
only; (2) disorganized only; (3) positive and disorganized; (4) positive and negative; (5) 
disorganized and negative; and (6) positive, disorganized and negative. Site differences 
across these six groups were then explored. 
 
We also examined the types of delusions and hallucinations experienced between sites, 
which were derived from categories assessed in the DIGS. The specific delusion 
categories include: bizarre; thought broadcast, insertion, or withdrawal; control; 
persecutory; referential; jealousy; guilt or sin; grandiose; religious; somatic; erotomanic; 
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and mind reading. The specific hallucination categories include: auditory; auditory with 
commentary or third person conversations; visual; olfactory or gustatory; and somatic or 
tactile. Three of these variables: delusions of thought broadcast, insertion, or withdrawal; 
control delusions; and auditory hallucinations with commentary or third person 
conversations were specifically included to capture Schneiderian First Rank Symptoms. 
 
Statistical analyses used the χ2 statistic in SAS software, version 9.3 for Windows (SAS 
Institute Inc.). Adequate statistical power for assessing the five dimension categories (no 
included individuals rated positively for the sixth category: disorganized dimension only) 
and nineteen symptom content variables utilizing three-way tests was confirmed using a 
Bonferroni correction (72 separate comparisons; adjusted p=0.0007). 
 
Results 
The present study was drawn from 1831 individuals from Australia (n=821), India (n=524) 
and Sarawak (n=486). We excluded 192 individuals with DSM-IV diagnoses other than 
schizophrenia or schizoaffective disorder (Australia, n=0; India, n=4; Sarawak, n=188). Of 
the resulting 1639 individuals we then excluded all individuals with missing data for any 
criterion A symptom variable (Australia, n=45; India, n=16; Sarawak, n=39). Therefore, the 
final sample comprised 1539 individuals (Australia, n=776; India, n=504; Sarawak, n=259). 
DIGS and FIGS data were available for over 90% of participants in Australia and India, 
and approximately 50% in Sarawak. Narrative summaries were available for over 90% of 
participants in Australia and Sarawak, and over 75% in India. Best-estimate final 
diagnoses were available for all participants across the three sites (except as previously 
noted). 
 
A summary of demographic and diagnostic details of included individuals by site is 
provided in Table 5-1. 
 
Table 5-1: Demographic and Diagnostic Characteristics of Included Individuals by 
Site 
Symptom Australia 
(N=776) 
India (N=504) Sarawak 
(N=259) 
Total (N=1539) 
Age in Years (Mean ± SD) 38.9 ± 11.73 37.9 ± 12.06 46.9 ± 14.86 39.93 ± 12.80 
Sex Male 547 (70.5%) 294 (58.3%) 152 (58.7%) 993 (64.5%) 
 Female 229 (29.5%) 210 (41.7%) 107 (41.3%) 546 (35.5%) 
Diagnosis Schizophrenia 724 (93.3%) 502 (99.6%) 203 (78.4%) 1429 (92.9%) 
 Schizoaffective 
Depressed 
23 (3.0%) 1 (0.2%) 37 (14.3%) 61 (4.0%) 
 Schizoaffective Bipolar 29 (3.7%) 1 (0.2%) 19 (7.3%) 49 (3.2%) 
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Symptoms/dimensions comprising schizophrenia criterion A for included individuals by site 
are provided as Table 5-2. 
 
Table 5-2: Criterion A symptoms of schizophrenia – Dimensions with established 
lifetime ratings† by site 
Criterion A Endorsed Dimensions‡ Australia India Sarawak Total 
Positive Only 2 (0.3%) 4  (0.8%) 8 (3.1%) 14 (0.9%) 
Positive + Disorganized 18 (2.3%) 7 (1.4%) 25 (9.7%) 50 (3.2%) 
Positive + Negative 88 (11.3%) 89 (17.7%) 20 (7.7%) 197 (12.8%) 
Disorganized + Negative 0 (0%) 20 (4.0%) 2 (0.8%) 22 (1.4%) 
Positive + Disorganized + Negative 668 (86.1%) 384 (76.2%) 204 (78.8%) 1256 (81.6%) 
Total 776 (100%) 504 (100%) 259 (100%) 1539 (100%) 
† No included individuals rated positively for the disorganized dimension only 
‡ A detailed breakdown of specific criterion A symptom frequencies by site is provided as Table 5-4S 
 
While the frequency of positive symptoms was high across each site (Australia 776/776: 
100%; India 484/504: 96.0%; Sarawak 257/259: 99.2%), there were noticeably lower 
frequencies of negative symptoms in Sarawak (Australia 756/776: 97.4%; India 493/504: 
97.8%; Sarawak 226/259: 87.3%), and disorganized symptoms in India (Australia 686/776: 
88.4%; India 411/504: 81.5%; Sarawak 231/259: 89.2%). 
 
There was a significant overall site difference using a Bonferroni-corrected p-value 
(p=0.0007) in the proportion of subjects who had each combination of endorsed symptom 
dimensions χ2(8, N=1539) = 111.72, p < 0.0001. The positive/disorganized/negative 
dimension category was reported most frequently in our Australian sample; the positive 
only and positive/disorganized dimension combinations were reported most frequently in 
our Sarawak sample; while the positive/negative and disorganized/negative dimension 
categories were reported most frequently in our Indian sample. Twenty (4.0%) individuals 
in India met the DSM-IV criteria for schizophrenia despite no lifetime delusions or 
hallucinations. Two individuals in Sarawak and no individuals in the Australian sample 
reported no positive symptoms. 
 
Symptom content comparisons for included individuals by site are provided as Table 5-3. 
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Table 5-3: Symptom Content Comparison by Site 
Symptom† Australia India Sarawak Total Χ2‡ DF P 
Global delusions 764/776 (98.5%) 465/504 (92.3%) 211/259 (81.5%) 1440/1539 
(93.6%) 
95.21 2 <0.0001 
Bizarre delusions 497/776 (64.1%) 181/504 (35.9%) 51/259 (19.7%) 729/1539 (47.4%) 203.67 2 <0.0001 
Broadcast/Insertion/Withdrawal 
delusions 
368/776 (47.4%) 64/504 (12.7%) 27/259 (10.4%) 459/1539 (29.8%) 257.49 2 <0.0001 
Control delusions 213/776 (27.5%) 106/504 (21.0%) 22/259 (8.5%) 341/1539 (22.2%) 45.69 2 <0.0001 
Persecutory delusions 683/776 (88.0%) 402/504 (79.8%) 172/259 (66.4%) 1257/1539 
(81.7%) 
60.43 2 <0.0001 
Referential delusions 585/776 (75.4%) 293/504 (58.1%) 72/259 (27.8%) 950/1539 (61.7%) 206.45 2 <0.0001 
Jealousy delusions 81/776 (10.4%) 37/504 (7.3%) 28/259 (10.8%) 146/1539 (9.5%) 1.96 2 0.3756 
Guilt/Sin delusions 122/776 (15.7%) 28/504 (5.6%) 8/259 (3.1%) 158/1539 (10.3%) 47.64 2 <0.0001 
Grandiose delusions 419/776 (54.0%) 73/504 (14.5%) 36/259 (13.9%) 528/1539 (34.3%) 283.07 2 <0.0001 
Religious delusions 279/776 (36.0%) 55/504 (10.9%) 58/259 (22.4%) 392/1539 (25.5%) 106.23 2 <0.0001 
Somatic delusions 173/776 (22.3%) 65/504 (12.9%) 23/259 (8.9%) 261/1539 (17.0%) 35.42 2 <0.0001 
Erotomanic delusions 85/776 (11.0%) 47/504 (9.3%) 16/259 (6.2%) 148/1539 (9.6%) 5.49 2 0.0644 
Mind reading delusions 327/776 (42.1%) 63/504 (12.5%) 13/259 (5.0%) 403/1539 (26.2%) 204.01 2 <0.0001 
Global hallucinations 721/776 (92.9%) 396/504 (78.6%) 245/259 (94.6%) 1362/1539 
(88.5%) 
73.11 2 <0.0001 
Auditory hallucinations 692/776 (89.2%) 379/504 (75.2%) 241/259 (93.1%) 1312/1539 
(85.3%) 
69.61 2 <0.0001 
Commentary/3rd person hallucinations 331/776 (42.7%) 246/504 (48.8%) 108/259 (41.7%) 685/1539 (44.5%) 1.29 2 0.5248 
Visual hallucinations 390/776 (50.3%) 96/504 (19.1%) 133/259 (51.4%) 619/1539 (40.2%) 125.49 2 <0.0001 
Olfactory/Gustatory hallucinations 170/776 (21.9%) 19/504 (3.8%) 57/259 (22.0%) 246/1539 (16.0%) 74.76 2 <0.0001 
Somatic/Tactile hallucinations 200/776 (25.8%) 46/504 (9.1%) 44/259 (17.0%) 290/1539 (18.8%) 49.47 2 <0.0001 
† Schneiderian First Rank Symptoms are presented in italics 
‡ χ2 analyses were conducted for each variable after ‘unknown’ responses were deleted (to remove any potential confounding effect). The percentage of responses 
deleted varied between 0 (0%) and 202 (13.1%), with only Commentary/3rd person hallucinations having greater than 6.7% of responses deleted. The average 
number of ‘unknown’ responses deleted for each variable was 59 (3.8%). 
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Frequencies differed significantly by site for sixteen of the nineteen delusion and 
hallucination categories after using a Bonferroni correction. Bizarre delusions, delusions of 
reference, and mind reading delusions were most frequently reported in Australia and least 
frequently reported in Sarawak, with the magnitude of site differences noticeably more 
pronounced than for global delusions. Both visual hallucinations and olfactory/gustatory 
hallucinations were comparatively rare in India compared with the other sites, whereas 
grandiose delusions were reported less frequently in both India and Sarawak than 
Australia. 
 
Of the three symptom variables that primarily capture Schneiderian First Rank Symptoms 
(FRS) (see Mellor, 1970), the frequency of auditory hallucinations with commentary or 3rd 
person conversations (Australia 42.7%, India 48.8%, Sarawak 41.7%) was similar (non-
significant) between sites; the frequency of control delusions (Australia 27.5%, India 
21.0%, Sarawak 8.5%) was lower in Sarawak; and frequency of thought 
broadcast/insertion/withdrawal delusions (Australia 47.4%, India, 12.7%, Sarawak 10.4%) 
was markedly lower in both India and Sarawak. 
 
Discussion 
As in previous transcultural studies (e.g. Jablensky et al., 1992) we identified broad 
symptom profile similarities across sites, and also notable differences. Variation was 
clearly demonstrated in the frequencies of both the DSM-IV criterion A symptoms of 
schizophrenia (broadly identifiable as core components of well established dimensions 
(Fiedorowicz et al., 2008)), and in the content of most delusions and hallucinations across 
our three ethnically distinct samples. Indian individuals reported negative symptoms more 
frequently than other sites, whereas individuals from Sarawak reported disorganized 
symptoms more frequently. These differences in schizophrenia expression across 
populations suggest potential differences in structural organization as well as symptom 
expression. 
 
Inconsistent findings from genetic linkage and association studies using the diagnostic 
category “schizophrenia” as a single phenotype suggest that the current concept of 
schizophrenia is not a single disease entity (Jablensky, 2006). Furthermore, there is 
increasing evidence that individual differences in clinical presentation are in part due to 
differences in genetic etiology (Fanous and Kendler, 2008). Breaking schizophrenia into 
clinical subtypes utilizing ethnically distinct populations may yield more meaningful results 
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(e.g. Holliday et al., 2009). Therefore, distinct population “groupings” of individual 
differences in clinical presentations of schizophrenia (as in the current study) suggest 
possible etiological differences, and by extension differences relevant to diagnostic 
classification, across populations.   
 
Readily identifiable clinical sub-populations within the three samples, such as the twenty 
Indian individuals (4.0%) with no positive symptoms – a symptom profile somewhat 
resembling the traditional concept “simple schizophrenia” (APA, 1994), further support the 
hypothesis that schizophrenia is not a single, continuous entity. This symptom pattern was 
rare in the Iban (n=2, 0.8%), and absent in our Australian sample. 
 
Interestingly, nine individuals from this Indian subgroup (1.8% of our entire Indian cohort) 
would no longer meet the criteria for schizophrenia when classified using the new DSM-5 
diagnostic criteria (APA, 2013), since they were diagnosed based on the presence of 
disorganized behaviour and negative symptoms; there was no evidence of any of the three 
“core” symptoms: delusions, hallucinations, or disorganized speech. One individual from 
Sarawak met the DSM-IV criteria for schizophrenia based on presence of bizarre 
delusions only, and would also no longer be diagnosed with schizophrenia in DSM-5. 
 
We identified both similarities and differences in the content of delusions and 
hallucinations across sites. The contrasting site frequencies for FRS are interesting. 
Significant cross-cultural variation in the frequency of FRS has been noted across many 
countries (Barrett, 2004), although Barrett found striking qualitative similarities in the 
appearance and frequency of auditory hallucinations between Australian (n=50) and Iban 
(n=50) schizophrenia cohorts, whereas subjective thought disorder (e.g. delusions of 
control and thought broadcast, insertion or withdrawal) was extremely rare in the Iban 
sample. Barrett (2004) had previously done extensive work translating the Present State 
Examination (Wing et al.,1974) into Iban, in close collaboration with both an experienced 
Iban mental health professional, an Iban educationalist, and an Iban language tutor. 
Despite exploring and testing a range of cultural idioms, Barrett was unable to arrive at a 
satisfactory translation of the questions specifically relating to subjective thought disorder, 
due primarily to differing concepts of personhood between Western cultures and Iban 
culture. He postulates that some components of the clinical definition of schizophrenia 
(e.g. subjective thought disorder) may be tied to the cultural and intellectual history of 
Western psychiatry more than others (e.g. auditory hallucinations with commentary or 3rd 
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person conversations), and therefore be culturally contingent rather than cross-culturally 
robust. 
 
The pattern of relevant FRS symptoms between our Australian and Iban samples mirrors 
the contrast reported by Barrett: frequency of auditory hallucinations with commentary or 
3rd person conversations was similar between sites, while the frequency of control 
delusions and thought broadcast/insertion/withdrawal delusions was markedly lower in 
Sarawak.  
 
The effect of cultural contingency, which we have explored as an important consideration 
for our Iban sample, also requires elucidation in our Indian sample. One illustrative domain 
is major mood symptoms. The differential importance of symptoms in diagnosing 
depression versus somatoform disorders in India is well documented (e.g. Weiss et al., 
1995). Moreover, within India itself there is significant cultural variation in the content of 
somatic complaints (Gautam and Jain, 2010). Extremely low frequencies of schizoaffective 
disorder have been previously reported in our Indian sample, potentially due to differential 
weighting given to mood symptoms by local diagnosticians or sample participants (McLean 
et al., 2012). This exemplifies almost inevitable, culturally mediated, imperfect conceptual 
equivalence in isolated domains across sites, even when an instrument is robustly 
equivalent overall. 
 
The potential impact of cultural contingency on FRS symptoms in our Indian sample is 
interesting. Curiously, India had the highest frequency of auditory hallucinations with 
commentary or 3rd person conversations (not significantly different from other sites) 
despite having the lowest frequency of auditory hallucinations overall. Our Indian 
population also reported fewer thought broadcast/insertion/withdrawal delusions than 
control delusions, unlike Australia and Sarawak; such between-site variability further 
supports the assertion that subjective thought disorder may be culturally contingent, while 
auditory hallucinations with commentary or 3rd person conversations may be culturally 
robust. 
 
Although questions relating to subjective thought disorder were problematic when 
translating their meaning into Iban (Barrett, 2004), highlighting imperfect conceptual 
equivalence, no significant issues were reported when translating questions relating to 
delusions generally, in either India or Sarawak. For example, the questions assessing 
 
 
106 
 
delusions of persecution and reference were similar across sites, and were assessed as 
having sound conceptual equivalence – does the questionnaire have the same relationship 
to the underlying concepts at each site?; item equivalence – do items estimate the same 
parameters on the latent traits being measured at each site?; and functional equivalence – 
does the instrument achieve its purpose equally well at each site (see Herdman et al., 
1998)? It is interesting, therefore, that most measured delusion categories had significant 
site differences. For most categories, Australia had the highest frequency, then India, then 
Sarawak, although the relative magnitude of differences between sites varied greatly by 
symptom. The two exceptions were delusions of jealousy, for which the frequency was 
highest in Sarawak, then Australia, then India; and religious delusions, for which the 
frequency was highest in Australia, then Sarawak, then India.  
 
Given general acceptance in both anthropology and psychiatry that culture plays an 
integral role in the content of psychotic symptoms, any attempt to identify and characterize 
clinical subtypes within the broader schizophrenia diagnosis should incorporate both 
symptom content and organizational structure. 
 
Further cultural considerations 
We acknowledge that categorization of research participants by ethnicity and/or culture is 
problematic and highly contested (Egede, 2006; Ma et al., 2007). Despite this, our sample 
is large for a transethnic comparative schizophrenia study (n=1539), individuals were 
assessed using the same battery of instruments, and individuals were diagnosed using the 
best-estimate final diagnosis method, which offers consistently high diagnostic reliability 
and stability (Beckmann et al., 1996; Calkins et al., 2007), and is the benchmark method 
available with current methods of classifying schizophrenia (McLean et al., 2012). We 
assessed ethnicity by self-report, which is considered the research “gold standard” in 
transcultural research (Ma, et al., 2007). Furthermore, we ascertained birthplace for 
individuals’ parents and grandparents, confirmed ethnic homogeneity genetically via 
principal component analyses of GWAS data, and interviewed individuals in their home 
countries using local interviewers. These measures avoid many confounding factors 
frequently experienced in cross-cultural research, which can limit generalizability of 
findings (McKenzie and Crowcroft, 1996a, 1996b). 
 
Transethnic schizophrenia samples can inform debate at every level of the diagnostic 
spectrum: (1) broad theoretical (universalist vs. relativist); (2) diagnostic (nosological vs. 
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dimensional); (3) structure of psychosis generally; and (4) structure of schizophrenia 
specifically. However, while multiple, distinct transethnic samples have been used 
(primarily from an anthropological perspective) to challenge DSM-IV at the two broader 
levels, less work has been undertaken at the more specific levels. If we generally 
acknowledge that DSM-IV may not accurately represent the structure of schizophrenia, 
then the variation consistently demonstrated across cultural groups (Kleinman, 1988) 
supports the view that examining transethnic samples at all levels of the diagnostic 
process is worthwhile, even accepting the pervasive, complex interaction between 
biological and social processes at all levels. 
 
Neither the “tightening” of the inclusion criteria for schizophrenia, nor the removal of 
schizophrenia subtypes in DSM-5 lessen the importance of transethnic samples in the 
diagnostic debate; rather, these classification changes elevate their status. Categorical 
classification systems, by definition, refine groupings through simplifying common 
membership characteristics (Möller, 2008), whereas transethnic samples force us to 
acknowledge the complex reality of real-world cases, providing sound evidence for clinical 
variation. The complex mix of culturally contingent and culturally robust symptoms 
between transethnic samples reminds us that culture is critical in nearly every aspect of 
the experience of schizophrenia (Jenkins and Barrett, 2004); even when an individual 
breaks away from accepted social norms, as in psychosis, those cultural norms and rituals 
still shape the illness (Kakar, 2012). 
 
The ‘Emerging Measures and Models’ section of the DSM-5 attempts to address variation 
in a clinically meaningful way, specifically through the ‘Clinician-Rated Dimensions of 
Psychosis Symptom Severity’ scales, and the ‘Cultural Formulation Interview’ (APA, 2013), 
although a categorical classification system will inevitably inadequately incorporate real 
world complexity, as it is not designed for that purpose (Fiedorowicz et al., 2008; Möller, 
2008). Therefore, cultural impact is still peripheral to the DSM-5 (relegated to Section III, 
separated from the diagnostic criteria), a criticism that has carried over from its 
predecessor, the DSM-IV (Kleinman, 1997). It could be argued that embracing a 
dimensional approach to characterizing the expression of schizophrenia, without strict 
qualifications regarding applicability, would be incompatible with the very diagnostic 
foundation of the DSM. 
 
Methodological limitations 
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First, imperfect sampling equivalence was unavoidable. Our samples were collected for 
specific genetic studies, thus there were differences in selection methods of included 
individuals. Both the Indian and Sarawak samples were chosen from ethnically 
homogeneous populations, whereas the Australian sample was not specifically recruited 
as such (although we targeted European Caucasian ethnicity). Furthermore, the Australian 
and Indian cohorts included sibling-pairs plus unrelated individuals recruited 
opportunistically, while only the Sarawak sample can be considered relatively 
epidemiologically sound. Differing recruitment methods also resulted in DIGS and FIGS 
data being unavailable for approximately half the Sarawak sample (i.e. those from the 
initial medical records screen). While these identified site differences may complicate 
attributing findings to culture, the strength of our study design: rigorously recruiting cohorts 
that are (1) ethnically homogeneous, and (2) geographically constrained, outweighs these 
shortcomings, as these two factors, taken together, form a valid, important variable in 
medical research for assessing culture (Azuonye, 1994).  
 
Second, limited precision or validity of diagnostic criteria may be problematic. Caution is 
required when using instruments across cultures, as converting thoughts and feelings 
across languages is difficult (Barrett, 2004), and language is central to understanding 
individuals’ subjective experience of schizophrenia (Jenkins and Barrett, 2004). To 
address this issue the chief investigators at each site undertook extensive cultural 
equivalence work in the planning stages of each study. We further employed state-of-the-
art methods, translating and back-translating the DIGS, and using local interviewers who 
interviewed in the native language across the three sites, and recorded responses in Iban 
(Sarawak) and English (India and Australia). The reliability of the instrument (inter-rater 
reliability within and across the samples) was also tested to establish reliability across 
sites, although diagnostic inter-rater reliability was not assessed between India and 
Sarawak, nor was inter-rater reliability assessed on individual diagnostic components other 
than the DIGS. 
 
Third, generalizability of our findings is limited, given that (1) the Iban in Malaysia and the 
Brahmin in India are homogeneous groups within diverse societies; and (2) we did not 
specifically collect socioeconomic data across our samples, and socioeconomic position 
has been proposed as a stronger determinant of health outcomes than ethnicity (Egede, 
2006). 
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Fourth, utilizing a sample of individuals meeting the DSM-IV criteria for either 
schizophrenia or schizoaffective disorder to potentially hypothesize about the latent 
structure of psychosis and/or schizophrenia itself may be problematic, in that we are not 
able to make comparisons with other DSM-IV diagnoses such as bipolar disorder, which 
would potentially give a “wider perspective” on the clustering of symptoms of psychosis. 
Additionally, using a homogeneous schizophrenia sample to examine clinical variation is 
not ideal as it excludes individuals with psychoses who do not meet the DSM-IV criteria, 
but are of particular cultural interest (Kleinman, 1988). The release of DSM-5 highlights the 
effect of this limitation: had this sample been recruited using the new criteria for 
schizophrenia, nine of the most interesting cases from a cultural perspective would not 
have been included.  
 
Fifth, while we used the same battery of diagnostic instruments across sites, significant 
variation was unavoidable, both due to the varying quality and quantity of medical records 
we could access, and also due to the reliance on retrospective assessment of lifetime 
symptoms. Therefore, it is possible bias may be introduced – for example through under-
reporting of criterion A symptoms in India where there have been fewer hospitalisations, or 
in Sarawak, where detailed records could not be accessed for many individuals. Under-
reporting of symptoms due to recall failure is a recognized, but difficult to quantify 
shortcoming of using a retrospective survey method to obtain symptom information (Moffitt 
et al., 2010); this effect is magnified in cases where medical records are unavailable for 
corroboration.   
 
Finally, while the use of transethnic samples to inform the debate on the structure of 
schizophrenia is a worthwhile pursuit, the well-known difficulties regarding operationalizing 
the role of culture introduces an additional confounder that makes isolating the source of 
non-cultural variation more difficult. For example, the content of one’s delusions can, in 
practice, only be accessed through language – asking them the content of their thoughts 
(Barrett, 2004). Yet, any attempt to understand the role of culture in this thought variation 
is obfuscated by the powerful cultural impact on language – the very concept we are 
attempting to understand integrally mediates the only method of assessment available to 
us. We acknowledge therefore, that the process of establishing cultural equivalence, while 
important, rigorously addressed in our study, and worthwhile, is necessarily imperfect. 
Thus, it is difficult to make assertions regarding the cultural underpinnings of our identified 
site differences in frequencies of measured delusion content categories, beyond 
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acknowledging well-established cultural differences in notions of self across our samples 
(Barrett, 2004; Corin et al., 2004; Kakar, 1991). Ethno-cultural exploration of our site 
differences in delusion content, while beyond the scope of this study, is warranted.  
 
Conclusions 
There is enough variation in both the frequency and the content of DSM-IV criterion A 
symptoms of schizophrenia across our three sites to make a comprehensive exploration of 
symptom profiles across the three samples worthwhile. While content-only symptom 
differences could be explained within the pathoplastic model favoured by Western 
psychiatry, the additional ‘weight’ provided by statistically-significant differences in the 
frequencies of the core diagnostically-significant symptom types across sites, illustrated by 
the greater frequency of disorganized symptoms in Sarawak and negative symptoms in 
India, cannot as easily be dismissed. The possibility of isolating and characterizing distinct 
clinical sub-groups within these populations, such as the individuals in India with no 
lifetime delusions or hallucinations, further strengthens this case. 
 
 
 
111 
 
Acknowledgement 
This work was supported by the Australian National Health and Medical Research Council 
(grant numbers 339454, 143027, 9937625, 496698) and the United States National 
Institute of Mental Health (grant number RO1 MH59588). 
 
We thank all participants and their families. We also acknowledge the contributions of: 
Deborah Nertney; Edward Jerah; SCARF, India; Sarawak Department of Health; 
University of Malaysia, Sarawak; the hospital and clinic staff in Kuching and Sri Aman; 
Queensland Health and the MGS Consortium. 
 
Declaration of Interest 
No conflicts declared. 
 
 
112 
 
Chapter 5 Supplemental Tables 
Supplementary Table 5-4S: Criterion A symptoms of schizophrenia – Frequencies of positive ratings by site 
Criterion A positive ratings† Dimensions Australia India Sarawak Total 
Any unknown values (Exclude) N/A 45 (5.5%) 16 (3.1%) 39 (13.1%) 100 (6.1%) 
All Combinations (Total Included) N/A 776 504 259 1539 
1. Bizarre Delusions Only Pos 0 (0%) 0 (0%) 1 (0.4%) 1 (0.1%) 
2. Third Person/Commentary Hallucinations Only Pos 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
3. Delusions + Hallucinations Pos 2 (0.3%) 4 (0.8%) 7 (2.7%) 13 (0.8%) 
4. Delusions + Disorganized Speech Pos, Dis 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
5. Delusions + Disorganized Behaviour Pos, Dis 1 (0.1%) 1 (0.2%) 1 (0.4%) 3 (0.2%) 
6. Delusions + Negative Symptoms Pos, Neg 7 (1.0%) 14 (2.8%) 1 (0.4%) 22 (1.4%) 
7. Hallucinations + Disorganized Speech Pos, Dis 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
8. Hallucinations + Disorganized Behaviour Pos, Dis 0 (0%) 0 (0%) 3 (1.2%) 3 (0.2%) 
9. Hallucinations + Negative Symptoms Pos, Neg 1 (0.1%) 3 (0.6%) 2 (0.8%) 6 (0.4%) 
10. Disorganized Speech + Disorganized Behaviour Dis 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
11. Disorganized Speech + Negative Symptoms Dis, Neg 0 (0%) 3 (0.6%) 0 (0%) 3 (0.2%) 
12. Disorganized Behaviour + Negative Symptoms Dis, Neg 0 (0%) 9 (1.8%) 0 (0%) 9 (0.6%) 
13. Delusions + Hallucinations + Disorganized Speech Pos, Dis 1 (0.1%) 1 (0.2%) 1 (0.4%) 3 (0.2%) 
14. Delusions + Hallucinations + Disorganized Behaviour Pos, Dis 6 (0.8%) 3 (0.6%) 9 (3.5%) 18 (1.2%) 
15. Delusions + Hallucinations + Negative Symptoms Pos, Neg 80 (10.3%) 72 (14.3%) 17 (6.6%) 169 (11.0%) 
16. Delusions + Disorganized Speech + Disorganized Behaviour Pos, Dis 0 (0%) 1 (0.2%) 2 (0.8%) 3 (0.2%) 
17. Delusions + Disorganized Speech + Negative Symptoms Pos, Dis, 
Neg 
7 (1.0%) 2 (0.4%) 2 (0.8%) 11 (0.7%) 
18. Delusions + Disorganized Behaviour + Negative Symptoms Pos, Dis, 
Neg 
15 (1.9%) 43 (8.5%) 1 (0.4%) 59 (3.8%) 
19. Hallucinations + Disorganized Speech + Disorganized Behaviour Pos, Dis 0 (0%) 0 (0%) 4 (1.5%) 4 (0.3%) 
20. Hallucinations + Disorganized Speech + Negative Symptoms Pos, Dis, 
Neg 
1 (0.1%) 1 (0.2%) 4 (1.5%) 6 (0.4%) 
21. Hallucinations + Disorganized Behaviour + Negative Symptoms Pos, Dis, 
Neg 
5 (0.6%) 8 (1.6%) 7 (2.7%) 20 (1.3%) 
22. Disorganized Speech + Disorganized Behaviour + Negative Symptoms Dis, Neg 0 (0%) 8 (1.6%) 2 (0.8%) 10 (0.6%) 
23. Delusions + Hallucinations + Disorganized Speech + Disorganized Behaviour Pos, Dis 10 (1.3%) 1 (0.2%) 5 (1.9%) 16 (1.0%) 
24. Delusions + Hallucinations + Disorganized Speech + Negative Symptoms Pos, Dis, 
Neg 
106 (13.7%) 16 (3.2%) 5 (1.9%) 127 (8.3%) 
25. Delusions + Hallucinations + Disorganized Behaviour + Negative Symptoms Pos, Dis, 
Neg 
91 (11.7%) 180 (35.7%) 25 (9.7%) 296 (19.2%) 
26. Delusions + Disorganized Speech + Disorganized Behaviour + Negative Symptoms Pos, Dis, 
Neg 
25 (3.2%) 27 (5.4%) 4 (1.5%) 56 (3.6%) 
27. Hallucinations + Disorganized Speech + Disorganized Behaviour + Negative Symptoms Pos, Dis, 
Neg 
5 (0.6%) 7 (1.4%) 26 (10.0%) 38 (2.5%) 
28. Delusions + Hallucinations + Disorganized Speech + Disorganized Behaviour + Negative 
Symptoms 
Pos, Dis, 
Neg 
413 (53.2%) 100 (19.8%) 130 (50.2%) 643 (41.8%) 
† Criterion A symptoms were dichotomized Yes/No (with observations having unknown values in any of the 5 symptoms deleted) 
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Chapter 6. Is ‘Deficit schizophrenia’ a distinct class within the syndrome of 
schizophrenia? Evidence from factor mixture modeling in three ethnically distinct 
population 
McLean D, Linscott R, Barrett R, McGrath J, Thara R and Mowry B. Is ‘Deficit 
schizophrenia’ a distinct, universal class within the syndrome of schizophrenia? Evidence 
from factor mixture modeling in three ethnically distinct populations. Submitted to 
Australian and New Zealand Journal of Psychiatry. 
 
 
Abstract 
Schizophrenia’s expression varies across ethnically-different populations, and its optimal 
structural and diagnostic representation remains unclear. The deficit subtype has been 
proposed as a discrete entity within schizophrenia with potential to elucidate genetic and 
clinical heterogeneity. 
 
We tested the underlying statistical demarcation of deficit schizophrenia (DS) among those 
with DSM-IV schizophrenia in three ethnically-distinct populations from Australia (n=812), 
India (n=474), and Sarawak, Malaysia (n=145). We analyzed twelve characteristic DS 
variables by exploratory factor analysis, latent class analysis, and factor mixture modeling 
in each population, to determine models with the best fit and utility. Results were 
corroborated using taxometric analyses: MAXCOV, MAXEIG and LMODE.  
 
Both single and multi-class models had good overall fit, with three models: one class/two 
factors, one class/three factors, and two classes/one factor in the four best-fitting models 
for each site. Broadly, variation within the single-class models was explained by one 
‘negative symptom’ dimension and one ‘dysfunction’ dimension, whereas the two-class 
models seemingly differentiated DS from non-DS more clearly in India and Sarawak than 
Australia. Taxometric findings favored a two-class distribution in each sample, 
distinguishing a relatively large deficit class.  
 
Our findings tentatively support the hypothesis that DS has a hybrid 
categorical/dimensional latent structure. Broad similarities in the structural appearance of 
DS variables in three ethnically-distinct schizophrenia populations, and taxometric 
confirmation of a two-class distribution in the data are suggestive of the universality of DS 
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across these populations, although between-site variability was also evident within the 
best-fitting models.  
 
Key Words: Psychotic disorders, Culture, Diagnosis, Taxonomy 
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Introduction 
Schizophrenia is often treated as a discrete diagnostic entity based on widely-used, 
reliable criteria consisting of symptoms, duration, illness course, and exclusion of allied 
disorders (APA, 2013a; WHO, 1992). However, the optimal representation of 
schizophrenia’s structure is unclear: (1) a continuous entity, with clinical variation 
represented as dimensions within a single class, or (2) two or more distinct entities, with 
variation indicative of multiple classes labelled schizophrenia (Fiedorowicz et al., 2008; 
Kendler et al., 1998; Linscott et al., 2009). 
 
Schizophrenia subtypes have long been proposed to aid understanding of phenotypic 
variability and genetic heterogeneity within schizophrenia (Jablensky, 2006), although they 
have historically lacked usefulness in both clinical and research settings (Fiedorowicz et 
al., 2008). For example, the traditional DSM-IV subtypes (paranoid, disorganized, 
catatonic, undifferentiated, residual) were dropped from DSM-5 due to their limited 
diagnostic stability, low reliability, and poor validity (APA, 2013b). In contrast, evidence 
concerning deficit schizophrenia (DS) suggests this may be a distinct illness subtype, 
holding promise for understanding heterogeneity in schizophrenia (Ahmed et al., 2015; 
Cohen et al., 2010; Kirkpatrick et al., 2001). 
 
DS is characterized by primary, enduring negative symptoms (Carpenter et al., 1988). Key 
symptoms identified as supporting the construct validity (forming an indirect measure of 
the criterion (Cronbach and Meehl, 1955)) of DS include: greater anhedonia, less 
depression, less suicidal ideation, and less severe delusions with exclusively social 
content (Kirkpatrick et al., 2001). Other symptoms identified in DS include: greater flat 
affect and alogia (Holliday et al., 2009), fewer suicide attempts (Holliday et al., 2009) and 
completed suicides (Fenton and McGlashan, 1994), and greater disorganized speech and 
behavior (Fenton and McGlashan, 1994; Holliday et al., 2009). A meta-analysis of DS 
symptomatology (Cohen et al., 2010) showed that patients with DS did not differ in positive 
or overall psychiatric symptoms from non-DS patients, but had less severe overall mood 
symptoms, more severe overall negative symptoms, and slightly more severe overall 
disorganization symptoms. 
 
Furthermore, regarding illness course, those with DS have poorer premorbid functioning 
(Buchanan et al., 1990), poorer social and occupational function (Holliday et al., 2009; 
Kirkpatrick et al., 2001; Tiryaki et al., 2003), and are more likely to have had an insidious 
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(gradual) onset (Fenton and McGlashan, 1994; Kirkpatrick et al., 2001) and a continuous 
illness course (Fenton and McGlashan, 1994) than those with non-DS.  
 
Examining variation in expression across ethnic groups may help clarify schizophrenia’s 
complex nature (Kleinman, 1988; Thakker and Ward, 1998). Evidence from genetic 
studies investigating specific ethnic groups suggests that DS may be a genetically-
significant, identifiable entity. Holliday et al. (2009) reported genomewide significant 
linkage to chromosome 1q23-25 of a subtype resembling DS (identified by latent class 
analysis), characterized by moderate-severe negative symptoms, prominent 
disorganization, and marked-severe functional impairment, in a Han Chinese 
schizophrenia sample. This linked chromosomal region, previously implicated in 
schizophrenia pathogenesis, was not detected when the traditional DSM-IV schizophrenia 
diagnosis was analyzed as the clinical phenotype. Bakker et al. (2007) reported that two 
genes, PIP5K2A and RGS4, were differentially associated with DS and non-DS in an 
ethnically-homogeneous Dutch schizophrenia sample. Rethelyi et al. (2010) partially 
replicated the Dutch study in a homogeneous Hungarian sample. 
 
Mixture modeling and taxometric methods were recently used to detect and validate the 
structure of negative symptoms within a US sample of individuals with psychoses (Ahmed 
et al., 2015), and taxometric methods had previously been used to examine negative 
symptoms in schizophrenia (Blanchard et al., 2005). These methods have yet to be 
applied to DS in multiple ethnically-distinct populations, to test the transethnic applicability 
of the subtype. 
 
The Genetics Research group at the Queensland Centre for Mental Health Research 
(QCMHR) and our collaborators recruited three ethnically-distinct cohorts of individuals 
with schizophrenia and related conditions for genetic analyses. These included: European 
Australians (n=821); Tamil Brahmin and geographically proximal caste groups from Tamil 
Nadu, India (n=520); and the Iban of Sarawak, Malaysia (n=298). Importantly, these 
samples allowed us to statistically model the symptom profile in each to determine if DS 
could be identified using factor mixture modeling with taxometric confirmation. We 
hypothesized that we would find a distinct ‘class’ resembling DS within each of our broad 
DSM-IV schizophrenia diagnosed samples. This would provide evidence both for the 
existence of a distinct subtype, and for the stability/universality of this class. We previously 
contrasted demographic and clinical characteristics (McLean et al., 2012), distinctive 
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symptom profiles (McLean et al., 2015), and variation within DSM-IV diagnostic criteria 
(McLean et al., 2014) between these samples.  
 
Methods 
Sample details 
Sample recruitment and clinical ascertainment are detailed elsewhere (McLean et al., 
2012). Briefly, recruitment involved: Australia – sibling-pairs and individuals were recruited 
for a major US/Australian collaboration (Molecular Genetics of Schizophrenia Consortium) 
from multiple sources, including treatment facilities, physician referrals, community 
organizations, supported accommodation facilities and advertisements; India – sibling-
pairs and individuals were identified/invited to participate through The Schizophrenia 
Research Foundation India’s (SCARF’s) well-established recruitment network of clinicians; 
and Sarawak – Iban individuals were identified through Malaysian census data, an initial 
medical records screen was undertaken, then a subset of individuals and families were 
contacted for in-depth follow-up. We included all individuals (probands and relatives) with 
a Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) (APA, 
1994) diagnosis of schizophrenia or schizoaffective disorder who met the ethnicity 
inclusion criterion: Australia – self-reported European Caucasian ancestry; India – 
membership of Brahmin caste from Tamil, Kerala, Karnataka, or Andhra Pradesh, or 
membership of geographically proximal caste groups from Tamil Nadu (for details see 
Thara, et al., 2009); and Sarawak – self-reported Iban ethnicity. Ethnicity was 
subsequently confirmed through genetic analysis (Australia: Shi et al., 2009; India and 
Sarawak: manuscripts in preparation), and ancestral/ethnic outliers were excluded from 
further analyses. Clinical exclusion criteria included: (1) inability to give informed consent; 
(2) psychosis assessed as secondary to substance use or a neurological disorder; and (3) 
severe intellectual disability. 
 
All Australian and Indian participants gave written informed consent, and individuals in 
Sarawak who participated in the detailed screening follow-up gave verbal, videotaped 
informed consent (given the Iban is traditionally a preliterate society). Individuals 
consented to an interview, a blood sample for genetic analyses and review of their 
psychiatric records. Local institutional review board approval was obtained for each study. 
 
Clinical ascertainment 
Clinical ascertainment included five elements. 
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(1) Trained clinicians used the semi-structured Diagnostic Interview for Genetic Studies 
(DIGS) (Nurnberger et al., 1994) to obtain DSM-IV diagnostic information. 
(2) A family informant, when possible, or the proband was interviewed about the family 
psychiatric history using the Family Interview for Genetic Studies (FIGS) (Gershon et al., 
1988; Maxwell, 1992). 
(3) Available medical records were retrieved and assessed by trained clinicians. 
(4) A trained clinician prepared a case summary based on all available information. 
(5) Diagnoses were assigned using the Best Estimate Final Diagnosis (BEFD) procedure 
(Leckman et al., 1982), with two experienced psychiatrists independently reviewing all 
available information outlined above then conferring to assign a consensus diagnosis. 
Approximately half the Sarawak sample had diagnoses formulated by one experienced 
psychiatrist, with a BEFD generated in a random subset (20 cases). 
 
DIGS data, FIGS data, and case summaries were available for over 96% of participants at 
all sites, except narrative summaries in India (84% available). BEFD were available for all 
participants. Inter-rater reliability was assessed within the full Australian/US sample 
(Suarez et al., 2006); within the Indian sample; within the Sarawak sample; between the 
Australian and Indian samples (disagreement in one of 20 cases; κ=0.89); and between 
the Australian and Sarawak samples (disagreement in one of 20 cases; κ=0.83). 
 
Cultural equivalence of the DIGS and FIGS was extensively addressed by the chief 
investigators at each site (see McLean et al., 2014). The DIGS and FIGS were translated 
into both Iban (Sarawak) and Tamil (India) with appropriate back-translation procedures. 
Affected individuals were interviewed by experienced bilingual research clinicians, and 
responses to questions were recorded and back-translated into English. This process was 
repeated until the research teams were sure that the final version accurately reflected 
clinical phenomenology. 
 
Data analysis 
We analyzed 13 symptom and illness course variables: 11 identified as important in either 
establishing the construct validity of DS, or differentiating the illness course of DS from 
non-DS (see Kirkpatrick et al., 2001); and two (disorganized speech, disorganized 
behavior) identified in previous studies of DS (Fenton and McGlashan 1994; Holliday et al., 
2009), which have been identified as important in schizophrenia expression in the Iban 
(McLean et al., 2014; McLean et al., 2015). These included: (i) affective flattening (past 30 
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days); (ii) alogia (past 30 days); (iii) avolition/apathy (past 30 days); (iv) anhedonia (past 
30 days); (v) disorganized speech (lifetime); (vi) disorganized behavior (lifetime); (vii) 
global dysfunction (past 30 days); (viii) social/occupational dysfunction (past 5 years); (ix) 
deterioration (over course of illness); (x) delusions with an exclusively social content; (xi) 
episodes of major depression (lifetime); (xii) one or more suicide attempts (lifetime); and 
(xiii) speed of psychosis onset. 
 
Affective flattening, alogia, avolition/apathy, and anhedonia were obtained from the SANS 
assessment (Andreasen, 1983) within the DIGS, and were dichotomized as 1=present, 
0=not present. Disorganized speech and disorganized behavior were dichotomized as 
1=present, 0=not present. Global dysfunction was obtained from the current GAF score 
(Endicott et al., 1976) within the DIGS, and was dichotomized as 1=1-60 (moderate-severe 
dysfunction), 0=61-100 (no-mild dysfunction). Social/occupational dysfunction was 
dichotomized as 1=severe dysfunction, 0=less than severe dysfunction. Deterioration was 
dichotomized as 1=severe deterioration, 0=less than severe deterioration. Delusions with 
an exclusively social content was a composite variable incorporating lifetime presence of 
grandiose delusions, guilt or sin delusions, erotomanic delusions, and jealousy delusions. 
It was dichotomized as 1=no social delusions present, 0=at least one social delusion 
present. Lifetime episodes of major depression was dichotomized as 1=no episodes, 
0=one or more episodes. Suicide attempts was dichotomized as 1=no attempts, 0=one or 
more attempts. Psychosis onset was dichotomized as 1=insidious onset (at least one 
month), 0=onset within one month. 
 
Included individuals were drawn from: Australia (n=821), India (n=520) and Sarawak 
(n=298). We only included individuals from Sarawak who participated in the detailed 
follow-up assessment (n=145), due to the detailed dysfunction and illness course data 
requirements. We excluded 55 individuals: Australia n=9 (1%); India n=46 (9%) with 
missing values for any of the three dysfunction/deterioration variables.  
 
We explored model fit in increasingly complex models using three statistical methods 
designed for modeling latent variables: exploratory factor analysis (EFA; all models with a 
single class and one or more factors explaining variation within that class); latent class 
analysis (LCA; all models with multiple discrete classes and no factors explaining variation 
within these classes); and factor mixture modeling (FMM; all models with multiple discrete 
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classes and at least one factor explaining variation within these classes). Analyses were 
conducted using Mplus, version 7.11 (Muthen and Muthen, 2013). 
 
Conceptually, FMM effectively performs EFA and LCA simultaneously. Whereas EFA only 
ever identifies dimensions in (continuous) data, and LCA only ever finds (categorical) 
classes (Linscott et al., 2009), FMM are latent variable models with categorical and 
continuous latent variables (Lubke and Neale, 2008). Thus, unlike EFA and LCA, FMM are 
unbiased and can provide evidence for either continuous or class hypotheses (Muthen and 
Asparouhov, 2006). We utilized all three modeling methods, and applied parameters for 
model fit aided by confirmation from observable data based on clinical experience (since 
these methods are not intelligent systems (Linscott et al., 2009)). Thus we contrasted the 
explanatory power of all likely combinations of factors and classes in the attempt to identify 
DS.  
 
We used taxometric analyses to further explore data structure at each site. Distinct from 
latent variable modeling, taxometric procedures distinguish continuous latent (one-class) 
distributions from two-class categorical distributions. Most taxometric procedures share an 
underlying principle: if a two-class structure exists and there is conditional independence, 
manipulating the presence and prevalence of class members within subsets of a 
population sample will lead to systematic changes in statistical parameters (e.g., difference 
score, covariance, eigenvalue) derived from those subsets. The primary taxometric 
method used was maximum covariance (MAXCOV), with results confirmed using 
maximum eigenvalue (MAXEIG) and latent mode (LMODE) methods. 
 
Variables were dichotomized to maximize their utility for analysis. In FMM, the loss of 
information when dichotomizing variables does not result in deterioration of results – the 
smaller number of estimated parameters compensates for the relatively ‘crude’ 
categorization (Lubke and Neale, 2008). 
 
The 13 DS variables were used to test 15 pure and hybrid models: one to four factors 
within a single class (EFA); one to five classes with no factors (LCA); and combinations of 
two classes with one to three factors, three classes with one or two factors, and four 
classes with one factor (FMM). All models used maximum likelihood estimation with robust 
standard errors. 
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One variable, suicide attempts, was dropped from the analyses, as it was consistently non-
significant across factors and classes in the initial models for each site. The analyses were 
re-run with the remaining twelve variables. The results of the twelve variable modeling are 
presented here. 
 
Item screening for taxometric analyses was undertaken using the Australian sample 
because it was the largest cohort. Subsequently, the same variables were used in 
taxometric analyses for India and Sarawak. In item screening, tetrachoric correlations 
among the 12 binary variables in the Australian sample were used to determine that 
variables were monotonically related. Subsequently, MAXCOV was applied iteratively 
using all possible triplets of variables, with slab n≥20, to identify variables with flat 
covariance curves. Flatness was judged on the basis of visual appearance and variances 
of raw and loess-smoothed covariances. 
 
When the final set of variables was identified with MAXCOV, MAXEIG and LMODE 
analyses were used to corroborate the MAXCOV findings. MAXEIG was applied using the 
inchworm consistency approach, starting with 5 windows overlapping by 90%. The number 
of windows was increased in steps to the point where windows were n≥~5 per variable 
(i.e., n=~60). Thus, for the Australian (n=812), Indian (n=474), and Sarawak (n=145) 
cohorts, the maximum number of windows were 125, 70, and 15, respectively. The taxon 
base rates obtained using MAXEIG were used as initial estimates of the factor score 
modes used in LMODE analyses. As LMODE does not require variables to be 
monotonically related, LMODE was applied to both the final variable set and to the initial 
12-item set. Taxometric analyses were undertaken in R (R Core Team, 3.1.2 Pumpkin 
Helmet ed., 2014) using MAXCOV, MAXEIG, and LMODE packages adapted from Grove 
(2003; 2004) and Waller and Meehl (1998). 
 
Results 
Fifteen statistical models were tested and ranked, as outlined in the data analysis section. 
Three of these models, both single-class with factors explaining variation within that class: 
(1) one class/two factors, (2) one class/three factors; and also multi-class with factors 
explaining variation within the classes: (3) two classes/one factor, showed good overall 
model fit. These three models were within the four best-fitting models (weighting the three 
well-established fit statistics equally) for each site. Demographic and diagnostic 
information for the final included sample, and fit statistics for these models are included as 
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Table 6-1. Fit indices for all fifteen models (each of the above models for all sites) are 
included as Table 6-6S. Details of the three above models for each site are provided as 
tables 6-7S – 6-15S. 
 
Table 6-1: Demographic, diagnostic, and best model fit information by site 
  Australia 
(n = 812) 
India 
(n = 474) 
Sarawak 
(n = 145) 
Sex Male 573 (70.6%) 273 (57.6%) 89 (61.4%) 
 Female 239 (29.4%) 201 (42.4%) 56 (38.6%) 
Mean Age (SD)  39.01 years 
(11.82) 
38.31 years 
(12.06) 
43.05 years 
(12.91) 
DSM-IV Diagnosis Schizophrenia 756 (93.1%) 472 (99.6%) 101 (69.7%) 
 Schizoaffective, 
Depressed 
24 (3.0%) 1 (0.2%) 32 (22.1%) 
 Schizoaffective, 
Bipolar 
32 (3.9%) 1 (0.2%) 12 (8.3%) 
1 Class/2 Factors AIC 10753.9 5434.3 1596.6 
 BIC 10918.4 5579.9 1700.8 
 SSA-BIC 10807.3 5468.8 1590.0 
 Total (Rank) 32479.6 (2nd) 16483.0 (2nd) 4887.4 (1st) 
1 Class/3 Factors AIC 10718.6 5430.5 1598.8 
 BIC 10930.1 5617.7 1732.8 
 SSA-BIC 10787.2 5474.9 1590.4 
 Total (Rank) 32435.8 (1st) 16523.1 (3rd) 4922.0 (2nd) 
2 Classes/1 Factor AIC 10758.2 5426.7 1604.4 
 BIC 10941.5 5589.0 1720.5 
 SSA-BIC 10817.6 5465.2 1597.1 
 Total (Rank) 32517.3 (4th) 16480.8 (1st) 4922.0 (3rd) 
AIC: Akaike information criterion 
BIC: Bayesian information criterion 
SSA-BIC: Sample size adjusted Bayesian information criterion 
 
Explanatory usefulness of FMM models 
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Both the one class/two factors, and the one class/three factors model in Australia 
differentiated one factor where intra-class variation was broadly explained by the four core 
negative symptom variables, and a second factor where variation was explained by the 
dysfunction and deterioration variables, along with major depression, onset and social 
delusions. The third factor in the three factor model differentiated from the other factors 
based on disorganized speech and behavior. 
 
One class in the two classes/one factor model in Australia contained individuals with 
significant affective flattening and deterioration, while the other contained individuals who 
did not have significant anhedonia, nor deterioration. Although all three dysfunction 
variables (30 day-, five year-, and deterioration) had high loadings on the factor, no 
variables were significant. Overall, the two classes/one factor model did not differentiate 
DS from non-DS within the Australian sample particularly well. 
 
The one class/two factors model in India differentiated one factor broadly on the negative 
symptom variables (except avolition), plus disorganized speech and social delusions. The 
second factor was differentiated by avolition, anhedonia, disorganized behavior, and the 
dysfunction variables. The one class/three factors model was less informative; no 
variables significantly loaded on one of the factors, only alogia and disorganized speech 
loaded on a second, and only deterioration loaded on the third. 
 
The two classes/one factor model in India appeared to differentiate a DS class more 
clearly than in Australia. One class displayed low thresholds for 9 of the 12 variables, with 
4 of these (affective flattening, avolition, anhedonia, and major depression) lower than -2, 
all highly significant (p<0.001). The other class was notable for its high threshold for alogia 
(11.04, p=0.04). The factor in this model did not have any variables with high loadings. 
 
The one class/two factors model in Sarawak clearly differentiated factors: one based on 
the negative symptom variables (except anhedonia), with disorganized behavior, major 
depression and social delusions; the other based on avolition, anhedonia, both 
disorganized symptoms, all dysfunction variables, and onset. As with India, the one 
class/three factors model was less informative, as no variables significantly loaded on one 
of the factors, the second was based on the dysfunction variables, and the third on 
affective flattening, alogia and major depression. 
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The two classes/one factor model in Sarawak also broadly identified a DS class with low 
thresholds for nine of the twelve variables, with four of these (avolition, disorganized 
speech, disorganized behavior, and major depression) lower than -2, all highly significant 
(p<0.001), except avolition (fixed – no p-value). Interestingly, the factor had three variables 
with very high loadings (>28): avolition (p<0.001), 5 year dysfunction (fixed – no value), 
and deterioration (ns). 
 
Taxometric confirmation 
In the Australian cohort, six (9%) tetrachoric rho coefficients were negative, indicating that 
the assumption of monotonicity was not met in the 12-variable distribution. To correct this, 
two variables (disorganized speech and disorganized behavior) were removed from the 
variable set. In the first two MAXCOV analysis iterations, covariance curves for affective 
flattening and anhedonia, respectively, were flat and these variables were removed. The 
final MAXCOV iteration was of eight variables and yielded a peaked covariance curve 
(Figure 6-3), a base rate of M=.76 (SD=.08), variable validity (K) of M=1.25 (SD=0.17), and 
a j-shaped distribution of Bayesian posterior class membership probabilities consistent 
with a large prevalence class (Table 6-2). Classification based on posterior probabilities 
placed n=735 (.91) in the DS class. The inchworm consistency test results from the 
Australian cohort corroborated a class structure: The MAXEIG curve developed a clear 
peak that remained as the number of windows increased (Figure 6-4). The observed base 
rate with 95 windows was .78 (SD=.15) and with 125 windows, .91 (SD=.08). Similarly, 
LMODE results from the 8- and 12-item variable sets provided evidence of bimodality in 
the factor score density functions (Figure 6-5) with base rate estimates of .76 and .75, 
respectively, and n=640 and n=633 in the class, respectively. 
 
Results obtained for the Indian and Sarawak cohorts were similarly taxonic across the 
three taxometric methods (Figures 6-3 to 6-5). In each case, the MAXCOV curves were 
peaked, the inchworm consistency curves remained peaked, and the factor scores were 
bimodal. 
 
Table 6-2: Parameter estimates obtained from the taxometric methods for the three 
cohorts 
Test Statistic Australia (n = 812) 
India 
(n = 474) 
Sarawak 
(n = 145) 
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MAXCOV Base rate estimate (p) .76 .68 .63 
 Class size (n) 735 384 106 
 Variable validity (K) 1.25 1.22 1.36 
MAXEIG Base rate estimate  .91 .69 .57 
LMODE Base rate estimate .76 .76 .67 
 Class size (n) 640 368 98 
 
 
 
Figure 6-3. Upper panel: MAXCOV covariance plot obtained using 8 variables for the Australian (n=812), 
Indian (n=474) and Sarawak (n=145) cohorts. The circles indicate mean covariance estimates, and the solid 
line the loess-smoothed covariance. Lower panel: Frequency histogram of the Bayesian posterior 
membership probabilities for class membership for each cohort. 
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Figure 6-4. MAXEIG inchworm consistency test results for the Australian (n=812), Indian (n=474), and 
Sarawak (n=145) cohorts. Curves are loess-smoothed eigenvalues obtained using the number of windows 
(w) shown. The y-axis λ-values are true for the curves with most windows, and curves with fewer windows 
are offset on the y-axis using steps of λ=+0.1. Consequently, the 5w curves are offset by +0.4 on the y-axis, 
the 35w, 21w, and 10w curves by +0.3, etc. 
 
 
 
Figure 6-5. Upper panel: Factor-score density plots for the Australian (n=812), Indian (n=474), and Sarawak 
(n=145) cohorts from LMODE analysis of the 8 variables, with modes indicated by vertical dashed lines. 
Lower panel: The corresponding plot obtained with 12 variables. 
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Discussion 
Broad structural similarity in model fit was evident across each of our three ethnically-
distinct schizophrenia populations. This data distribution concordance across sites is 
potentially indicative of the universality of DS across certain ethnically-distinct populations 
although there were subtle but important variations between sites. Comparability between 
single-class and hybrid multi-class models in FMM fit statistics across the three sites 
tentatively supports the assertion of Ahmed and colleagues (2015) that DS may have a 
hybrid categorical/dimensional structure. 
 
The single class models across all sites, particularly the one class/two factors model, 
broadly differentiated one factor explaining within-class variation based on core negative 
symptoms, and a second factor based on dysfunction variables. Overall, the two 
classes/one factor model in India and Sarawak differentiated DS from non-DS more clearly 
than in Australia. The size of the FMM deficit class across the sites: Australia, n=303 
(37.3%); India, n=345 (72.8%); Sarawak, n=109 (75.2%) was broadly congruent with the 
taxometric analyses, in that the deficit class was larger, in India and Sarawak, but 
incongruent in Australia. This potentially confirms that the Australian two classes/one 
factor model lacks explanatory usefulness for defining DS, as neither class closely 
resembled the subtype. 
 
Tantalizingly, there was a striking similarity in the taxometric two-class appearance of the 
data distribution of DS variables across sites, as has been identified previously (Blanchard 
et al., 2005). Analyses of the Australian sample suggest a large DS class, comprising 75% 
to 90% of the sample. Similar DS classes were identified in the Indian and Sarawak 
cohorts although the relative class sizes appear slightly smaller. Importantly, flat affect and 
anhedonia appeared to reduce the clarity of findings, suggesting that these components of 
DS may not have the same population structure as other components. This makes sense 
clinically, as these two symptoms can be characteristic in depression co-occurring in non-
DS as well as representing core symptoms in DS. Overall, however, the taxometric 
analyses appear to support the existence of a distinct DS class, although this class 
(between 57% and 91% across sites) is larger than previously identified in general 
schizophrenia populations (between 15% and 30% (Kirkpatrick et al., 2001)). 
 
Methodological limitations 
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First, our cohorts were recruited for specific genetic studies and thus were not 
representative schizophrenia samples. In particular they did not represent the entire 
chronicity spectrum, which may, at least partially, explain our larger-than-expected DS 
classes. Chronic, long-term cases were over-represented, particularly in the Australian and 
Indian samples, since these cohorts were recruited opportunistically. In contrast, the 
Sarawak sample can be considered relatively epidemiologically sound. 
 
Second, the study protocol did not include a standardized instrument for diagnosis of DS. 
Therefore, we can only demarcate a proxy for the diagnostic entity identified by Kirkpatrick 
and colleagues (2001). Some variation in results has been identified between studies that 
assess DS using the Schedule for the Deficit Syndrome (SDS) (Kirkpatrick et al., 1989), 
and other validated self-report and interview-based instruments (Cohen et al., 2010).  
 
Third, several potentially significant attributes of DS were not ascertained, e.g. 
suspiciousness, suicidal ideation (Kirkpatrick et al., 1989), marital status prior to onset, and 
completed suicides (Fenton and McGlashan 1994). Hence, the inability of our cross-
sectional assessment to differentiate between primary negative symptoms in DS, and a 
broader category of persistent negative symptoms (see Ahmed et al., 2015), may 
contribute to our identified DS taxometric class being significantly larger than expected. 
 
Conclusions 
The broad similarities in the structural appearance of key DS variables in our three 
ethnically-distinct schizophrenia populations from Australia, India and Sarawak provide 
tentative support for the universality of DS across these populations. Furthermore, both 
single-class and multi-class models exhibited good fit statistics, which supports the 
hypothesis that DS has a hybrid categorical/dimensional latent structure. 
 
Ethnically-distinct schizophrenia populations are important in elucidating the underlying 
distribution and heterogeneity of schizophrenia. Not only could we attempt to identify DS in 
other ethnically-distinct populations, but homogeneous populations can also be used to 
test the universality/stability of other schizophrenia subtypes identified either clinically or 
genetically. 
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Chapter 6 Supplemental Tables 
Table 6-6S: Fit indices for all included models by site 
Model Type Australia India Sarawak 
AIC BIC SSA-BIC AIC BIC SSA-BIC AIC BIC SSA-BIC 
1 class 
0 factor 
LCA 11543.67 11600.07 11561.96 6248.18 6298.11 6260.03 2032.02 2067.74 2029.77 
1 class 
1 factor 
EFA 10844.12 10956.91 10880.70 5486.84 5586.71 5510.54 1638.25 1709.69 1633.74 
1 class 
2 factors 
EFA 10753.94 10918.42 10807.28 5434.28 5579.92 5468.84 1596.58 1700.76 1590.01 
1 class 
3 factors 
EFA 10718.59 10930.07 10787.17 5430.48 5617.73 5474.91 1598.82 1732.78 1590.38 
1 class 
4 factors 
EFA **** **** **** 5427.67 5652.37 5480.98 1597.27 1758.01 1587.14 
2 classes 
0 factors 
LCA 10921.64 11039.12 10959.73 5580.75 5684.78 5605.44 1701.47 1775.89 1696.78 
2 classes 
1 factor 
FMM 10758.20 10941.48 10817.63 5426.68 5588.97 5465.19 1604.41 1720.50 1597.09 
2 classes 
2 factors 
FMM 10724.43 10978.20 10806.72 5431.46 5656.17 5484.78 1604.82 1765.56 1594.68 
2 classes FMM 10703.31 11032.28 10809.98 5426.79 5718.08 5495.91 **** **** **** 
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3 factors 
3 classes 
0 factors 
LCA 10801.21 10979.79 10859.12 5500.43 5658.56 5537.95 1652.77 1765.88 1645.64 
3 classes 
1 factor 
FMM 10733.16 10986.93 10815.45 **** **** **** 1595.14 1755.88 1585.01 
3 classes 
2 factors 
FMM 10699.61 11033.28 10807.81 5429.25 5724.69 5499.35 1612.02 1823.37 1598.70 
4 classes 
0 factors 
LCA 10763.71 11003.38 10841.43 5456.89 5669.11 5507.24 1628.01 1779.83 1618.45 
4 classes 
1 factor 
FMM 10714.53 11038.80 10819.68 5414.81 5701.93 5482.93 1595.07 1800.46 1582.12 
5 classes 
0 factors 
LCA 10747.45 11048.21 10844.98 5446.87 5713.19 5510.06 1624.67 1815.18 1612.66 
AIC: Akaike information criterion 
BIC: Bayesian information criterion 
SSA-BIC: Sample size adjusted Bayesian information criterion 
EFA: Exploratory factor analysis 
LCA: Latent class analysis 
FMM: Factor mixture model 
 
Bolded data reflect the best/optimal scores for each criterion at each site 
**** No data available due to model failure 
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Table 6-7S: One class/two factors model in Australia 
Model Type Exploratory Factor Analysis (EFA)  
Fit Statistics (Rank)a Akaike information criterion (AIC) 10753.94 (8/15) 
 BIC: Bayesian information criterion (BIC) 10918.42 (1/15) 
 SSA-BIC: Sample size adjusted 
Bayesian information criterion (SSA-BIC) 
10807.28 (3/15) 
 Total 32479.65 (2/15) 
Factor Loadingsb Factor 1 Factor 2 
Affective flattening 0.52* -0.05 
Alogia 0.41* 0.19* 
Avolition 0.65* 0.23* 
Anhedonia 0.85* -0.08* 
Disorganized speech -0.08 0.25* 
Disorganized behavior -0.08 0.09 
Dysfunction (5 year) -0.03 0.72* 
Dysfunction (30 day) 0.01 0.94* 
Deterioration 0.04 0.72* 
Major depression -0.05 0.35* 
Onset 0.03 0.32* 
Social delusions 0.12 0.20* 
a Rank (lowest to highest) out of all fifteen models for each fit statistic 
b Quartimin Rotated Loadings 
* p < 0.05 
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Table 6-8S: One class/two factors model in India 
Model Type Exploratory Factor Analysis (EFA)  
Fit Statistics (Rank)a Akaike information criterion (AIC) 5434.28 (8/15) 
 BIC: Bayesian information criterion (BIC) 5579.92 (1/15) 
 SSA-BIC: Sample size adjusted 
Bayesian information criterion (SSA-BIC) 
5468.84 (2/15) 
 Total 16483.04 (2/15) 
Factor Loadingsb Factor 1 Factor 2 
Affective flattening 0.77* 0.14 
Alogia 0.93* -0.04 
Avolition 0.12 0.82* 
Anhedonia 0.37* 0.52* 
Disorganized speech 0.29* 0.05 
Disorganized behavior -0.09 0.36* 
Dysfunction (5 year) -0.04 0.81* 
Dysfunction (30 day) 0.05 0.84* 
Deterioration -0.08 0.96* 
Major depression 0.34 -0.27 
Onset 0.17 0.09 
Social delusions 0.29* -0.12 
a Rank (lowest to highest) out of all fifteen models for each fit statistic 
b Quartimin Rotated Loadings 
* p < 0.05 
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Table 6-9S: One class/two factors model in Sarawak 
Model Type Exploratory Factor Analysis (EFA)  
Fit Statistics (Rank)a Akaike information criterion (AIC) 1596.58 (3/15) 
 BIC: Bayesian information criterion (BIC) 1700.76 (1/15) 
 SSA-BIC: Sample size adjusted 
Bayesian information criterion (SSA-BIC) 
1590.01 (4/15) 
 Total 4887.35 (1/15) 
Factor Loadingsb Factor 1 Factor 2 
Affective flattening 0.77* 0.24 
Alogia 0.72* 0.27 
Avolition 0.25* 0.87* 
Anhedonia 0.24 0.67* 
Disorganized speech -0.32 0.46* 
Disorganized behavior -0.54* 0.60* 
Dysfunction (5 year) -0.05 0.97* 
Dysfunction (30 day) 0.02 0.93* 
Deterioration 0.04 0.97* 
Major depression 0.61* 0.02 
Onset -0.14 0.30* 
Social delusions 0.47* -0.08 
a Rank (lowest to highest) out of all fifteen models for each fit statistic 
b Quartimin Rotated Loadings 
* p < 0.05 
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Table 6-10S: One class/three factors model in Australia 
Model Type Exploratory Factor 
Analysis (EFA) 
  
Fit Statistics (Rank)a Akaike information 
criterion (AIC) 
10718.59 (4/15)  
 BIC: Bayesian 
information criterion 
(BIC) 
10930.07 (2/15)  
 SSA-BIC: Sample 
size adjusted 
Bayesian 
information criterion 
(SSA-BIC) 
10787.17 (1/15)  
 Total 32435.83 (1/15)  
Factor Loadingsb Factor 1 Factor 2 Factor 3 
Affective flattening 0.51* -0.04 -0.00 
Alogia 0.43* 0.15 0.12* 
Avolition 0.64* 0.26* -0.07 
Anhedonia 0.86* -0.09* 0.03 
Disorganized speech 0.01 0.01 0.96* 
Disorganized behavior -0.03 -0.03 0.33* 
Dysfunction (5 year) -0.03 0.71* 0.02 
Dysfunction (30 day) 0.01 0.94* 0.04 
Deterioration 0.03 0.76* -0.06 
Major depression -0.02 0.28* 0.19* 
Onset 0.03 0.32* 0.01 
Social delusions 0.11 0.24* -0.11 
a Rank (lowest to highest) out of all fifteen models for each fit statistic 
b Quartimin Rotated Loadings 
* p < 0.05 
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Table 6-11S: One class/three factors model in India 
Model Type Exploratory Factor 
Analysis (EFA) 
  
Fit Statistics (Rank)a Akaike information 
criterion (AIC) 
5430.48 (6/15)  
 BIC: Bayesian 
information criterion 
(BIC) 
5617.73 (4/15) 
 
 
 SSA-BIC: Sample 
size adjusted 
Bayesian 
information criterion 
(SSA-BIC) 
5474.91 (3/15)  
 Total 16523.12 (3/15)  
Factor Loadingsb Factor 1 Factor 2 Factor 3 
Affective flattening 0.80 0.08 0.05 
Alogia 0.95* -0.06 -0.04 
Avolition 0.18 0.60 0.37 
Anhedonia 0.47 0.43 0.14 
Disorganized speech 0.35* -0.44 0.29 
Disorganized behavior -0.06 -0.09 0.42 
Dysfunction (5 year) 0.08 0.09 0.66 
Dysfunction (30 day) 0.14 0.33 0.56 
Deterioration -0.03 -0.04 1.03* 
Major depression 0.30 -0.34 -0.02 
Onset 0.20 0.20 -0.08 
Social delusions 0.25 0.18 -0.21  
a Rank (lowest to highest) out of all fifteen models for each fit statistic 
b Quartimin Rotated Loadings 
* p < 0.05 
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Table 6-12S: One class/three factors model in Sarawak 
Model Type Exploratory Factor 
Analysis (EFA) 
  
Fit Statistics (Rank)a Akaike information 
criterion (AIC) 
1598.82 (5/15)  
 BIC: Bayesian 
information criterion 
(BIC) 
1732.78 (4/15)  
 SSA-BIC: Sample 
size adjusted 
Bayesian 
information criterion 
(SSA-BIC) 
1590.38 (5/15)  
 Total 4921.98 (2/15)  
Factor Loadingsb Factor 1 Factor 2 Factor 3 
Affective flattening 0.75* 0.25 -0.27 
Alogia 0.72* 0.23 -0.08 
Avolition 0.38 0.64 0.25 
Anhedonia 0.44 0.41 0.39 
Disorganized speech -0.02 0.09 0.59 
Disorganized behavior -0.14 0.12 0.65 
Dysfunction (5 year) -0.07 0.99* -0.00 
Dysfunction (30 day) 0.01 0.96* -0.02 
Deterioration 0.03 0.96* 0.04 
Major depression 0.81* -0.24 0.13 
Onset 0.04 0.08 0.39 
Social delusions 0.34 0.11 -0.43 
a Rank (lowest to highest) out of all fifteen models for each fit statistic 
b Quartimin Rotated Loadings 
* p < 0.05 
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Table 6-13S: Two classes/one factor model in Australia 
Model Type Factor Mixture 
Model (FMM) 
   
Fit Statistics 
(Rank)a 
Akaike 
information 
criterion (AIC) 
10758.20 (9/15)   
 BIC: Bayesian 
information 
criterion (BIC) 
10941.48 (3/15)   
 SSA-BIC: 
Sample size 
adjusted 
Bayesian 
information 
criterion (SSA-
BIC) 
10817.63 (7/15)   
 Total 32517.32 (4/15)   
Model Results 
Factor 1 By 
Estimate S.E. Est./S.E. Two-Tailed 
P-Value 
Affective flattening 1.00 0.00 999.00 999.00 
Alogia 2.66 1.41 1.89 0.06 
Avolition 4.59 2.54 1.81 0.07 
Anhedonia 1.35 1.60 0.85 0.40 
Disorganized 
speech 
1.84 1.26 1.46 0.14 
Disorganized 
behavior 
0.52 0.67 0.77 0.44 
Dysfunction (5 
year) 
7.43 4.95 1.50 0.13 
Dysfunction (30 
day) 
25.94 17.08 1.52 0.13 
Deterioration 8.09 5.53 1.46 0.14 
Major depression 2.65 1.81 1.46 0.14 
Onset 2.68 1.82 1.47 0.14 
Social delusions 1.73 1.04 1.66 0.10 
Class 1 (n = 303)     
Means Factor 1 0.56 0.33 1.70 0.09 
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Class 1 
Thresholds 
Estimate S.E. Est./S.E. Two-Tailed 
P-Value 
Affective flattening -3.00 0.71 -4.21 <0.01** 
Alogia 0.40 0.57 0.70 0.48 
Avolition -0.78 1.66 -0.47 0.64 
Anhedonia -0.50 1.24 -0.40 0.69 
Disorganized 
speech 
0.03 0.56 0.05 0.96 
Disorganized 
behavior 
-0.55 0.40 -1.39 0.17 
Dysfunction (5 
year) 
2.05 1.53 1.34 0.18 
Dysfunction (30 
day) 
7.86 6.62 1.19 0.24 
Deterioration 5.15 1.94 2.66 0.01* 
Major depression 0.94 0.59 1.60 0.11 
Onset -0.49 0.63 -0.79 0.43 
Social delusions 1.21 0.00 999.00 999.00 
Variances Factor 1 0.05 0.07 0.67 0.50 
Class 2 (n = 509)     
Means Factor 1 0.00 0.00 999.00 999.00 
Class 2 
Thresholds 
Estimate S.E. Est./S.E. Two-Tailed 
P-Value 
Affective flattening -1.40 0.16 -8.90 <0.01** 
Alogia 0.71 0.16 4.35 <0.01** 
Avolition 0.50 0.22 2.26 0.02* 
Anhedonia 2.17 0.37 5.95 <0.01** 
Disorganized 
speech 
-1.01 0.17 -6.05 <0.01** 
Disorganized 
behavior 
-0.99 0.13 -7.54 <0.01** 
Dysfunction (5 
year) 
-1.11 0.23 -4.79 <0.01** 
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Dysfunction (30 
day) 
-3.19 1.68 -1.90 0.06 
Deterioration 2.09 0.34 6.15 <0.01** 
Major depression -0.29 0.14 -2.09 0.04* 
Onset -1.50 0.15 -9.77 <0.01** 
Social delusions 0.98 0.12 7.97 <0.01** 
Variances Factor 1 0.05 0.06 0.81 0.42 
a Rank (lowest to highest) out of all fifteen models for each fit statistic 
* p < 0.05 
** p < 0.01 
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Table 6-14S: Two classes/one factor model in India 
Model Type Factor Mixture 
Model (FMM) 
   
Fit Statistics 
(Rank)a 
Akaike 
information 
criterion (AIC) 
5426.68 (2/15)   
 BIC: Bayesian 
information 
criterion (BIC) 
5588.97 (3/15)   
 SSA-BIC: 
Sample size 
adjusted 
Bayesian 
information 
criterion (SSA-
BIC) 
5465.19 (1/15)   
 Total 16480.85 (1/15)   
Model Results 
Factor 1 By 
Estimate S.E. Est./S.E. Two-Tailed 
P-Value 
Affective flattening 1.00 0.00 999.00 999.00 
Alogia 1.43 0.66 2.17 0.03* 
Avolition 0.97 0.25 3.96 <0.01** 
Anhedonia 0.81 0.19 4.19 <0.01** 
Disorganized 
speech 
0.19 0.06 3.42 <0.01** 
Disorganized 
behavior 
0.16 0.05 3.08 <0.01** 
Dysfunction (5 
year) 
0.78 0.18 4.27 <0.01** 
Dysfunction (30 
day) 
0.95 0.22 4.29 <0.01** 
Deterioration 1.32 0.40 3.28 <0.01** 
Major depression 0.05 0.08 0.56 0.57 
Onset 0.14 0.05 2.79 0.01* 
Social delusions 0.08 0.04 1.95 0.05 
Class 1 (n = 129)     
Means Factor 1 0.70 2.68 0.26 0.79 
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Class 1 
Thresholds 
Estimate S.E. Est./S.E. Two-Tailed 
P-Value 
Affective flattening -0.09 2.64 -0.04 0.97 
Alogia 11.04 5.33 2.07 0.04* 
Avolition -29.59 0.00 999.00 999.00 
Anhedonia -2.81 2.15 -1.30 0.19 
Disorganized 
speech 
1.49 0.58 2.55 0.01* 
Disorganized 
behavior 
-1.55 0.52 -3.00 <0.01** 
Dysfunction (5 
year) 
0.41 2.27 0.18 0.86 
Dysfunction (30 
day) 
-3.11 3.17 -0.98 0.33 
Deterioration 0.02 3.77 0.01 1.00 
Major depression -2.68 0.37 -7.18 <0.01** 
Onset -1.00 0.39 -2.59 0.01* 
Social delusions -0.37 0.00 999.00 999.00 
Variances Factor 1 2.89 1.63 1.78 0.08 
Class 2 (n = 345)     
Means Factor 1 0.00 0.00 999.00 999.00 
Class 2 
Thresholds 
Estimate S.E. Est./S.E. Two-Tailed 
P-Value 
Affective flattening -2.70 0.49 -5.45 <0.01** 
Alogia -0.61 0.69 -0.88 0.38 
Avolition -2.64 0.50 -5.34 <0.01** 
Anhedonia -2.93 0.47 -6.21 <0.01** 
Disorganized 
speech 
0.59 0.14 4.32 <0.01** 
Disorganized 
behavior 
-1.13 0.16 -7.25 <0.01** 
Dysfunction (5 
year) 
1.21 0.27 4.55 <0.01** 
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Dysfunction (30 
day) 
-1.17 0.28 -4.17 <0.01** 
Deterioration 1.80 0.55 3.26 <0.01** 
Major depression -4.30 0.52 -8.32 <0.01** 
Onset -1.00 0.14 -7.23 <0.01** 
Social delusions -0.99 0.13 -7.58 <0.01** 
Variances Factor 1 10.57 3.62 2.92 <0.01** 
a Rank (lowest to highest) out of all fifteen models for each fit statistic 
* p < 0.05 
** p < 0.01 
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Table 6-15S: Two classes/one factor model in Sarawak 
Model Type Factor Mixture 
Model (FMM) 
   
Fit Statistics 
(Rank)a 
Akaike 
information 
criterion (AIC) 
1604.41 (6/15)   
 BIC: Bayesian 
information 
criterion (BIC) 
1720.50 (3/15)   
 SSA-BIC: 
Sample size 
adjusted 
Bayesian 
information 
criterion (SSA-
BIC) 
1597.09 (7/15)   
 Total 4922 (3/15)   
Model Results 
Factor 1 By 
Estimate S.E. Est./S.E. Two-Tailed 
P-Value 
Affective flattening 1.00 0.00 999.00 999.00 
Alogia 0.92 0.23 4.03 <0.01** 
Avolition 32.70 7.70 4.25 <0.01** 
Anhedonia 1.41 0.46 3.04 <0.01** 
Disorganized 
speech 
0.28 0.18 1.55 0.12 
Disorganized 
behavior 
0.33 0.26 1.29 0.20 
Dysfunction (5 
year) 
30.06 0.00 999.00 999.00 
Dysfunction (30 
day) 
3.04 1.04 2.92 <0.01** 
Deterioration 28.45 129.73 0.22 0.83 
Major depression 0.51 0.25 2.04 0.04* 
Onset 0.22 0.15 1.49 0.14 
Social delusions 0.17 0.11 1.49 0.14 
Class 1 (n = 36)     
Means Factor 1 0.68 3.10 0.22 0.83 
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Class 1 
Thresholds 
Estimate S.E. Est./S.E. Two-Tailed 
P-Value 
Affective flattening 1.42 2.98 0.48 0.63 
Alogia 2.53 2.98 0.85 0.40 
Avolition 19.90 101.07 0.20 0.84 
Anhedonia 1.51 4.48 0.34 0.74 
Disorganized 
speech 
-2.17 1.09 -2.00 0.05 
Disorganized 
behavior 
-27.63 0.00 999.00 999.00 
Dysfunction (5 
year) 
-5.09 0.00 999.00 999.00 
Dysfunction (30 
day) 
-0.69 9.33 -0.07 0.94 
Deterioration 20.17 0.00 999.00 999.00 
Major depression 1.95 1.32 1.47 0.14 
Onset 1.08 0.93 1.16 0.25 
Social delusions 0.56 0.00 999.00 999.00 
Variances Factor 1 3.75 2.66 1.41 0.16 
Class 2 (n = 109)     
Means Factor 1 0.00 0.00 999.00 999.00 
Class 2 
Thresholds 
Estimate S.E. Est./S.E. Two-Tailed 
P-Value 
Affective flattening -1.94 0.42 -4.58 <0.01** 
Alogia -0.85 0.35 -2.42 0.02* 
Avolition -43.73 0.00 999.00 999.00 
Anhedonia -1.722 0.518 -3.325 <0.01** 
Disorganized 
speech 
-2.05 0.33 -6.31 <0.01** 
Disorganized 
behavior 
-3.01 0.48 -6.31 <0.01** 
Dysfunction (5 
year) 
0.14 0.42 0.34 0.74 
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Dysfunction (30 
day) 
-1.15 0.49 -2.36 0.02* 
Deterioration 1.24 0.63 1.96 0.05 
Major depression -2.41 0.46 -5.22 <0.01** 
Onset 1.22 0.26 4.72 <0.01** 
Social delusions -0.90 0.23 -3.96 <0.01** 
Variances Factor 1 3.25 1.58 2.06 0.04* 
a Rank (lowest to highest) out of all fifteen models for each fit statistic 
* p < 0.05 
** p < 0.01 
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Chapter 7. Summary and General Discussion 
Overview: Defining the scope of the project 
This thesis aimed to: (1) compare and contrast the way ‘schizophrenia’ is experienced by 
three ethnically different populations, (2) to identify significant demographic, clinical and 
symptom differences in these populations, (3) to examine these differences in the context 
of their relevance to the structure of schizophrenia, and (4) to identify dimensions and/or 
clusters based on these differences, both within and across these populations, which may 
contribute to the discourse on the diagnostic classification of schizophrenia. 
 
While the impact of culture on the expression and experience of schizophrenia was 
centrally important in the conceptualisation, operationalisation, and interpretation of the 
project, it was not possible to meaningfully elucidate the role of culture on schizophrenia in 
ethnically-distinct populations – this was clearly beyond the scope of this thesis. Rather, 
the impact of culture was acknowledged in the methodology, cultural equivalence was 
prioritised in the ascertainment of the samples, and a ‘cultural lens’ was applied to the 
interpretation of the analyses undertaken in Chapters Three, Four, Five and Six. While this 
thesis approached the expression of schizophrenia from a psychiatric (universalist) 
perspective, this was judged by the candidate to be a necessary concession to the 
anthropological (relativist) perspective, acknowledging that culture is critical in nearly every 
aspect of schizophrenic illness experience (Jenkins and Barrett, 2004). 
 
The three transethnic schizophrenia samples were contrasted using increasingly broad 
criteria. First, site differences in individual demographic and clinical characteristics were 
investigated (Chapter Three); next, characteristic symptom profiles were sought (Chapter 
Four); and then, the core schizophrenia diagnostic criteria widely used in psychiatry were 
examined in relation to the differential schizophrenia expression identified across sites 
(Chapter Five). 
 
For the final analyses (Chapter Six), the scope of enquiry was narrowed, and the lessons 
learned in previous chapters were used to guide the search for a deficit schizophrenia 
subtype in each of the three ethnically-distinct populations. Deficit schizophrenia was 
chosen as the target subtype because: (a) the candidate’s group had previously published 
on a subtype resembling DS (Holliday et al., 2009); (b) the subtype is of current interest in 
the literature against the backdrop of subtypes being dropped from DSM-5 (APA, 2013b); 
(c) the available ethnically-distinct samples provided a unique opportunity to seek DS in 
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multiple ethnicities using similar statistical methods to those utilised in contemporary, 
single population studies (see Ahmed et al., 2015); and (d) the candidate’s group had 
compiled anecdotal evidence that the Indian sample appeared generally ‘more unwell’, 
with a high frequency of negative symptoms in their diagnostic symptomatology. While this 
may be considered a modest goal in isolation (necessarily so for the scope of this thesis), 
the methodology used for these analyses can be applied to other schizophrenia subtypes 
and other ethnically-distinct populations, and potentially to other complex disorders. 
 
Contributions to the literature 
The thesis makes a significant independent and original contribution to the academic 
discourse on the expression of schizophrenia in ethnically different populations across 
each of the aims outlined above. 
 
Compare and contrast the experience of ‘schizophrenia’ in three ethnically different 
populations 
A significant contribution of this thesis has been the consistent, successful application of a 
transcultural/transethnic lens to a theoretical debate that has generally been conducted in 
single, often ‘Western’ populations. The decisions to: (1) meaningfully engage with the 
anthropological literature (best exemplified by Chapter Five) in order to enrich the 
transcultural understanding generated from this work; (2) use well-ascertained and 
confirmed ethnicity as a proxy to explore cultural impact on illness experience; and (3) 
contrast three unique schizophrenia populations, have resulted in a greater depth of 
enquiry than would otherwise be possible when approaching this topic from a universalist, 
psychiatric perspective.  
 
These studies have shown that the complex, multi-dimensional role of culture is not 
necessarily an impediment to isolating candidates for genetic studies (Chapter Three). 
Rather, examining ethnically-distinct populations can potentially uncover candidates due to 
their differing expression across samples (Chapter Five). 
 
Identify significant demographic, clinical and symptom differences in these 
populations 
At every level of enquiry, significant differences in these populations were identified and 
explored. Whereas Chapter Three identified site differences across individual variables, 
Chapter Four identified differences in symptom profiles, using previously reported Iban 
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characteristic symptoms as a framework for enquiry and comparison, and Chapter Five 
identified significant differences in the frequencies of core diagnostic criteria across sites, 
and also the content of delusions and hallucinations. 
 
The older AAO finding in the Iban (Chapter Three) is worthy of further genetic 
interrogation, since the reported mean age was older than both the figure for LAMI 
countries (Large et al., 2008), and that reported for indigenous groups in Malaysia (Chee 
et al., 2010), and AAO heritability has been reported (Hare et al., 2010), with AAO-
associated genetic variants having been uncovered (Renou et al., 2007). 
 
As with any stark result, particularly one that can be considered counter-intuitive, caution is 
needed in interpreting and generalising this finding. While it is certainly possible that the 
reported AAO result identifies a population-specific illness characteristic, it is also possible 
the finding may be confounded by other characteristics or by differences in the overarching 
social determinants (economic and social conditions that influence health status) between 
sites (see limitations below for more detail). For example, duration of untreated psychosis 
(DUP) in the Sarawak sample was significantly shorter than for the other sites, age at 
assessment was significantly older in Sarawak, as was age at first treatment, and 
frequency of rapid psychosis onset was higher in the Iban. It is logical that this group of 
age and onset related symptoms may be related, and may be acted upon by a common 
confounding variable or variables. 
 
Examine these differences in the context of their relevance to the structure of 
schizophrenia 
Chapters Four, Five and Six have each made a modest novel contribution either to our 
understanding of the structure of the entity we call ‘schizophrenia’, or by generating 
avenues for future research. 
 
This thesis has confirmed the value of searching for specific symptom profiles, both within 
ethnically distinct populations (e.g. the Iban of Sarawak – Chapter Four), and between 
them (e.g. deficit schizophrenia – Chapter Six). Chapter Four also provides confirmation of 
a characteristic Iban symptom profile proposed by Professor Barrett (Barrett, 2004; Barrett 
et al., 2005) in an extended, more comprehensively ascertained sample. While small scale 
replication is certainly not a ground-breaking contribution, it is an important scientific 
undertaking.   
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The Indian sub-group with no positive schizophrenia symptoms (Chapter Five) is of 
particular interest because this expression somewhat resembled “simple schizophrenia” 
(APA, 1994), a profile that was absent in the largest ethnically-distinct (Australian) cohort. 
Thus, this may not only be an attractive candidate for genetic interrogation, but it also 
supports the hypothesis that schizophrenia is not a single, continuous entity. 
 
The identification of the simple schizophrenia subtype has widely been attributed to Bleuler 
in 1911 (Black and Boffeli, 1989), although Diem described the first few cases as early as 
1903 (Martinez Serrano et al., 2012). The diagnosis has always been controversial (Black 
and Boffeli, 1989; Martinez Serrano et al., 2012), with only two of eight reported symptom 
complexes, avolition and deteriorating course, accepted as core components in all major 
diagnostic texts (Black and Boffeli, 1989). The subtype was first included in ICD-6 in 1948, 
and DSM-I in 1952 (Black and Boffeli, 1989). Although it has remained in each subsequent 
iteration of the International Classification of Diseases, up to and including ICD-10, simple 
schizophrenia was dropped from DSM-III and DSM-IIIR, brought back (as simple 
deteriorative disorder) in the Appendices of DSM-IV and DSM-IV-TR as a “Criteria Set 
Provided for Further Study” (APA, 1994, 2000), and then dropped again from DSM-5. 
 
Importantly for transcultural/transethnic research, simple schizophrenia was recognised as 
a diagnostic category for both the IPSS and DOSMed, although it was consistently applied 
rarely across sites. In a subtype analysis conducted on the IPSS sample, Carpenter et al. 
(1976) reported that simple schizophrenia was diagnosed in only 31 cases out of 811 
(3.8%), and there were never more than seven cases at any site, making comparisons 
problematic. The DOSMed reported a similar trend, “Diagnoses of simple schizophrenia, 
latent schizophrenia and residual schizophrenia were rarely made in either type 
[developed or developing] of setting” (Sartorius et al., 1986: 920). Thus, the WHO studies 
were unable to identify significant differences in the rates of simple schizophrenia 
diagnosis across sites. 
 
A contemporary literature review by Martinez Serrano et al. (2012), found that, although 
the literature on the disorder remains scant, many (>26) of the articles published on simple 
schizophrenia were in languages other than English or Spanish, which is certainly of 
interest from a transcultural perspective. The authors propose several explanations for the 
low rate of diagnosis that may disguise its true prevalence: (1) the less dramatic clinical 
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presentation may reduce the likelihood of individuals affected by simple schizophrenia to 
seek psychiatric assistance in contrast to other subtypes; (2) the loss of insight and 
initiative that are characteristic of simple schizophrenia may reduce the likelihood of 
individuals seeking assistance; and (3) the general lack of interest in the subtype from 
clinicians may lead to the under-diagnosis of simple schizophrenia, as individuals receive 
other diagnoses when they present for assistance (Martinez Serrano et al., 2012). 
 
Certainly, the Indian subgroup identified in Chapter Five is interesting, as the factors 
identified above would likely lead to the under-reporting of simple schizophrenia in India, 
given that the sample was recruited opportunistically from a primarily clinical cohort. Thus, 
the true proportion of those with simple schizophrenia in the Tamil Brahmin and 
geographically proximal caste groups in Chennai, may be greater than the reported 4%. 
Given that the opportunistic Australian sample recruited in this thesis would be expected to 
have similar ‘classification biases’ to the Indian sample, the finding of a difference in the 
presence/absence of a subtype resembling simple schizophrenia appears robust. 
Furthermore, Carpenter et al. (1976) noted that, whereas most subtypes of schizophrenia 
were indistinguishable from each other in the IPSS sample based on 27 psycho-pathologic 
signs and symptoms, both the simple and catatonic subtypes were modest exceptions (i.e. 
they were distinguishable from other subtypes). Thus, simple schizophrenia may offer 
promise as a discrete entity, despite its controversial history.  
 
Identify dimensions and/or clusters based on these differences, both within and 
across these populations, which may contribute to the discourse on the diagnostic 
classification of schizophrenia 
The analyses presented in Chapter Six are extremely topical, given the current interest in 
deficit schizophrenia (Cohen et al., 2010), and the growing use and acceptance of Factor 
Mixture Modeling methods in the schizophrenia field (e.g. Ahmed et al., 2014; Linscott et 
al., 2009). The thesis has made a small, but important novel contribution, both directly to 
testing the deficit schizophrenia construct using FMM through the interrogation of multiple 
relevant schizophrenia samples, but also indirectly through proposing directions for future 
enquiry (see below). 
 
In relation to testing the DS construct, the structural similarity of DS variables across 
populations (Chapter Six) is important in a syndrome where there does appear to be 
structural variation (Chapter Five). Both single class and multi-class models exhibited good 
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model fit, although a degree of interpretability is common in analysing FMM results. It is 
particularly noteworthy that taxometric analyses strongly indicate a two class structure in 
all three populations, irrespective of symptom and illness course variation across sites. 
While these results offer tentative support to previous studies examining negative 
symptoms in schizophrenia (see Ahmed et al., 2014; Blanchard et al., 2005), it is 
noteworthy that the identified ‘deficit’ class is significantly larger than previous studies, 
possibly due to the analyses in Chapter Six identifying a larger class of general, persistent 
negative symptoms (rather than primary, idiopathic negative symptoms), and possibly 
related to the characteristics of included individuals (see limitations below). Given that this 
result was somewhat unexpected, it will be important to explore how accurately the 
identified deficit class truly represents deficit schizophrenia. Until more work is undertaken, 
this finding should be interpreted with caution.  
 
In assessing the novel contribution of these DS findings, it is worthwhile viewing these 
results as two separate entities: (1) structural similarity across the three sites, and (2) 
potential identification of a deficit class. The former finding is noteworthy, regardless of 
what construct the latter is truly demarcating. Despite the differences in expression 
identified in Chapter Three and Chapter Four, and the diagnostic differences identified in 
Chapter Five, there was broad similarity in the appearance of the data distribution across 
sites when structure was assessed on the presence or absence of the twelve variables 
selected (based on prior research) in Chapter Six. Furthermore, the broad similarity was 
apparent utilising two different statistical methods, factor mixture modelling and taxometric 
analyses. Thus, against a background of identified contrasts in the expression and 
experience of schizophrenia between ethnically distinct groups, it is apparent that some 
aspects and symptom groupings are similar and consistent. This finding has overarching 
importance when interpreted with previous chapters in that it places the true construct of 
what we currently call schizophrenia somewhere on the continuum between universalism 
and relativism. On a more specific diagnostic level, it adds weight to the notion that 
schizophrenia is not a single, homogeneous entity. 
 
The second finding is also important, independent of whether it can truly be ascribed to 
deficit schizophrenia as defined by Carpenter et al. (1988). A clear, categorical (two-class) 
distribution was identified by multiple taxometric methods, and this finding was not 
contradicted by factor mixture modelling. Therefore, there is an entity worthy of further 
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investigation, incorporating the twelve variables examined, regardless of what that entity 
represents clinically. 
 
The thesis has also confirmed the usefulness of FMM and taxometric analyses in 
interrogating complex disorders such as schizophrenia, building on past (Blanchard et al., 
2005; Linscott et al., 2009) and contemporary (Ahmed et al., 2015) studies in the field. 
This thesis is a partial replication of the methods utilised by Ahmed et al. (2015), the 
research group that pioneered the concept of a deficit schizophrenia subtype (Carpenter et 
al., 1988). Whereas their group interrogated a single cohort of mixed-ethnicity 
schizophrenia patients in the United States, this thesis was able to extend this work to 
contrasting three ethnically-different populations. These methods are valuable in 
exploratory endeavours specifically because they are unintelligent systems that make 
fewer assumptions about data distribution than other commonly used statistical methods. 
These methods are relatively new in this field, so replication of the method in three distinct 
populations is methodologically worthwhile, regardless of the results. 
 
Important strengths and limitations 
There are many noteworthy strengths of the body of work undertaken in this thesis. The 
candidate had access to three unique schizophrenia samples recruited and ascertained by 
Professor Mowry and his collaborators that are relatively large for transethnic studies 
(Australia, n=821; India, n=520; Sarawak, n=298). Two of these samples are from 
genetically isolated groups – the Tamil Brahmin in India and the Iban of Sarawak, and the 
Iban sample in particular was logistically difficult to obtain. Thus, the three samples for 
comparison are truly unique, and the expression of schizophrenia in similar samples has 
never previously been contrasted. 
 
The psychiatric and anthropological groundwork undertaken collaboratively by the 
experienced site coordinators resulted in a high degree of cultural equivalence in the 
ascertainment of the samples, combined with genetic confirmation of their ethnic 
distinctness. In summary, this confirmation involved undertaking genomewide association 
analyses (GWAS) for each sample. One quality control procedure involved conducting 
principal component analyses to confirm each individual’s GWAS data – typically the first 
three principal component scores for each subject using single nucleotide polymorphisms 
(SNPs) from the particular study population that are in common with SNPs from 
international HapMap or 1000 Genome populations in order to exclude ancestral/ethnic 
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outliers from further analyses. Thus, all included individuals at each site were closely 
‘grouped’ genetically, consistent with externally-generated control populations for each 
ethnicity. These procedures are routinely conducted in genetic analyses. This rigour in 
study design either negated or minimised the impact of many criticisms of cross-cultural 
research. 
 
The samples were collected primarily for genetic studies, thus the quality of demographic, 
clinical, symptom and illness course data required was relatively high. Since the effect 
sizes in schizophrenia genetic studies tend to be relatively small, it is particularly important 
to minimise phenotypic heterogeneity. As a result, these studies used the BEFD method, 
which is the benchmark method available with current methods of classifying 
schizophrenia (McLean et al., 2012a). The data available were therefore both rich and 
comprehensive. 
 
The extensive data cataloguing, extraction, formatting and checking strategy (outlined in 
Appendix C) resulted in a clean, easy to interrogate data set. This allowed the candidate to 
have a high degree of confidence in the results obtained from the analyses undertaken. 
 
Finally, although this thesis was not able to ‘unravel’ the complex impact of culture (which 
was beyond the scope of this work), the analyses contained herein were able to control for 
many conditions that are often ‘possibly’ attributable to cultural confounding.   
 
There are many significant limitations that also must be acknowledged across five major 
areas: (1) data collection issues, (2) population characteristics, (3) directly culture-based 
issues, (4) limitations of diagnostic methods and scope of study, and (5) overarching 
confounders in the data. 
 
(1) Data collection issues: There was an unavoidable lack of measurement equivalence 
across samples, due to differing recruitment methods and the fact that these samples were 
primarily collected for genetic studies. Notably, there was a potential confounding effect of 
including both related and unrelated individuals in analyses. Consequently, conservative 
models were selected for analyses that were likely confounded by a lack of complete 
independence; specifically, only unrelated individuals were included in the logistic 
regressions undertaken in Chapter Four. 
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Additionally, there were differences in the quality of clinical and diagnostic data (e.g. 
differing comprehensiveness of available medical records) obtained across sites. The lack 
of measurement equivalence across sites certainly introduces the potential for significant 
selection bias, as the coverage of the treatment ‘spectrum’ at each site differs. For 
example, many of the included individuals accessed through initial comprehensive medical 
records screen in the Sarawak sample would not be identified using the opportunistic 
recruitment methods from primarily clinical settings that were utilised in both Australia and 
India. This necessarily limits the generalisability of any findings to ‘schizophrenia’ as a 
general population-wide category at each site.   
 
Regardless of the rigour of the methodology used for establishing cultural equivalence 
across sites, there will inevitably be limited precision and uncertainties regarding the 
validity of diagnostic instruments used across different cultural groups. 
 
(2) Population characteristics: There is limited generalisability of findings due to the Iban 
and Tamil Brahmin being distinct, unique subgroups within larger societies. Certainly, 
while findings of equivalence across the three samples in this thesis can, to a degree, be 
generalised more widely to these specific schizophrenia populations, there is no assertion 
that these findings may imply universality across ‘schizophrenia’. 
 
(3) Directly culture-based issues: While the robustly ascertained and genetically confirmed 
ethnicity of the three schizophrenia populations is certainly a strength of the thesis, it must 
be acknowledged that although working with ethnically homogeneous and geographically 
constrained samples enables assessment of cultural confounders because these two 
factors represent the best available proxy for culture (Azuonye, 1994), ethnicity is still a 
proxy. Therefore, consistent with the summary provided in Chapter One, it is not possible 
to elucidate the complexities of cultural impact on psychoses (e.g. cultural variation within 
the European Caucasian Australian sample and differences between the included castes 
in India), and this was certainly beyond the scope of the thesis.   
 
The confounding role of culture will also necessarily be problematic due to the importance 
of language (a culture-bound construct) in diagnosing the syndrome of schizophrenia. 
Furthermore, using a sample diagnosed with DSM-IV schizophrenia or schizoaffective 
disorder to interrogate the classification of schizophrenia itself is problematic, from both 
cultural and validity standpoints.  
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(4) Limitations of diagnostic methods and scope of study: Excluding cases of Bipolar 
Affective Disorder (BPAD) prevents the possibility of meaningfully examining the interplay 
between mood and psychotic symptoms, whereas excluding cases of psychosis that do 
not meet DSM-IV schizophrenia or schizoaffective disorder criteria ignores cases that may 
be of the most transcultural interest. A related, general limitation of using DSM-IV to 
assess psychosis in diverse, often non-clinical settings, results from the DSM system 
primarily relying on clinical observations made by mental health professionals to generate 
a diagnosis. Thus, a significant proportion of people with mental disorders world-wide will 
never be assessable, and will be missed in studies such as the work undertaken in this 
thesis. 
 
The samples ascertained in this thesis are necessarily cross-sectional, with no opportunity 
to revisit included individuals at a later time point. As a result, there are significant 
limitations in determining temporal relationships between certain symptoms, and 
establishing detailed illness course variables. This limitation is particularly relevant to the 
analyses in Chapter Six, making it difficult to distinguish between primary negative 
symptoms in DS, and a broader category of persistent negative symptoms. 
 
Finally, there are limitations imposed from using genetic samples to explore non-genetic 
constructs and culturally-sensitive variables. The researchers did not ask follow-up 
questions that may have been able to clarify ambiguities, and there were limited qualitative 
data recorded. The problematic ascertainment of deficit schizophrenia without using the 
Schedule for the Deficit Syndrome exemplifies this issue. 
 
(5) Overarching confounders in the data: Significant differences in some clinical phenotype 
variables between sites results in the potential for these to confound all other explanations 
of psychopathology. For example, the speed of psychosis onset (rapid onset being 
significantly more frequent in Sarawak) may confound any results showing associations 
with positive symptoms. The importance of speed of onset as a crucial variable in 
understanding site differences is certainly acknowledged in Chapter Four and Chapter Six, 
although it is unrealistic in an exploratory research design to control for all potential 
confounding variables. Instead, the thesis highlights many candidates for future 
interrogation, and speed of psychosis onset is certainly an illness characteristic deserving 
of future examination. 
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A related overarching confounder that must be acknowledged is the global effect of social 
determinants such as gender and socio-economic deprivation on illness expression. As 
has been acknowledged throughout the thesis, socioeconomic position is a strong 
determinant of health outcomes (Egede, 2006), as it is crucial to many aspects of the 
illness experience. The differential sex effects by site (Table 3-2S and Table 3-3S) show 
the importance of sex as a mediating variable. Other examples of important factors in 
illness experience are caste in India and differential access to health care by site (as noted 
in the introduction of Chapter Three). 
 
Translation of research into other applications (e.g. genetics) 
The analyses undertaken in this thesis derive from samples recruited specifically for 
genetic studies. Certainly, there are opportunities for the findings generated herein to aid 
genetic exploration within the complex syndrome of schizophrenia. Specific directions for 
future enquiry are detailed below. 
 
Moreover, the demarcation of three relatively large, ethnically distinct, equivalently 
ascertained schizophrenia samples has applications beyond just the field of schizophrenia 
genetics. The candidate and his collaborators have already published on the drug and 
alcohol variables in the Australian sample (McLean et al., 2012b). Multiple peer-reviewed 
papers have been accepted for publication in the vocational rehabilitation field in Australia, 
based on variables from the Australian dataset (Westcott et al., in press(a); Westcott et al., 
in press(b)). Variables from the Australian dataset have also been used in multiple 
publications on neuroimaging in schizophrenia (Martin et al., 2014a; Martin et al., 2014b), 
in addition to the genetics of schizophrenia (Martin and Mowry, in press; Martin et al., 
2015; Martin et al., 2014c). 
 
Having access to these samples also allows researchers to begin to test the universality of 
findings regarding schizophrenia generated in single samples, both within and outside the 
genetics field. 
 
Directions for future enquiry 
The general methodology laid out in this thesis has potential to guide future genetic 
enquiries, both generating and testing candidates that will assist in ‘unravelling’ the 
complex clinical phenotype of schizophrenia. Variation in individual variables can be 
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identified in ethnically-distinct populations, such as the older AAO finding in Sarawak 
(Chapter Three) that may be novel targets for genetic analyses. Characteristics that have 
been identified as heritable in other ethnic populations can be tested in multiple, ethnically-
distinct samples, whereas other characteristics may be initially targeted due to their 
distinctive clinical phenotype in one or more ethnically-distinct cohorts. Between-group 
clinical variation can be identified and interrogated through examination of distinct 
symptom profiles (Chapter Four). Where observable between-site differences are present, 
variation can be quantified and tested by either clusters of cases, such as the Indian 
subgroup with no positive symptoms (Chapter Five), or by clusters of symptoms, such as 
attempting to demarcate deficit schizophrenia (Chapter Six). 
 
These search strategies and statistical methods could certainly be transferred to 
genetically-complex disorders other than schizophrenia. Of more direct relevance to this 
thesis however, this general design can be used to test proposed subtypes of 
schizophrenia other than DS in the Australian, Indian, and Sarawak samples. Additionally, 
these specific ethnically-distinct schizophrenia samples can be used to clinically 
interrogate additional novel genetic findings identified in the future, which may be 
important given the promising results being generated currently. 
 
The specific findings presented in this thesis can potentially be tested and/or replicated in 
other, single ethnically-distinct populations, without needing to specifically recruit multiple 
samples. Increasing recognition of the need to pool large schizophrenia samples to 
produce meaningful genetic results (see Schizophrenia Working Group of the Psychiatric 
Genomics Consortium, 2014) has resulted in researchers world-wide having greater 
access to well-ascertained samples of diverse ethnicities. 
 
Alternatively, given that many transcultural studies in the health field focus on ethnic 
migrant groups, each of the samples ascertained in this thesis potentially has a role in 
providing contrast to migrant studies. Do these populations (i.e. European Caucasian 
Australians, Tamil Brahmin and geographically proximal caste groups from Chennai, and 
the Iban of Sarawak) retain the same demographic, clinical, and symptom characteristics 
when they migrate to other countries, and does their taxonic profile remain stable in a new 
setting? Recruiting migrant schizophrenia populations would certainly be problematic due 
to the Iban and Tamil Brahmin being distinct, unique subgroups, although such a sample 
may be achievable in expatriate Australians. 
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The three samples ascertained in this thesis will continue to be interrogated and widely 
reported, due to (1) the high quality, uniqueness and equivalence of the data, (2) the 
responsibility of the candidate and his collaborators to maximise the research impact of 
these cohorts, and (3) the currency and open-endedness of several of the study ethics 
approvals. There are multiple variables (e.g. treatment resistance) that were painstakingly 
extracted in all three populations, but have yet to be comprehensively analysed (see 
Appendix B). Given the importance of schizophrenia treatment resistance as a variable 
both clinically and genetically, there is certainly scope to test further hypotheses in these 
samples.   
 
On reflection, there are characteristics of the samples that could be improved should major 
transethnic schizophrenia cohorts be recruited in the future. Ideally, once target 
populations and/or sites are identified, standardised, epidemiologically-sound sampling 
methods should be used at all included sites, incorporating a longitudinal design capturing 
illness onset. An explicit framework for establishing cultural equivalence, such as that 
presented by Herdman et al. (1998) would be useful, as this would make explicit both the 
steps taken in establishing equivalence, and also the theoretical underpinning of the study. 
Furthermore, the standardised diagnostic instruments used would be subjected to this 
rigorous testing prior to the commencement of the study. 
 
Recruiting ethnically-distinct cohorts specifically for comparing and contrasting 
schizophrenia expression would allow key qualitative questions to be included in the 
assessment battery, and could incorporate a longitudinal study design. This would allow 
for in-depth examination of the complex relationship between cultural identity, national 
identity, and self-assigned ethnicity, which would enhance the potential for generalisability 
of results where equivalence can be reasonably established. Furthermore, broad 
populations that are not genetic isolates could be targeted to enhance wider applicability. 
 
A target set of variables for extraction could be identified in the study design that would 
address specific research questions. For example, a more comprehensive assessment of 
illness course would have greatly enhanced this thesis, as it would have allowed the 
candidate to better elucidate the temporal relationships between variables. This enables 
researchers to test the stability of characteristics and profiles over time, and would greatly 
facilitate the assessment of subtypes such as DS. Also, known and expected cultural-
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confounding variables could be purposefully collected, along with crucial variables in 
transcultural research, such as socio-economic status. 
 
However, recruiting samples such as those included in this thesis is a prodigious task that 
is both time consuming and expensive. Therefore, it is unrealistic to expect large 
ethnically-distinct schizophrenia cohorts to be collected primarily for these purposes. 
Certainly, the immediate future for the field is likely to rely upon existing genetic and 
epidemiological collaborations to provide samples for analysis. 
 
Conclusions 
Overall, there is support for schizophrenia not being a discrete, homogeneous condition. 
Some elements of expression (individual variables, symptom profiles, diagnostic 
demarcations) differ between the three ethnically-distinct populations presented here, 
whereas other elements of expression (e.g. tentative evidence for deficit schizophrenia) 
appear stable across these samples. There is also evidence that some expressions are 
population-specific, for example the subgroup in India (n=20) with no positive symptoms. 
 
Transcultural schizophrenia samples can have an important role in unravelling and 
understanding clinical complexity, assisting genetic enquiry, and informing diagnostic 
classification, particularly when samples are equivalent and viewed through a culturally 
sensitive lens. 
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Appendix B: Data Dictionary 
Variable Type Format Characteristic Definition Range Coding Decisions/Implications 
PrimID Char $12. Primary ID number Primary ID number 1639 unique code 
numbers 
Different formats retained across sites/studies: Australia/MGS1: 41-XXXX-
XXX; Australia/MGS2: 141-XXXX-XXX; India: XXXX-XXX; Sarawak XXX. 
SecID Char $7. Secondary ID number ID number for Sarawak detailed pedigree 
subset 
Australia: NA 
India: NA 
Sarawak: 1-001 – 203-
001 
Only relevant for Sarawak pedigree subset (n=145) 
Country Char $3. Site Australia, India, Sarawak AUS; IND; SWK  
Diagnosis Char $8. Diagnosis DSMIV Diagnosis SAD; SAM; SZ SAD = Schizoaffective, depressed 
SAM = Schizoaffective, bipolar 
SZ = Schizophrenia 
SEX Char $1. Sex Sex: Male or Female M; F M = Male; F = Female 
AGE Char $3. Age at Assessment Age at Assessment (Current age) 14-100; UU UU = Unknown 
OnsetAge Char $3. Onset Age Age at onset of psychosis 3-81; UU UU = Unknown 
IllDur Char $3. Illness Duration Illness duration (onset to current) in years 0-62; 16+; 20+; UU 16+ = at least 16 years 
20+ = at least 20 years 
UU = Unknown 
When changing ‘n+’ values to numeric, each becomes ‘n’. 
‘0’ encompasses all individuals with illness duration <1 year (at 
assessment). 
FirstTr Char $3. Age at First Treatment Age at which psychiatric treatment first 
accessed 
12-81; N/A; UU N/A = Not applicable/never treated 
UU = Unknown 
DUP Char $3. Duration of Untreated 
Psychosis 
Period between onset and first treatment 
(in years) 
0-57; 16+; 20+; UU 16+ = at least 16 years 
20+ = at least 20 years 
UU = Unknown 
When changing ‘n+’ values to numeric, each becomes ‘n’. 
‘0’ encompasses all individuals with DUP <1 year. 
Marital Char $8. Marital Status Current marital status (at time of 
assessment) 
married; nevmar; 
sepdiv; widowed; 
unknown 
married = married 
nevmar = single, never married 
sepdiv = separated or divorced 
widowed = widowed, not remarried 
unknown = unknown 
How the widowed category is grouped is dependent on the hypothesis 
being tested 
LivArr Char $8. Living Arrangements Who the individual currently resides with 
(at time of assessment) 
alone; facility; family; 
others; unknown 
alone = lives alone (including hostel) 
facility = lives in a psychiatric treatment facility 
family = lives with biological family members and/or spouse 
others = lives with people who are not family (e.g. friends, housemates) 
unknown = unknown 
Hos_YN Char $4. Hospitalised (Yes/No) Whether the individual has ever been 
hospitalised for psychiatric reasons 
No; Yes; Unk Unk = Unknown 
Hospital Char $4. Number of hospitalisations Number of psychiatric hospitalisations 
(lifetime) 
0-104; >10; >12; >14; >2; 
>20; >25; >3; >5; Unk 
Unk = Unknown 
When changing ‘>n’ values to numeric, each becomes ‘n+1’. 
YrsSchl Char $4. Years of Formal Schooling Years of formal schooling 0-22; Unk Unk = Unknown 
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Tertiary study years as defined by the DIGS: 
1 year college or any amount technical school (TAFE) = 13 
2,3,4 years college = 14,15,16 
Masters = 18 
PhD = 20+ 
CurrEmp Char $12. Current Employment 
Status 
Employment status (at time of 
assessment) 
disabled; homemaker; 
never worked; student; 
unemployed; working; 
unknown 
disabled = formerly worked, no longer able 
homemaker = homemaker primary role 
never worked = never worked at least 30% of time 
student = full-time student 
unemployed = not disabled but not working 
working = working at least 30% of time 
EmpHist Char $2. Employment History Level of occupational disability over the 
past 5 years 
1; 2; 3; 4; 5; U 1 = Always worked 
2 = Periods of unemployment not related to illness 
3 = Minor occupational dysfunction 
4 = Moderate occupational dysfunction 
5 = Severe occupational dysfunction 
U = Unknown 
Thyroid Char $4. Thyroid Definite evidence of clinically significant 
thyroid problems 
No; Yes; Unk Unk = Unknown 
Epilepsy Char $4. Epilepsy Definite evidence of epilepsy or clinically 
significant seizures 
No; Yes; Unk Unk = Unknown 
HeadInj Char $4. Head Injury Definite evidence of a significant head 
injury (i.e.  serious enough to involve loss 
of consciousness) (lifetime) 
No; Yes; Unk Unk = Unknown 
AbnoBED Char $4. Abnormal Birth or Early 
Development 
Definite evidence of clinically significant 
birth complications during individual’s 
birth, or definite delayed developmental 
milestones 
No; Yes; Unk Unk = Unknown 
IntDis Char $4. Intellectual Disability Intellectual disability: IQ assessed <75 No; Yes; Unk Unk = Unknown 
Alcohol Char $4. Alcohol Use Disorder DSMIV lifetime alcohol abuse and/or 
dependence 
No; Yes; Unk Unk = Unknown 
Cannabis Char $4. Cannabis Use Disorder DSMIV lifetime cannabis abuse and/or 
dependence 
No; Yes; Unk Unk = Unknown 
OthDrug Char $4. Other Drug Use Disorder DSMIV lifetime other illicit drug abuse 
and/or dependence 
No; Yes; Unk Unk = Unknown 
DrugType Char $60. Illicit Drug Use Disorder 
Type 
Types of illicit drugs for which the 
individual meets the DSMIV criteria for 
lifetime abuse and/or dependence 
Text field Blank for all individuals where OthDrug is not ‘Yes’ 
Suicide Char $4. Suicide Attempts Whether the individual has ever 
attempted suicide 
No; Yes; Unk Unk = Unknown 
SerInt Char $4. Serious Suicidal Intent Whether the individual’s most 
serious/severe suicide attempt involved 
serious intent to die 
No; Yes; Unk; N/A Unk = Unknown 
N/A = Not applicable, no suicide attempts 
FinDel Char $4. Final Delusions Definite (lifetime) presence of delusions No; Yes; Unk Unk = Unknown 
SevCuDel Char $8. Severity of Current 
Delusions 
Severity of current delusions (past 30 
days) 
None; Question; Mild; 
Moderate; Marked; 
Severe; Unknown 
‘Question’ category usually grouped with ‘Unknown’ category for analyses 
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BizDel Char $4. Bizarre Delusions Presence (lifetime) of definitely bizarre 
delusions 
No; Yes; Unk Unk = Unknown 
BIWDel Char $4. Broadcast/Insertion/Withd
rawal Delusions 
Presence (lifetime) of thought 
broadcast/insertion/withdrawal delusions 
No; Yes; Unk Unk = Unknown 
ContDel Char $4. Control Delusions Presence (lifetime) of delusions of control 
of thought or actions 
No; Yes; Unk Unk = Unknown 
PersDel Char $4. Persecutory Delusions Presence (lifetime) of persecutory 
delusions 
No; Yes; Unk Unk = Unknown 
RefDel Char $4. Referential delusions Presence (lifetime) of delusions of 
reference 
No; Yes; Unk Unk = Unknown 
JealDel Char $4. Jealousy Delusions Presence (lifetime) of delusions of 
jealousy 
No; Yes; Unk Unk = Unknown 
GuSinDel Char $4. Guilt/Sin Delusions Presence (lifetime) of guilt or sin 
delusions 
No; Yes; Unk Unk = Unknown 
GrandDel Char $4. Grandiose delusions Presence (lifetime) of grandiose delusions No; Yes; Unk Unk = Unknown 
ReligDel Char $4. Religious/Magic Delusions Presence (lifetime) of religious delusions 
or delusions of magic 
No; Cul; Yes; Unk Cul = Culturally acceptable (non-delusional) beliefs 
Unk = Unknown 
SomatDel Char $4. Somatic Delusions Presence (lifetime) of somatic delusions No; Yes; Unk Unk = Unknown 
ErotoDel Char $4. Erotomanic Delusions Presence (lifetime) of erotomanic 
delusions 
No; Yes; Unk Unk = Unknown 
MindRDel Char $4. Mind Reading Delusions Presence (lifetime) of delusions of mind 
reading (of individual’s mind by others) 
No; Yes; Unk Unk = Unknown 
FinHal Char $4. Final Hallucinations Definite (lifetime) presence of 
hallucinations 
No; Yes; Unk Unk = Unknown 
SevCuHal Char $8. Severity of Current 
Hallucinations 
Severity of current hallucinations (past 30 
days) 
None; Question; Mild; 
Moderate; Marked; 
Severe; Unknown 
‘Question’ category usually grouped with ‘Unknown’ category for analyses 
AuditHal Char $4. Auditory hallucinations Presence (lifetime) of auditory 
hallucinations 
No; Yes; Unk Unk = Unknown 
ComTPHal Char $4. Commentary/3rd Person 
Auditory Hallucinations 
Presence (lifetime) of auditory 
hallucinations involving commentary or 
third person conversations between 
voices 
No; Yes; Unk Unk = Unknown 
VisHal Char $4. Visual Hallucinations Presence (lifetime) of visual hallucinations No; Yes; Unk Unk = Unknown 
OlGusHal Char $4. Olfactory/Gustatory 
Hallucinations 
Presence (lifetime) of olfactory or 
gustatory hallucinations 
No; Yes; Unk Unk = Unknown 
SomatHal Char $4. Somatic/Tactile 
Hallucinations 
Presence (lifetime) of somatic/tactile 
hallucinations 
No; Yes; Unk Unk = Unknown 
DisorgSp Char $4. Disorganised Speech Definite (lifetime) presence of 
disorganised speech/positive formal 
thought disorder 
No; Yes; Unk Unk = Unknown 
SevCuDS Char $8. Severity of Current 
Disorganised Speech 
Severity of current disorganised 
speech/positive formal thought disorder 
(past 30 days) 
None; Question; Mild; 
Moderate; Marked; 
Severe; Unknown 
‘Question’ category usually grouped with ‘Unknown’ category for analyses 
DisorgBe Char $4. Disorganised/Catatonic 
Behaviour 
Definite (lifetime) presence of 
disorganised/catatonic behaviour 
No; Yes; Unk Unk = Unknown 
SevCuDB Char $8. Severity of Current Severity of current disorganised/catatonic None; Question; Mild; ‘Question’ category usually grouped with ‘Unknown’ category for analyses 
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Disorganised Behaviour behaviour (past 30 days) Moderate; Marked; 
Severe; Unknown 
NegatSym Char $4. Negative Symptoms Definite (lifetime) presence of negative 
symptoms 
No; Yes; Unk Unk = Unknown 
AffFlat Char $8. Affective Flattening Severity of current affective 
flattening/inappropriate affect (past 30 
days) 
None; Question; Mild; 
Moderate; Marked; 
Severe; Unknown 
‘Question’ category usually grouped with ‘Unknown’ category for analyses 
Alogia Char $8. Alogia Severity of current alogia/negative 
thought disorder (past 30 days) 
None; Question; Mild; 
Moderate; Marked; 
Severe; Unknown 
‘Question’ category usually grouped with ‘Unknown’ category for analyses 
Avolit Char $8. Avolition/Apathy Severity of current avolition/apathy (past 
30 days) 
None; Question; Mild; 
Moderate; Marked; 
Severe; Unknown 
‘Question’ category usually grouped with ‘Unknown’ category for analyses 
Anhed Char $8. Anhedonia/Asociality Severity of current anhedonia/asociality 
(past 30 days) 
None; Question; Mild; 
Moderate; Marked; 
Severe; Unknown 
‘Question’ category usually grouped with ‘Unknown’ category for analyses 
WLGAF Char $8. Worst Lifetime Global 
Assessment of Function 
Lowest (lifetime) rating on the Global 
Assessment of Function Scale 
Mild; Moderate; Severe; 
Unknown 
Mild = 61-80 
Moderate = 31-60 
Severe = 1-30 
CurrGAF Char $8. Current Global Assessment 
of Function 
Current (past 30 days) rating on the 
Global Assessment of Function Scale 
None; Mild; Moderate; 
Severe; Unknown 
None = 81-100 
Mild = 61-80 
Moderate = 31-60 
Severe = 1-30 
IllCour Char $4. Illness Course Categorical illness course, as defined in 
the DIGS 
1; 2; 3; 4; 5; 6 1 = Episodic with interepisode residual symptoms 
2 = Episodic with no interepisode residual symptoms 
3 = Continuous 
4 = Single episode in partial remission 
5 = Single episode in full remission 
6 = Other, unspecified, unknown course 
SymptPat Char $4. Symptom Pattern Relationship between positive and 
negative symptoms throughout the 
course of the illness, as defined in the 
DIGS 
1; 2; 3; 5; U 1 = Continuously positive 
2 = Predominantly negative 
3 = Positive converting to negative 
4 = Negative converting to positive (0 observations coded ‘4’) 
5 = Continuous mixture of positive and negative symptoms 
U = Unknown 
SevPat Char $4. Severity Pattern Pattern of severity of decline in 
functioning over the course of the illness, 
as defined in the DIGS 
1; 2; 3; 4; U 1 = Episodic shift (no deterioration when not actively unwell) 
2 = Mild deterioration 
3 = Moderate deterioration 
4 = Severe deterioration 
U = Unknown 
Onset Char $8. Onset of Psychosis Rapidity of prodromal period (between 
noticeable social/occupational decline 
and definite onset of psychosis) 
Abrupt; Acute; 
ModAcute; Gradual; 
Unknown 
Abrupt = within a day 
Acute = within a week 
ModAcute = within a month 
Gradual = Longer than one month 
FinDEP Char $4. Final Depression Definite (lifetime) presence of at least one 
DSMIV major depressive episode 
No; Yes; Unk Unk = Unknown 
DepMood Char $4. Depressed Mood Persistent depressed mood for 2+ weeks No; Yes; Unk Unk = Unknown 
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(DSMIV depression symptom – either 
depressed mood or anhedonia must be 
present for a major depressive episode) 
DepAnh Char $4. Anhedonia (Depression) Persistent anhedonia for 2+ weeks 
(DSMIV depression symptom – either 
depressed mood or anhedonia must be 
present for a major depressive episode) 
No; Yes; Unk Unk = Unknown 
AWChange Char $4. Appetite/Weight Change Significant appetite and/or weight change 
during depression (DSMIV depression 
symptom) 
No; Yes; Unk Unk = Unknown 
SleepDis Char $4. Sleep Disturbance Significant sleep pattern disturbance – 
either trouble sleeping or sleeping too 
much during depression (DSMIV 
depression symptom) 
No; Yes; Unk Unk = Unknown 
PsyChang Char $4. Psychomotor Change Psychomotor agitation or retardation 
during depression (DSMIV depression 
symptom) 
No; Yes; Unk Unk = Unknown 
FatLosEn Char $4. Fatigue/Energy Loss Fatigue or loss of energy during 
depression (DSMIV depression symptom) 
No; Yes; Unk Unk = Unknown 
WorGuilt Char $4. Worthlessness/Guilt Persistent feelings of worthlessness or 
guilt during depression (DSMIV 
depression symptom) 
No; Yes; Unk Unk = Unknown 
DecConc Char $4. Decreased Concentration Decreased concentration during 
depression (DSMIV depression symptom) 
No; Yes; Unk Unk = Unknown 
DeathSui Char $4. Thoughts of Death/Suicide Persistent thoughts of death or suicide 
during depression (DSMIV depression 
symptom) 
No; Yes; Unk Unk = Unknown 
DepCount Char $4. Count of Depressive 
Symptoms 
Count of DSMIV depressive symptoms 
used to establish the presence/absence of 
an episode (0-9) 
0-9 Symptoms are operationalised to correspond with the DSMIV diagnostic 
criteria. 5+ required, one of which must be depressed mood or anhedonia 
(although presence of symptoms concurrently does not guarantee a 
positive rating for an episode due to time criterion). 
FinMania Char $4. Final mania Definite (lifetime) presence of at least one 
DSMIV manic episode 
No; Yes; Unk Unk = Unknown 
ElevMood Char $4. Elevated/Elated mood Elated mood for 1+ week (or any duration 
if hospitalised) (either elated or irritable 
mood must be present for a DSMIV manic 
episode) 
No; Yes; Unk Unk = Unknown 
IrriMood Char $4. Irritable mood Irritable mood for 1+ week (or any 
duration if hospitalised) (either elated or 
irritable mood must be present for a 
DSMIV manic episode) 
No; Yes; Unk Unk = Unknown 
Grandios Char $4. Grandiosity Grandiosity/inflated self-esteem (DSMIV 
manic symptom) 
No; Yes; Unk Unk = Unknown 
DecSleep Char $4. Decreased Need for Sleep Decreased need for sleep – feels rested 
on little or no sleep (DSMIV manic 
symptom) 
No; Yes; Unk Unk = Unknown 
PrSpeech Char $4. Pressured Speech More talkative or pressured speech No; Yes; Unk Unk = Unknown 
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(DSMIV manic symptom) 
RacingTh Char $4. Racing Thoughts/Flight of 
Ideas 
Flight of ideas or subjective racing 
thoughts (DSMIV manic symptom) 
No; Yes; Unk Unk = Unknown 
Distract Char $4. Distractibility Distractibility (DSMIV manic symptom) No; Yes; Unk Unk = Unknown 
PsychAgi Char $4. Psychomotor Agitation Increased goal-oriented activity or 
psychomotor agitation (DSMIV manic 
symptom) 
No; Yes; Unk Unk = Unknown 
RiskyBe Char $4. Risky Behaviour Excessive risky pleasurable behaviour 
(DSMIV manic symptom) 
No; Yes; Unk Unk = Unknown 
ManCount Char $4. Count of Manic Symptoms Count of DSMIV manic symptoms used to 
establish the presence/absence of an 
episode (0-7) 
0-7 Symptoms are operationalised to correspond with the DSMIV diagnostic 
criteria. 3+ required (if elevated mood is present), 4+ required (if only 
irritable mood is present). One of elevated or irritable mood is essential for 
a manic episode (note: the presence of symptoms concurrently does not 
guarantee a positive rating for an episode due to time criterion). 
CuAntMed Char $4. Current Antipsychotic 
medication 
Whether the individual is definitely taking 
antipsychotic medication at the time of 
assessment 
No; Yes; Unk Unk = Unknown 
Clozstat Char $3. Clozapine Status Whether the individual is definitely taking 
clozapine at the time of assessment 
No; Yes Only rated yes if there was clear evidence for current clozapine 
prescription and compliance, otherwise rated no. 
TreatRes Char $4. Treatment Resistant Whether the individual meets strictly 
defined criteria for treatment resistance 
No; Yes Criteria for treatment resistance were formulated in consultation with the 
treatment resistance literature. The binary coding favoured negative 
ratings; we acknowledge that some treatment resistant individuals will be 
rated ‘no’, but we are confident that all individuals who rate ‘yes’ are 
definitely treatment resistant. 
Criterion 1: Two of Delusions, Hallucinations, Disorganisation, and 
Negative Symptoms must rate positive. 
Criterion 2: CurrGAF must be ‘Moderate’ or ‘Severe’ 
Criterion 3: IllCour must be ‘3’ (continuous) 
Criterion 4: SevPat must be 3 (moderate) or 4 (severe) 
Criterion 5: CuAntMed must be ‘Yes’ 
To rate positive, each dimension in criterion 1 must rate as follows: 
Delusions: SevCuDel must be ‘Moderate’, ‘Marked’, or ‘Severe’ 
Hallucinations: SevCuHal must be ‘Moderate’, ‘Marked’, or ‘Severe’ 
Disorganisation: Either SevCuDS or SevCuDB must be ‘Moderate’, 
‘Marked’, or ‘Severe’ 
Negative Symptoms: Two of AffFlat, Alogia, Avolit, and Anhedonia must be 
‘Moderate’, ‘Marked’, or ‘Severe’ 
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Appendix C: Establishing and Confirming Data Source and Formatting Equivalence 
 
Establishing data source equivalence was a nine step process. 
 
DE-1. Set inclusion criteria 
Preliminary inclusion criteria and the framework for a comprehensive data search were set 
based on the candidate’s prior knowledge of existing datasets, and in consultation with 
Professor Mowry, who reviewed all cases across the three sites. Broadly, individuals with 
a confirmed DSM-IV diagnosis of schizophrenia or schizoaffective disorder would be the 
target of the search, since all included individuals in the two Molecular Genetics of 
Schizophrenia studies in Australia (MGS1, MGS2) had these diagnoses, all included 
probands in the Indian sample had these diagnoses, and approximately 83% of Iban 
individuals included in the detailed pedigree subset had these diagnoses. These samples 
would form the basis for the three ethnically distinct samples compared in this thesis. 
 
DE-2. Identify all available individuals and map data sources 
The candidate searched all available sources (electronic and paper) and compiled a list of 
every individual ID/code number. At this stage, all individuals were retained, and potential 
errors, inconsistencies and duplicates were flagged for follow up. Concurrently, as the ID 
list was being compiled, a map of all data sources where demographic, clinical, symptom, 
illness course, and (crucially) diagnostic information was available was also compiled. This 
data map was continually updated, and formed the ‘backbone’ of the search strategy. 
 
At this stage, the sample included 819 Australian individuals (167 from MGS1 and 652 
individuals from MGS2), 524 Indian individuals, and 486 Iban individuals (comprising all 
those included in the general screening sample – of which the 192 detailed pedigree group 
was a subset). Two additional individuals from MGS 1 in Australia were later also included 
who had been excluded from the genetic study due to a problem with their DNA samples 
but for whom all data needed for this thesis were available. 
 
DE-3. Catalogue data source availability for each individual 
Availability of each of the six major data types (DIGS interview, FIGS interview, medical 
records, narrative summary, consensus diagnosis, and Lifetime Dimensions of Psychosis 
Scale (LDPS)) was catalogued (initially in Microsoft Excel) for each ID number. Availability 
categories were set as: 0=No; 1=Yes (electronic); 2=Yes (hard copy only); 3=Yes (proof of 
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existence but unable to locate); 9=Unknown. This complete data set complemented, and 
was used in conjunction with the data map created in step two. 
 
DE-4. Quarantine all ‘potentially useful’ electronic files 
All electronic files identified in the data map (step two) were copied and ‘quarantined’ by 
the candidate. From this point forward, all work relating to the thesis was undertaken on 
these files only. This ensured that there was consistency in the data used, and that later 
changes to files available to individuals other than the candidate would not cause 
problems in data cleaning and future analyses. Twenty six electronic files were mapped 
and quarantined, with all included tables and worksheets catalogued. 
 
DE-5. Confirm accuracy of all ID numbers 
The candidate consulted all data sources (both electronic and hard copy) to confirm the 
accuracy of all ID numbers, resolving all conflicts identified in step two, and 
(conservatively) dropping all IDs from the dataset that could not be confirmed or were 
ambiguous. 
 
DE-6. Confirm DSM-IV diagnoses for all ID numbers 
The candidate checked the DSM-IV diagnoses for all included ID numbers and excluded 
all individuals whose schizophrenia/schizoaffective diagnosis could not be confirmed. This 
step included reading all narrative summaries and consensus diagnosis sheets across the 
three sites. 
 
After this step, the available sample consisted of 821 Australian individuals, 520 Indian 
individuals, and 298 individuals from Sarawak (total n=1639). 
 
DE-7. Identify target variables  
The candidate next defined an initial set of demographic, clinical and symptom variables in 
consultation with Professor Mowry that were both useful and feasible to extract based on 
available data sources. This process relied heavily on multiple DIGs interview variable 
indexes (data dictionaries) that had previously been compiled by the candidate for both the 
Australian and Indian samples. This guided variable extraction for Chapter Three; although 
the final master file eventually contained 89 distinct variables (see Appendix B). 
 
DE-8. Create SAS master file 
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The candidate created a dataset (master file) in SAS with 1639 unique IDs, comprising all 
included individuals confirmed in step six. While the above steps were completed (a 
protracted process), the candidate had learned SAS coding, as this package was 
determined to be the most appropriate for the planned analyses, given the expertise 
available within Professor Mowry’s team, the format of other analyses utilising these 
samples, and the licenses available to the candidate. 
 
DE-9. Confirm data source availability for each included individual 
Prior to the commencement of data extraction, the candidate rechecked data source 
availability for each final ID number (repeating step 3). This additionally served as an ‘error 
check’ of previous steps. 
 
Once all available data for all included individuals had been identified and located, the 
extraction, cleaning and formatting of variables was systematically undertaken as a nine 
step process.  
 
CF-1. Set SAS rules and coding conventions 
The candidate, in consultation with Professor Mowry, Professor McGrath, and Dr. McLean, 
devised a ‘set’ of SAS rules, coding conventions and real-time error checking steps to 
ensure systematic cleaning, importing, and merging of variables. 
 
All SAS files (datasets) were divided, saved, and interrogated in three general categories: 
raw files – datasets as extracted from quarantined files (e.g. from Excel workbooks, 
Access tables); intermediate files – datasets that had been worked on in SAS but were not 
cleaned or merged into a final form; and merged files – datasets that had been cleaned 
and merged in SAS. All analyses for Chapters Three to Six were conducted only on 
merged datasets. 
 
The general strategy (detailed below) involved the following steps: 1. Extract given 
variable in Australia (MGS1); 2. Extract given variable in Australia (MGS2); 3. Extract 
given variable in India; 4. Extract given variable in Sarawak (General screen); 5. Extract 
given variable in Sarawak (pedigree subset); 6. Merge the five subsets into a single 
variable set; and 7. Append the variable onto the master set. 
 
CF-2. Convert relevant quarantined data files into SAS datasets 
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Potentially important tables and worksheets were previously identified and catalogued 
when all relevant files were quarantined (see above). Each table and worksheet was 
imported into SAS as an individual dataset, and stored as a ‘raw’ file.  
 
CF-3. Extract each variable 
Eighty-nine variables (eighty-six excluding ID numbers and site) were extracted, one at a 
time, for each unique individual (ID) in Australia, then India, then Sarawak. Data were 
imported from available electronic sources first, then manually extracted from hard 
copy/paper sources. No coding decisions were made at this stage. 
 
CF-4. Clean each variable 
All unknown values, missing values, and outliers were then interrogated (using logic 
checks in SAS built into the rules and coding conventions). All available sources were 
consulted to extract previously missing values and resolve conflicts. Generally, in cases 
where there was any doubt over the veracity of a given value, that data point was rated 
either down, absent or unknown (as appropriate for the variable). Details of cleaning 
modifications were meticulously recorded in SAS code notes. 
 
CF-5. Recode each variable as required 
Variable value sets were set to those of the ‘least detailed’ site, and ‘scoring’ of data points 
was modified as necessary to ensure that the same variable represented the same 
concept across the three datasets/sites. In practice, that meant that some detail was 
necessarily lost, particularly at the Australian site. For example, where a severity rating for 
a symptom variable was available in Australia and India, but only the lifetime presence of 
that symptom was available in Sarawak, the Australian and Indian datasets were recoded 
to present/absent for the purposes of site comparisons. Details of recoding modifications 
were meticulously recorded in SAS code notes. 
 
CF-6. Merge each variable across sites 
Once coding was consistent across sites, all observations for each of the five data subsets 
(Australia MGS1, Australia MGS2, India, Sarawak general screen, and Sarawak detailed 
pedigree subset) were appended into a single variable data set. The two Australian 
subsets were appended to each other, the two Sarawak subsets were appended to each 
other, and then the Indian set was appended to the Australian set, and the Sarawak set 
was appended to the Australian/Indian set. Checks were then conducted to ensure that 
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each of the 1639 unique IDs had a valid value for the variable, and random records were 
checked with source data (e.g. narrative summaries, consensus sheets) to ensure the 
correct value was recorded for the given variable. 
 
CF-7. Append each variable to master dataset 
Once a given variable was ‘cleaned’, ‘checked’, and all sites were merged into a single 
‘column’, the variable was appended (by unique ID) onto the latest iteration of a master 
dataset in SAS. The file was then interrogated for any missing values, as a check that the 
merge had executed correctly. 
 
CF-8. Build master dataset 
Steps three to seven were repeated for each variable requiring extraction. 
  
CF-9. Record audits 
Random audits of records were undertaken during each iteration of the SAS master file. 
This ensured that any unintended coding anomalies (as opposed to coding errors that 
were routinely picked up by the SAS software itself) were identified and rectified at the 
earliest opportunity. For example, it is possible in SAS to merge datasets without correctly 
sorting/specifying the variable to merge ‘by’, without triggering a SAS error. The result is a 
‘decoupling’ of IDs and associated data points. Record audits ensured that errors such as 
these were not perpetuated through the master file. 
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Appendix D 
McLean D, John S, Barrett R, McGrath J, Loa P, Thara R and Mowry B (2012) Refining 
clinical phenotypes by contrasting ethnically different populations with schizophrenia from 
Australia, India and Sarawak. Psychiatry Research 196(2-3): 194-200. 
 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&
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Comparing schizophrenia symptoms in the Iban of Sarawak with other populations to 
elucidate clinical heterogeneity. Asia-Pacific Psychiatry 7(1): 36-44. 
 
http://www.ncbi.nlm.nih.gov/pubmed/24038814 
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Appendix F 
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“criterion A” schizophrenia symptoms across ethnically different populations: evidence for 
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Psychiatry 38(3): 408-426. 
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